SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
(Mark One)
ý |
|
ANNUAL REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE
|
For the Fiscal Year Ended December 31, 2003 |
|
Commission File No. 1-9328 |
o |
|
TRANSITION REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE
|
For the transition period from to
ECOLAB INC.
(Exact name of registrant as specified in its charter)
Delaware |
|
41-0231510 |
(State or other jurisdiction of incorporation or organization) |
|
(I.R.S. Employer Identification No.) |
|
|
|
370 Wabasha Street North, St. Paul, Minnesota |
|
55102 |
(Address of principal executive offices) |
|
(Zip Code) |
Registrants telephone number, including area code: (651) 293-2233
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class |
|
Name of Each Exchange on Which Registered |
|
|
|
Common Stock, $1.00 par value |
|
New York Stock Exchange, Inc. |
|
|
Pacific Exchange, Inc. |
|
|
|
Preferred Stock Purchase Rights |
|
New York Stock Exchange, Inc. |
|
|
Pacific Exchange, Inc. |
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
YES ý NO o
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrants knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. o
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act). Yes ý No o
Aggregate market value of voting and non-voting common equity held by non-affiliates of Registrant on June 30, 2003: $6,634,889,062 (see Item 12, under Part III hereof).
The number of shares of Registrants Common Stock, par value $1.00 per share, outstanding as of February 27, 2004: 257,215,105 shares.
DOCUMENTS INCORPORATED BY REFERENCE
1. Portions of the Registrants Annual Report to Stockholders for the year ended December 31, 2003 (hereinafter referred to as Annual Report) are incorporated by reference into Parts I, II and IV.
2. Portions of the Registrants Proxy Statement for the Annual Meeting of Stockholders to be held May 7, 2004 and to be filed within 120 days after the Registrants fiscal year ended December 31, 2003 (hereinafter referred to as Proxy Statement) are incorporated by reference into Part III.
TABLE OF CONTENTS
Except where the context otherwise requires, references in this report to either Ecolab, Company, we and our are to Ecolab Inc. and its subsidiaries, collectively.
Forward-Looking Statements and Risk Factors
The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements. In this Report on Form 10-K (including Managements Discussion and Analysis of Financial Condition and Results of Operations incorporated into Item 7 hereof), Management discusses expectations regarding our future performance which include anticipated business progress and expansion, business acquisitions, debt repayments, susceptibility to changes in technology, global economic conditions and liquidity requirements. Without limiting the foregoing, words or phrases such as will likely result, are expected to, will continue, is anticipated, we believe, estimate, project (including the negative or variations thereof) or similar terminology, generally identify forward-looking statements. Additionally, we may refer to this section of the Form 10-K to identify risk factors related to other forward looking statements made in oral presentations, including telephone conferences and/or webcasts open to the public.
Forward-looking statements represent challenging goals for us. As such, they are based on current expectations and are subject to certain risks and uncertainties. We caution that undue reliance should not be placed on such forward-looking statements which speak only as of the date made. In order to comply with the terms of the safe harbor, we identify for investors important factors which could affect our financial performance and could cause actual results for future periods to differ materially from the anticipated results or other expectations expressed in the forward-looking statements.
Risks and uncertainties that may affect operating results and business performance include: the vitality of the foodservice, hospitality and travel industries; restraints on pricing flexibility due to competitive factors and customer and vendor consolidations; changes in oil or raw material prices or unavailability of adequate and reasonably priced raw materials; the occurrence of capacity constraints or the loss of a key supplier; the effect of future acquisitions or divestitures or other corporate transactions; our ability to achieve plans for past acquisitions; the costs and effects of complying with: (i) laws and regulations relating to the environment and to the manufacture, storage, distribution, efficacy and labeling of our products, and (ii) changes in tax, fiscal, governmental and other regulatory policies; economic factors such as the worldwide economy, interest rates, and currency movements including, in particular, our exposure to foreign currency risk; the occurrence of (a) litigation or claims, (b) the loss or insolvency of a major customer or distributor, (c) war, (d) natural or manmade disasters (including material acts of terrorism or hostilities which impact our markets) and (e) severe weather conditions or public health epidemics affecting the foodservice, hospitality and travel industries; loss of, or changes in, executive management; our ability to continue product introductions and technological innovations; and other uncertainties or risks reported from time to time in our reports to the Securities and Exchange Commission. In addition, we note that our stock price can be affected by fluctuations in quarterly earnings. There can be no assurances that our earnings levels will meet investors expectations. Ecolab undertakes no duty to update its Forward-Looking Statements.
2
Item 1. Business
Item 1(a) General Development of Business
Ecolab was incorporated as a Delaware corporation in 1924. Our fiscal year is the calendar year ending December 31.
On November 30, 2001, we acquired the 50 percent of the Henkel-Ecolab joint venture (Henkel-Ecolab) which we did not previously own (the JV Acquisition), from our former joint venture partner, Henkel KGaA, Düsseldorf, Germany (Henkel).
Prior to the JV Acquisition, we accounted for our interest in Henkel-Ecolab under the equity method of accounting. As a result of the JV Acquisition, the legal entities constituting Henkel-Ecolab became wholly-owned entities of Ecolab. Following the JV Acquisition, the assets, liabilities, revenues, expenses and cash flows of Henkel-Ecolab are reflected in our consolidated financial statements as a part of the International Cleaning & Sanitizing reportable segment.
During 2003, we continued to make business acquisitions and divestitures to broaden our product and service offerings, or to dispose of non-strategic businesses, in line with our Circle the Customer Circle the Globe strategy. These transactions included:
Subsequent to the 2002 year-end of our International Operations, we entered the hospital hygiene market in the U.K. by acquiring the Adams Healthcare business of Medical Solutions plc in December 2002.
In December 2002, we sold Darenas, a U.K. janitorial products distribution business.
In June 2003, we sold our investment in Comac S.p.A. of Italy, a floor care machine manufacturing company.
In September 2003, we sold a U.K. consumer dermatology business obtained as part of Adams Healthcare.
Additional details regarding the JV Acquisition and these other transactions are found in Notes 5 and 6, located on pages 38 through 40 of the Annual Report and incorporated into Item 8 hereof.
Effective January 2004, we reorganized our businesses serving janitorial and healthcare customers by splitting the Professional Products group into two divisions, Professional Products and Healthcare.
In January 2004, we expanded our Pest Elimination business into France by acquiring Nigiko, a Paris-based business that primarily operates through Amboile Services.
In February 2004, we acquired Daydots International, a provider of food safety products, for our U.S. Cleaning & Sanitizing Operations.
Item 1(b) Financial Information About Operating Segments
The financial information about reportable segments appearing under the heading Operating Segments in Note 16, located on page 48 of the Annual Report, is incorporated herein by reference.
3
Item 1(c) Narrative Description of Business
General: Ecolab develops and markets premium products and services for the hospitality, foodservice, institutional and industrial markets. We provide cleaning, sanitizing, pest elimination, maintenance and repair products, systems and services primarily to hotels and restaurants, healthcare and educational facilities, quick-service (fast-food and other convenience store) units, grocery stores, commercial and institutional laundries, light industry, dairy plants and farms, food and beverage processors, pharmaceutical and cosmetics facilities and the vehicle wash industry. A strong commitment to customer support is a distinguishing characteristic of Ecolab. Additional information on our business philosophy is found below under the heading Additional Information - Competition of this Item 1(c).
The following description of business is based upon our three reportable segments (segments) as reported in Ecolabs consolidated financial statements. However, the Company pursues a Circle the Customer - Circle the Globe strategy by providing products, systems and services which serve our customer base, and does so on a global basis to meet the needs of our customers various operations around the world. Therefore, one customer may utilize the services of all three of the segments and there is a degree of interdependence among the operating segments - particularly between the International Cleaning & Sanitizing and the United States Cleaning & Sanitizing businesses.
The United States Cleaning & Sanitizing segment is comprised of seven divisions which provide cleaning and sanitizing services to United States markets.
Institutional : Our Institutional Division is our largest division and sells specialized cleaners and sanitizers for washing dishes, glassware, flatware, foodservice utensils and kitchen equipment (warewashing), for on-premise laundries (typically used by hotel and health care customers) and for general housekeeping functions, as well as dishwasher racks and related kitchen sundries to the foodservice, lodging, educational and healthcare industries and water filters to the foodservice industry. The Institutional Division also provides pool and spa treatment programs for commercial and hospitality customers and, through its Facilitec business, provides rooftop grease filter products and kitchen exhaust cleaning services for restaurants and other foodservice operations. The Institutional Division also manufactures and markets various chemical dispensing device systems, which are made available to customers, to dispense the Companys cleaners and sanitizers. In addition, the Institutional Division markets primarily to smaller and mid-size customer units, a program comprised of energy-efficient dishwashing machines, detergents, rinse additives and sanitizers, including full machine maintenance.
We believe we are the leading supplier of chemical warewashing products to institutions in the United States.
The Institutional Division sells its products and services primarily through Company-employed field sales-and-service personnel. However, to a significant degree, we also utilize independent, third-party foodservice distributors to market and sell our products to smaller accounts or accounts which purchase through food distributors. We provide the same service to accounts served by food distributors as to direct customers.
Kay : Our Kay Division (which consists of certain wholly-owned subsidiaries of Ecolab Inc.) supplies chemical cleaning and sanitizing products primarily to the quick-service restaurant industry. This includes traditional fast-food restaurants but also other retail locations where fast food is
4
prepared and served, such as convenience stores, airport and shopping center kiosks and other public venues typically serviced by national or regional restaurant chains. Kay also sells cleaning and sanitizing products to the food retail (i.e., grocery store) industry. Kays products include specialty and general purpose hard surface cleaners, degreasers, sanitizers, polishes, hand care products and assorted cleaning tools. Products are sold under the Kay brand or the customers private label. In addition, Kay supports its product sales with employee training programs and technical support designed to meet the special needs of its customers. Kays customized cleaning and sanitation programs are designed to reduce labor costs and product usage while increasing sanitation levels, cleaning performance, equipment life and safety levels.
Kay employs a direct field sales force which primarily calls upon national and regional quick-service restaurant and food retail chains and franchisees, although the sales are made to distributors who supply the chain or franchisees units.
We believe that our Kay Division is the leading supplier of chemical cleaning and sanitizing products to the traditional quick-service restaurant industry in the United States. While Kays customer base has been growing, Kays business is largely dependent upon a limited number of major quick-service restaurant chains and franchisees.
Food & Beverage : Our Food & Beverage Division addresses cleaning and sanitation at the start of the food chain to facilitate the production of products for human consumption. The Division provides detergents, cleaners, sanitizers, lubricants and animal health products, as well as cleaning systems, electronic dispensers and chemical injectors for the application of chemical products, primarily to dairy plants, dairy farms, breweries, soft-drink bottling plants, and meat, poultry and other food processors as well as to pharmaceutical and cosmetic plants. The Division also markets food irradiation services through an alliance with Ion Beam Applications (IBA). The Food & Beverage Division also designs, engineers and installs CIP (clean-in-place) process control systems and facility cleaning systems for its customer base. Farm products are sold through dealers and independent, third-party distributors, while plant products are sold primarily by our field sales personnel.
We believe that we are one of the leading suppliers of cleaning and sanitizing products to the dairy plant, dairy farm, food, meat and poultry, and beverage/brewery processor industries in the United States.
Textile Care : Our Textile Care Division provides chemical laundry products and proprietary dispensing systems, as well as related services, to large industrial and commercial laundries. Typically these customers process a minimum of 1,000,000 pounds of linen each year and include free-standing laundry plants used by institutions such as hotels, restaurants and healthcare facilities as well as industrial and textile rental laundries. The Division also serves the shirt laundry market, typically comprised of smaller laundry units. Products and services include laundry cleaning and specialty products and related dispensing equipment, which are marketed primarily through a Company-employed sales force and, to a lesser extent, through independent, third-party distributors. The Divisions programs are designed to meet our customers need for exceptional cleaning, while extending the useful life of linen and reducing the customers overall operating cost.
Professional Products: The Professional Products Division provides a broad range of janitorial and infection prevention/healthcare offerings to the janitorial and medical markets in the United States. Effective January 2004, we reorganized our businesses serving janitorial and healthcare customers by splitting the Professional Products group into two divisions, Professional Products and Healthcare. Professional Products proprietary janitorial products (detergents, general purpose cleaners, carpet care, furniture polishes, disinfectants, floor care products, hand soaps and odor counteractants) are sold primarily under the brand name Airkem. These products are sold
5
primarily through a network of independent, third-party distributors, supported by a Company-employed sales force. Healthcares proprietary infection prevention/healthcare products (skin care, disinfectants and instrument sterilants) are sold primarily under the Huntington brand name.
Vehicle Care: Our Vehicle Care Division provides vehicle appearance products which include soaps, polishes, wheel and tire treatments and air fresheners. Products are sold to vehicle rental, fleet and consumer car wash and detail operations. Brand names utilized by the Vehicle Care Division include Blue Coral Ò , Black Magic Ò and Rain-X Ò .
Water Care Services : Our Water Care Services Division supplements our Circle the Customer - Circle the Globe strategy by offering water treatment programs that are critical to our customer base. Water Care Services provides water and wastewater treatment products, services and systems for commercial/institutional customers (full service hotels, cruise ships, hospitals, healthcare, commercial real estate, government, and commercial laundries), food and beverage customers (dairies, meat, poultry, food processing and beverage) and other light industry. Water Care Services works closely with the our Institutional, Textile Care and Food & Beverage Divisions to offer customized water care strategies to their accounts that have water care needs, primarily to treat water used in heating and cooling systems and manufacturing processes and to treat wastewater.
The United States Other Services segment is comprised of two business units: Pest Elimination and GCS Service. In general, these businesses provide service or equipment which can augment or extend our product offering to our business customers as a part of our Circle the Customer approach.
Pest Elimination : Our Pest Elimination Division provides services for the detection, elimination and prevention of pests to restaurants, food and beverage processors, educational and healthcare facilities, hotels, quick-service restaurant and grocery operations and other institutional and commercial customers. These services are sold and performed by Company-employed sales and service personnel. In addition, through our EcoSure Food Safety Management business, the Division provides customized on-site evaluations, training and quality assurance services to foodservice operations.
GCS Service : GCS provides commercial kitchen parts and equipment repair services including parts distribution. GCS offers these services to restaurant and other foodservice operations, while providing warranty service for equipment manufacturers. In addition, GCS offers parts at a wholesale level to repair services companies and end users.
The Company conducts business in approximately 70 countries outside of the United States through wholly-owned subsidiaries or, in the case of China, Israel and Venezuela, through majority-owned joint ventures with local partners. In other countries, selected products are sold by our export operations to distributors, agents or licensees, although the volume of those sales is not significant in terms of our overall revenues. Our largest International operations are located in Europe, Asia Pacific, Latin America and Canada, with smaller operations in Africa and the Middle East.
In general, the businesses conducted internationally are similar to those conducted in the United States, although we customize our products and services to meet unique local requirements. The businesses which are similar to the United States Institutional and Food & Beverage businesses are the largest businesses in our International operations. They are conducted in virtually all our International locations and, compared to the United States, constitute a larger portion of the overall
6
business. Kay also has sales in a number of International locations. A significant portion of Kays International sales are to international units of United States-based quick-service restaurant chains. Consequently, a substantial portion of Kays international sales are made either to domestic or internationally-located third-party distributors who serve these chains.
We expanded our Pest Elimination business to the United Kingdom and the Republic of Ireland in September 2002, and to France in January 2004, through acquisitions. In addition, we entered the hospital hygiene market in the United Kingdom by acquiring a supplier of hospital hygiene products in December 2002. Our other businesses are conducted less extensively in our International locations. However, in general, most of the principal businesses conducted in the United States are operated in Canada and Mexico.
International businesses are subject to the usual risks of foreign operations, including possible changes in trade and foreign investment laws, tax laws, currency exchange rates and economic and political conditions abroad. The profitability of our International operations has historically been lower than the profitability of our businesses in the United States. This has been due to the smaller scale of the International operations as well as the additional cost of operating in numerous and diverse foreign jurisdictions.
Additional Information
Competition : Our business units have two significant classes of competitors. First, each business unit competes with a small number of large companies selling directly or through distributors on a national or international scale. Second, all of our business units have numerous smaller regional or local competitors which focus on more limited geographies, product lines and/or end-user segments.
Our objective is to achieve a significant presence in each of our business markets. In general, competition is based on service, product performance and price. We believe we compete principally by providing superior value and differentiated products. Value is provided by state-of-the-art cleaning, sanitation and maintenance products and systems coupled with high customer support standards and continuing dedication to customer satisfaction. This is made possible, in part, by our significant on-going investment in training and technology and by our standard practice of advising customers on means to lower operating costs and comply with safety, environmental and sanitation regulations. In addition, we emphasize our ability to uniformly provide a variety of related premium cleaning and sanitation services to our customers and to provide that level of service to multiple locations of chain customer organizations worldwide. This approach is succinctly stated in our Circle the Customer - Circle the Globe strategy which is discussed above in this Item 1(c) under the heading General.
Sales and Service : Products, systems and services are primarily marketed in domestic and international markets by Company-trained sales and service personnel who also advise and assist our customers in the proper and efficient use of the products and systems in order to meet a full range of cleaning and sanitation needs. Independent, third-party distributors are utilized in several markets, as described in the business unit descriptions found under the discussion of the three reportable segments above.
Customers and Classes of Service : We believe that our business is not materially dependent upon a single customer although, as described above in this Item 1(c) under the description of the Kay business, Kay is largely dependent upon a limited number of national and international quick-service chains and franchisees. Additionally, although we have a diverse customer base and no customer or distributor constitutes ten percent or more of our consolidated revenues, we do have customers and independent, third-party distributors (for example, ARAMARK, Compass, Sodexho, Sysco and U.S. Foodservice), the loss of which could have a material negative effect on results of operations
7
for the affected earnings periods; however, we consider it unlikely that such an event would have a material adverse impact on the financial position of the Company. No material part of our business is subject to renegotiation or termination at the election of a governmental unit. We sell two classes of products which each constitute 10 percent or more of our sales. Sales of warewashing products in 2003, 2002 and 2001 approximated 23, 23 and 26 percent, respectively, of our consolidated net sales. In addition, through our Institutional and Textile Care businesses, we sell laundry products and services to a broad range of laundry customers. Sales of laundry products and services in 2003, 2002 and 2001 approximated 10, 11 and 10 percent, respectively, of our consolidated net sales. Sales of our European operations are reflected in these percentages beginning in 2002.
Patents and Trademarks : We own and license a number of patents, trademarks and other intellectual property, including a license agreement with Henkel KGaA. While we have an active program to protect our intellectual property by filing for patents or trademarks, and pursuing legal action, when appropriate, to prevent infringement, we do not believe that our overall business is materially dependent on any individual patent or trademark.
Seasonality : Overall our business does not have a significant degree of seasonality.
Working Capital : We have invested in the past, and will continue to invest in the future, in merchandising equipment consisting primarily of systems used by customers to dispense our cleaning and sanitizing products. Otherwise, we have no unusual working capital requirements. The investment in merchandising equipment is discussed under the heading Cash Flows located on page 28 of the Annual Report and incorporated into Item 7 hereof.
Manufacturing and Distribution : We manufacture most of our products and related equipment in Company-owned manufacturing facilities. Some products are also produced for us by third-party contract manufacturers, including Henkel KGaA. Other products and equipment are purchased from third-party suppliers. Additional information on product/equipment sourcing is found in the segment discussions above and additional information on our manufacturing facilities is located beginning at page 14 hereof under the heading Properties.
Deliveries to customers are made from our manufacturing plants and a network of distribution centers and public warehouses. We use common carriers, our own delivery vehicles, and distributors. Additional information on our plant and distribution facilities is located beginning at page 14 hereof under the heading Properties.
Raw Materials : Raw materials purchased for use in manufacturing our products are inorganic chemicals, including phosphates, silicates, alkalies, salts and organic chemicals, including surfactants and solvents. These materials are generally purchased on an annual contract basis from a diverse group of chemical manufacturers. When practical, we use global sourcing for production as well as for purchasing raw materials so that our operations can be shifted among locations worldwide to control product costs at globally competitive levels. Pesticides used by our Pest Elimination Division are purchased as finished products under contract or purchase order from the producers or their distributors. We also purchase packaging materials for our manufactured products and components for our specialized cleaning equipment and systems. Most raw materials, or substitutes for those materials, used by us, with the exception of a few specialized chemicals which we manufacture, are available from several suppliers.
Research and Development : Our research and development program consists principally of devising and testing new products, processes, techniques and equipment, improving the efficiency of existing ones, improving service program content, and evaluating the environmental compatibility of products. Key disciplines include analytical and formulation chemistry, microbiology, process and packaging engineering and product dispensing technology. Substantially all of our principal
8
products have been developed by our research, development and engineering personnel. At times, technology has also been licensed from third parties to develop offerings. Note 13, entitled Research Expenditures located on page 44 of the Annual Report, is incorporated herein by reference.
Environmental and Regulatory Considerations : Our businesses are subject to various legislative enactments and regulations relating to the protection of the environment and public health. While we cooperate with governmental authorities and take commercially practicable measures to meet regulatory requirements and avoid or limit environmental effects, some risks are inherent in our businesses. Among the risks are costs associated with managing hazardous substances, waste disposal or plant site clean-up, fines and penalties if we were found to be in violation of law, as well as modifications, disruptions or discontinuation of certain operations or types of operations including product recalls. Additionally, although we are not currently aware of any such circumstances, there can be no assurance that future legislation or enforcement policies will not have a material adverse effect on our consolidated results of operations, financial condition or liquidity. Environmental and regulatory matters most significant to us are discussed below.
Ingredient Legislation: Various laws and regulations have been enacted by state, local and foreign jurisdictions pertaining to the sale of products which contain phosphorous, volatile organic compounds, or other ingredients that may impact human health or the environment. Under California Proposition 65, label disclosures are required for certain products containing chemicals listed by California. To date, we generally have been able to comply with such legislative requirements by reformulation or labeling modifications. Such legislation has not had a material negative effect on our consolidated results of operations, financial condition or liquidity to date.
Pesticide Legislation: Various federal and state environmental laws and regulations govern the manufacture and/or use of pesticides. We manufacture and sell certain disinfecting and sanitizing products which kill microorganisms (bacteria, viruses, fungi) on environmental surfaces and on certain food products. Such products constitute pesticides or antimicrobial pesticides under the current definitions of the Federal Insecticide Fungicide and Rodenticide Act (FIFRA), as amended by the Food Quality Protection Act of 1996, the principal federal statute governing the manufacture, labeling, handling and use of pesticides. We maintain approximately 400 product registrations with the United States Environmental Protection Agency (EPA). Registration entails the necessity to meet certain efficacy, toxicity and labeling requirements and to pay on-going registration fees. In addition, each state in which these products are sold requires registration and payment of a fee. In general, the states impose no substantive requirements different from those required by FIFRA. However, California and certain other states have adopted additional regulatory programs, and California imposes a tax on total pesticide sales in that State. While the cost of complying with rules as to pesticides has not had a material adverse effect on our financial condition, liquidity or the results of our operations to date, the costs and delays in receiving necessary approvals for these products have increased in recent years. Total fees paid to the EPA and the states to obtain or maintain pesticide registrations, and for the California tax, were approximately $2,400,000 in 2003 and $2,500,000 in 2002. Congress is evaluating legislation that would increase these fees. Absent such a change, anticipated registration costs are not expected to significantly affect our consolidated results of operations, financial condition or liquidity.
9
In addition, our Pest Elimination Division applies restricted-use pesticides which it generally purchases from third parties. That Division must comply with certain standards pertaining to the use of such pesticides and to the licensing of employees who apply such pesticides. Such regulations are enforced primarily by the states or local jurisdictions in conformity with federal regulations. We have not experienced material difficulties in complying with these requirements.
FDA Antimicrobial Product Requirements : Various laws and regulations have been enacted by federal, state, local and foreign jurisdictions regulating certain products manufactured and sold by us for controlling microbial growth on humans, animals, processed foods, and medical devices. In the United States, these requirements generally are administered by the U.S. Food and Drug Administration (FDA). The FDA has been expanding requirements applicable to such products, including proposing regulations in a Tentative Final Monograph for Healthcare Antiseptic Drug Products dated June 17, 1994 that may impose additional requirements and associated costs when finalized by the FDA. To date, such requirements have not had a material negative effect on our consolidated results of operations, financial condition or liquidity.
Other Environmental Legislation: Our manufacturing plants are subject to federal, state, local or foreign jurisdiction laws and regulations relating to discharge of hazardous substances into the environment and to the transportation, handling and disposal of such substances. The primary federal statutes that apply to our activities are the Clean Air Act, the Clean Water Act and the Resource Conservation and Recovery Act (RCRA). We are also subject to the Superfund Amendments and Reauthorization Act of 1986, which imposes certain reporting requirements as to emissions of toxic substances into the air, land and water. We make capital investments and expenditures to comply with environmental laws and regulations, to ensure employee safety and to carry out its announced environmental stewardship principles. To date, such expenditures have not had a significant adverse effect on our consolidated results of operations, financial condition or liquidity. Our capital expenditures for environmental health and safety projects were approximately $1,800,000 for 2003 and $1,600,000 for 2002. Approximately $3,600,000 has been budgeted globally for 2004.
Environmental Remediation and Proceedings : Along with numerous other potentially responsible parties (PRPs), we are currently involved with waste disposal site clean-up activities imposed by the federal Comprehensive Environmental Response, Compensation and Liability Act (CERCLA) or state equivalents at approximately 20 sites in the United States. Additionally, we have similar liability at eight sites outside the United States. In general, under CERCLA, we and each other PRP which actually contributes hazardous substances to a Superfund site are jointly and severally liable for the costs associated with cleaning up the site. Customarily, the PRPs will work with the EPA to agree and implement a plan for site remediation.
Based on an analysis of our experience with such environmental proceedings, our estimated share of all hazardous materials deposited on the sites referred to in the preceding paragraph, and our estimate of the contribution to be made by other PRPs which we believe have the financial ability to pay their shares, we have accrued our best estimate of our probable future costs relating to such known sites. Unasserted claims are not reflected in the accrual. In establishing accruals, potential insurance
10
reimbursements are not included. The accrual is not discounted. It is not feasible to predict when the amounts accrued will be paid due to the uncertainties inherent in the environmental remediation and associated regulatory processes.
Our worldwide net expenditures for contamination remediation were approximately $500,000 in 2003 and $500,000 in 2002. Including the ChemLawn matters described below, our worldwide accruals at December 31, 2003 for probable future remediation expenditures totaled approximately $3,900,000. We review our exposure for contamination remediation costs periodically and our accruals are adjusted as considered appropriate. While the final resolution of these issues could result in costs below or above current accruals and, therefore, have an impact on our consolidated financial results in a future reporting period, we believe the ultimate resolution of these matters will not have a material effect on our consolidated results of operations, financial condition or liquidity. In connection with the JV Acquisition, we entered into an Environmental Agreement dated December 7, 2000 with Henkel under which Henkel agreed to indemnify us for certain environmental liabilities associated with the former JV. As of December 31, 2003, Henkels earlier outstanding reimbursement obligation to us for such environmental liabilities of 108,319 euro (or approximately $116,000) was paid. In addition, we have retained responsibility for certain sites where our former ChemLawn business is a PRP. Currently there are five such locations and, at each, ChemLawn is a de minimis party. Anticipated costs currently accrued for these matters were included in our loss from our discontinued ChemLawn operations in 1991. The accrual remaining reflects our best estimate of probable future costs.
Number of Employees : We currently have approximately 20,800 employees.
Item 1(d) Financia l Information About Geographic Areas
The financial information about geographic areas appearing under the heading Operating Segments in Note 16, located on page 48 of the Annual Report, is incorporated herein by reference.
Our Internet address is www.ecolab.com. Copies of our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to these reports, are available free of charge on our website at www.ecolab.com/investor as soon as reasonably practicable after such material is filed with, or furnished to, the Securities and Exchange Commission.
11
Executive Officers of the Company
The persons listed in the following table are our current executive officers. Officers are elected annually. There is no family relationship among any of the directors or executive officers, and, except as noted, no executive officer has been involved during the past five years in any legal proceedings described in applicable Securities and Exchange Commission regulations.
Name |
|
Age |
|
Office |
|
Positions Held Since Jan. 1, 1999 |
A. L. Schuman |
|
69 |
|
Chairman of the Board and Chief Executive Officer |
|
Aug. 2002 - Present |
|
|
|
|
|
|
|
|
|
|
|
Chairman of the Board, President and Chief Executive Officer |
|
Mar. 2002 Jul. 2002 |
|
|
|
|
|
|
|
|
|
|
|
Chairman of the Board and Chief Executive Officer |
|
Jan. 2001 - Feb. 2002 |
|
|
|
|
|
|
|
|
|
|
|
Chairman of the Board, President and Chief Executive Officer |
|
Jan. 2000 - Dec. 2000 |
|
|
|
|
|
|
|
|
|
|
|
President and Chief Executive Officer |
|
Jan. 1999 Dec. 1999 |
|
|
|
|
|
|
|
D. M. Baker, Jr. |
|
45 |
|
President and Chief Operating Officer |
|
Aug. 2002 - Present |
|
|
|
|
|
|
|
|
|
|
|
President - Institutional Sector |
|
Mar. 2002 Jul. 2002 |
|
|
|
|
|
|
|
|
|
|
|
Senior Vice President - Institutional Sector |
|
Jan. 2001 - Feb. 2002 |
|
|
|
|
|
|
|
|
|
|
|
Vice President and General Manager, Kay Chemical Company |
|
Jan. 1999 - Dec. 2000 |
|
|
|
|
|
|
|
L. T. Bell |
|
56 |
|
Senior Vice President-Law, General Counsel and Secretary |
|
Jul. 2002 Present |
|
|
|
|
|
|
|
|
|
|
|
Senior Vice President-Law and General Counsel |
|
Jan. 2001 Jun. 2002 |
|
|
|
|
|
|
|
|
|
|
|
Vice President-Law and General Counsel |
|
Jan. 1999 - Dec. 2000 |
|
|
|
|
|
|
|
S. L. Fritze |
|
49 |
|
Executive Vice President and Chief Financial Officer |
|
Feb. 2004 - Present |
|
|
|
|
|
|
|
|
|
|
|
Senior Vice President and Chief Financial Officer |
|
Mar. 2002 - Jan. 2004 |
12
Name |
|
Age |
|
Office |
|
Positions Held Since Jan. 1, 1999 |
|
|
|
|
Senior Vice President - Finance and Controller |
|
May 2001 Feb. 2002 |
|
|
|
|
|
|
|
|
|
|
|
Vice President and Controller |
|
Jul. 1999 Apr. 2001 |
|
|
|
|
|
|
|
|
|
|
|
Vice President and Treasurer |
|
Jan. 1999 Jun. 1999 |
|
|
|
|
|
|
|
T. W. Handley |
|
49 |
|
Executive Vice President-Specialty Sector |
|
Jan. 2004 - Present |
|
|
|
|
|
|
|
|
|
|
|
Senior Vice President - Strategic Planning |
|
Aug. 2003 - Dec. 2003 (1) |
|
|
|
|
|
|
|
L. Iannuzzi |
|
47 |
|
Executive Vice President - Europe, Africa and Middle East |
|
Jan. 2004 to Present |
|
|
|
|
|
|
|
|
|
|
|
Vice President and General Manager - Europe |
|
Jun. 2002 - Dec. 2003 |
|
|
|
|
|
|
|
|
|
|
|
Vice President - Region West & Region South Europe |
|
Jan. 2002 - May 2002 |
|
|
|
|
|
|
|
|
|
|
|
Vice President Region South Europe - Henkel-Ecolab |
|
Dec. 1999 - Dec. 2001 (2) |
|
|
|
|
|
|
|
D. D. Lewis |
|
57 |
|
Senior Vice President - Human Resources |
|
Jan. 2001 - Present |
|
|
|
|
|
|
|
|
|
|
|
Vice President - Human Resources |
|
Jan. 1999 - Dec. 2000 |
|
|
|
|
|
|
|
J. A. Miller |
|
47 |
|
Executive Vice President -Institutional Sector North America |
|
Jan. 2004 - Present |
|
|
|
|
|
|
|
|
|
|
|
Vice President and General Manager - Institutional |
|
Sept. 2002 - Dec. 2003 |
|
|
|
|
|
|
|
|
|
|
|
Institutional Vice President-Marketing North America |
|
Oct. 2001 - Aug. 2002 (3) |
|
|
|
|
|
|
|
S. K. Nestegard |
|
43 |
|
Vice President-Research, Development and Engineering and Chief Technical Officer |
|
Mar. 2003 - Present (4) |
|
|
|
|
|
|
|
S. D. Newlin |
|
51 |
|
President-Industrial Sector |
|
Jul. 2003 - Present (5) |
|
|
|
|
|
|
|
M. Nisita |
|
63 |
|
Senior Vice President- Global Operations |
|
Jan. 1999 - Present |
13
Name |
|
Age |
|
Office |
|
Positions Held Since Jan. 1, 1999 |
D. J. Schmechel |
|
44 |
|
Vice President and Controller |
|
Apr. 2002 - Present |
|
|
|
|
|
|
|
|
|
|
|
Vice President and Treasurer |
|
Jul. 1999 - Mar. 2002 |
|
|
|
|
|
|
|
|
|
|
|
Assistant Treasurer |
|
Jan. 1999 - Jun. 1999 |
|
|
|
|
|
|
|
J. P. Spooner |
|
57 |
|
President - International |
|
Mar. 2002 - Present |
|
|
|
|
|
|
|
|
|
|
|
Executive Vice President- International |
|
Dec. 2001 - Feb. 2002 |
|
|
|
|
|
|
|
|
|
|
|
Chief Executive Officer Henkel Ecolab |
|
Jan. 2001 Nov. 2001 |
|
|
|
|
|
|
|
|
|
|
|
Executive Vice President International Group |
|
Jan. 1999 Dec. 2000 |
1 Prior to joining Ecolab in August, 2003, Mr. Handley was employed by the Procter & Gamble Company for 22 years in various management, marketing and executive positions including assignments in Japan and Mexico. Mr. Handleys last position at P&G was Vice President - Feminine Care Strategic Planning.
2 Mr. Iannuzzi joined Ecolabs European operations in December 1999. Prior to that, Mr. Iannuzzi was employed by O.C.E. SpA of Italy as Managing Director and General Manager.
3 From April 1998 to April 2000, Mr. Miller served as Senior Vice President and General Manager, The Minute Maid Co. (a subsidiary of The Coca Cola Company). In May 2000, Mr. Miller was hired as President and CEO of Busy Body, Inc., a privately held retailer of home fitness equipment in the western U.S., to remedy operations that were underperforming the owners expectations. Busy Body, Inc. filed for Chapter 11 protection under federal bankruptcy laws in May 2001 and was subsequently liquidated. Mr. Miller re-joined the Company in October 2001.
4 Prior to joining Ecolab in March 2003, Ms. Nestegard was employed by 3M Company for 20 years, most recently as Business Director of Optical Components. Ms. Nestegards experience includes product and process development and technical management as Director Engineering Systems Technology Center and as Technical Director of the Electronic Products Division of 3M in Austin, Texas.
5 Prior to joining Ecolab in July 2003, Mr. Newlin was an executive with Nalco Company, a manufacturer of specialty chemicals, services and systems, where he was employed for 23 years. Following various executive assignments, Mr. Newlin became President and a Director of Nalco Chemical Company in December 1998, and served as President, Director, Chief Operating Officer and Vice Chairman from February 2000 to June 2001. From January 2000 to June 2001, Mr. Newlin also was Chairman of Nalco Exxon Energy Chemicals, a joint venture of Nalco and Exxon Energy Chemicals.
Our manufacturing philosophy is to manufacture products wherever an economic, process or quality assurance advantage exists or where proprietary manufacturing techniques dictate internal production processes. Currently, most products sold by us are manufactured at our facilities.
Our manufacturing facilities produce chemical products or equipment for all of our businesses, although the businesses constituting the United States Other Services segment purchase the majority of their products and equipment from outside suppliers. Our chemical production process consists primarily of blending and packaging powders and liquids and casting solids. Our equipment manufacturing operations consist primarily of producing chemical product dispensers and ejectors and other mechanical equipment and dishwasher racks and related sundries.
14
The following chart profiles our main manufacturing facilities with ongoing production activities.
In general, manufacturing facilities located in the United States serve the United States Cleaning & Sanitizing segment and facilities located outside of the United States serve the International Cleaning & Sanitizing segment. However, certain of the United States facilities do manufacture products for export and which are used by the International segment. The facilities having export involvement are marked with an asterisk(*).
Location |
|
Size (Sq. Ft.) |
|
Types of Products |
|
Majority Owned or Leased |
|
|
|
|
|
|
|
|
|
UNITED STATES |
|
|
|
|
|
|
|
Joliet, IL * |
|
610,000 |
|
Solids, Liquids, Powders |
|
Owned |
|
South Beloit, IL * |
|
313,000 |
|
Equipment |
|
Owned |
|
Garland, TX * |
|
239,000 |
|
Solids, Liquids |
|
Owned |
|
Martinsburg, WV |
|
228,000 |
|
Liquids |
|
Owned |
|
Hebron, OH |
|
225,000 |
|
Liquids |
|
Owned |
|
Greensboro, NC |
|
193,000 |
|
Liquids, Powders |
|
Owned |
|
San Jose, CA |
|
175,000 |
|
Liquids |
|
Owned |
|
McDonough, GA* |
|
141,000 |
|
Solids, Liquids |
|
Owned |
|
Eagan, MN * |
|
133,000 |
|
Solids, Liquids, Emulsions, Powders |
|
Owned |
|
Huntington, IN * |
|
127,000 |
|
Liquids |
|
Owned |
|
City of Industry, CA |
|
125,000 |
|
Liquids |
|
Owned |
|
Elk Grove Village, IL * |
|
115,000 |
|
Equipment |
|
Leased |
|
Cairo, IL |
|
11,000 |
|
Liquids |
|
Owned |
|
Dallas, TX |
|
24,000 |
|
Liquids, Powders |
|
Owned |
|
Baldwin Park, CA |
|
14,000 |
|
Equipment |
|
Leased |
|
INTERNATIONAL |
|
|
|
|
|
|
|
Chalons, FRANCE |
|
280,000 |
|
Liquids, Powders |
|
Owned |
|
Nieuwegein, NETHERLANDS |
|
168,000 |
|
Powders |
|
Owned |
|
Tessenderlo, BELGIUM |
|
153,000 |
|
Solids, Liquids |
|
Owned |
|
Melbourne, AUSTRALIA |
|
145,300 |
|
Liquids, Powders |
|
Owned |
|
Santa Cruz, BRAZIL |
|
142,000 |
|
Liquids, Powders |
|
Owned |
|
Rozzano, ITALY |
|
126,000 |
|
Liquids |
|
Owned |
|
Mississauga, CANADA |
|
120,400 |
|
Liquids |
|
Owned |
|
Siegsdorf, GERMANY |
|
114,000 |
|
Equipment |
|
Owned |
|
Johannesburg, SOUTH AFRICA |
|
100,000 |
|
Liquids, Powders |
|
Owned |
|
Hamilton, NEW ZEALAND |
|
96,000 |
|
Solids, Liquids, Powders |
|
Owned |
|
Valby, DENMARK |
|
70,000 |
|
Liquids |
|
Owned |
|
Shika, JAPAN |
|
60,000 |
|
Liquids |
|
Owned |
|
15
Location |
|
Size (Sq. Ft.) |
|
Types of Products |
|
Majority Owned or Leased |
|
Santiago, CHILE |
|
60,000 |
|
Liquids, Powders |
|
Leased |
|
Revesby, AUSTRALIA |
|
59,200 |
|
Liquids, Powders |
|
Owned |
|
Cheadle (Hulme), UK |
|
52,575 |
|
Liquids |
|
Leased |
|
Noda, JAPAN |
|
49,000 |
|
Solids, Liquids, Powders |
|
Owned |
|
Mexico City, MEXICO |
|
40,000 |
|
Liquids, Powders |
|
Owned |
|
Maribor, SLOVENIA |
|
39,000 |
|
Liquids, Powders |
|
Owned |
|
Leeds, U.K. |
|
35,000 |
|
Liquids |
|
Owned |
|
Pilar, ARGENTINA |
|
30,000 |
|
Liquids, Powders |
|
Owned |
|
Shanghai, CHINA |
|
27,000 |
|
Solids, Liquids, Powders |
|
Owned |
|
Perth, AUSTRALIA |
|
26,900 |
|
Liquids, Powders |
|
Owned |
|
Dorado, PUERTO RICO |
|
25,000 |
|
Liquids, Powders |
|
Leased |
|
Singapore, SINGAPORE |
|
25,000 |
|
Liquids, Powders |
|
Owned |
|
Dar es Salaam, TANZANIA |
|
22,900 |
|
Liquids, Powders |
|
Leased |
|
Seoul, SOUTH KOREA |
|
22,160 |
|
Liquids, Powders |
|
Owned |
|
Mandras, GREECE |
|
18,000 |
|
Liquids |
|
Owned |
|
Dublin, IRELAND |
|
17,000 |
|
Liquids |
|
Leased |
|
San Jose, COSTA RICA |
|
11,000 |
|
Liquids, Powders |
|
Owned |
|
Cikarang, INDONESIA |
|
10,000 |
|
Solids, Liquids, Powders |
|
Owned |
|
Bangkok, THAILAND |
|
10,000 |
|
Liquids, Powders |
|
Owned |
|
Manilla, PHILIPPINES |
|
7,600 |
|
Liquids, Powders |
|
Owned |
|
We believe our manufacturing facilities are in good condition and are adequate to meet our existing production needs.
Most of our manufacturing plants also serve as distribution centers. In addition, around the world, we operate distribution centers, all of which are leased, and utilize various public warehouses to facilitate the distribution of our products and services. In the United States, our sales and service associates are located in approximately 60 leased offices. Additional sales offices are located internationally.
Our corporate headquarters is comprised of three adjacent multi-storied buildings located in downtown St. Paul, Minnesota. The main 19-story building was constructed to our specifications and is leased through 2008. Thereafter, it is subject to multiple renewals at our option. The second building is also subject to a long-term lease by us and the third building is owned. The corporate headquarters includes an employee training center. We also own a computer center in St. Paul and a research facility located in a suburb of St. Paul.
Item 3. Legal Proceedings
Proceedings arising under laws relating to protection of the environment are discussed at Item 1(c) above, under the heading Environmental Considerations.
16
The Company and certain of our subsidiaries are defendants in various lawsuits and claims arising out of the normal course of business. Accruals have been established reflecting our best estimate of probable future costs relating to such matters.
The estimated effects of the future results of existing litigation is subject to certain estimates, assumptions and uncertainties and should be considered in light of the discussion of Forward-Looking Statements and Risk Factors found under Part I at the beginning of this Report.
Item 4. Submission of Matters to a Vote of Security Holders
No matters were submitted to a vote of our security holders, through the solicitation of proxies, or otherwise, during the fourth quarter of 2003.
Item 5. Market for Registrants Common Equity and Related Stockholder Matters and Issuer Purchases of Equity Securities
All per share and number of share information in Item 5, including dividends per share in Item 5(c), reflect a two-for-one stock split paid June 6, 2003 in the form of a 100 percent stock dividend to shareholders of record on May 23, 2003.
Our Common Stock is listed on the New York Stock Exchange and the Pacific Exchange, Inc. under the symbol ECL. The Common Stock is also traded on an unlisted basis on certain other United States exchanges. The high and low sales prices of our Common Stock on the consolidated transaction reporting system during 2003 and 2002 were as follows:
|
|
2003 |
|
2002 |
|
||||||||
Quarter |
|
High |
|
Low |
|
High |
|
Low |
|
||||
First |
|
$ |
26.00 |
|
$ |
23.08 |
|
$ |
23.94 |
|
$ |
19.43 |
|
Second |
|
$ |
27.92 |
|
$ |
24.21 |
|
$ |
24.00 |
|
$ |
21.25 |
|
Third |
|
$ |
26.80 |
|
$ |
23.78 |
|
$ |
24.51 |
|
$ |
18.27 |
|
Fourth |
|
$ |
27.89 |
|
$ |
25.15 |
|
$ |
25.20 |
|
$ |
20.71 |
|
The closing Common Stock price on February 27, 2004 was $27.31.
Item 5(b) Holders
On February 27, 2004, we had 4,725 holders of Common Stock of record.
Item 5(c) Dividends
We have paid Common Stock dividends for 67 consecutive years. Quarterly cash dividends of $0.0675 per share were declared in February, May and August 2002. Cash dividends of $0.0725 per share were declared in December 2002, and February, May and August 2003. A dividend of $0.08 per share was declared in December 2003.
17
Item 5(d) Issuer Purchases of Equity Securities
Period |
|
(a)
|
|
(b)
|
|
(c)
|
|
(d)
|
|
|
Month #1 (October 2003) |
|
595,300 |
|
$ |
26.7104 |
|
595,300 |
|
10,815,400 |
|
Month #2 (November 2003) |
|
288,600 |
|
$ |
26.1302 |
|
288,600 |
|
10,526,800 |
|
Month #3 (December 2003) |
|
169,700 |
|
$ |
27.2460 |
|
169,700 |
|
10,357,100 |
|
Total |
|
1,053,600 |
|
$ |
26.6377 |
|
1,053,600 |
|
10,357,100 |
|
(1) On December 7, 2000, we announced that our Board of Directors authorized us to repurchase up to 10,000,000 shares of Common Stock in open market or privately negotiated transactions. As a part of this repurchase authorization, we announced on March 18, 2003 that we may also repurchase shares under Rule 10b5-1 of the Securities Exchange Act of 1934, during times when we ordinarily would not be in the market because of self-imposed trading blackout periods. On October 17, 2003, we announced that our Board of Directors authorized the repurchase of up to 10,000,000 additional shares of Common Stock, including shares to be repurchased under Rule 10b5-1. We intend to repurchase all shares under the aforementioned authorizations, for which no expiration dates have been established, subject to market conditions.
Item 6. Selected Financial Data
The comparative data for the years ended December 31, 2003, 2002, 2001, 2000 and 1999 inclusive, which are set forth under the heading entitled Summary Operating and Financial Data located on pages 52 and 53 of the Annual Report, are incorporated herein by reference.
Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations
The material appearing under the heading entitled Financial Discussion, located on pages 20 through 51 of the Annual Report, is incorporated herein by reference.
The material appearing under the heading entitled Market Risk, located on pages 29 and 30 of the Annual Report, is incorporated herein by reference.
Item 8. Financial Statements and Supplementary Data
The financial statements and material which are an integral part of the financial statements listed under Item 15.I(1). below and located on pages 31 through 51 of the Annual Report, are incorporated herein by reference.
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
None.
18
As of December 31, 2003, we carried out an evaluation, under the supervision and with the participation of our management, including the Chairman of the Board and Chief Executive Officer and the Executive Vice President and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon that evaluation, our Chairman of the Board and Chief Executive Officer and the Executive Vice President and Chief Financial Officer concluded that our disclosure controls and procedures are effective, among other things, in timely alerting them to material information relating to us (including its consolidated subsidiaries) required to be included in our reports filed under the Securities Exchange Act of 1934, as amended.
During the period October 1 - December 31, 2003, there were no changes in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, Ecolabs internal control over financial reporting.
The biographical material regarding our directors and the paragraph relating to understandings concerning the election of directors between Henkel KGaA and the Company located in the Proxy Statement appearing under the heading entitled Proposal to Elect Directors, is incorporated herein by reference. Information regarding executive officers is presented under the heading Executive Officers of the Company in Part I on pages 12 through 14 hereof.
Disclosures concerning policies of our Board of Directors, corporate governance principles and corporate ethics practices, including our Code of Conduct, are available on our website at www.ecolab.com/investor/governance. Copies of our Code of Conduct as last amended in 1995 and the Code of Ethics for Senior Officers and Finance Associates adopted in 2003, also are filed as Exhibit (99) to this Annual Report on Form 10-K, and will be mailed free of charge to any shareholder upon request to the Corporate Secretary at our headquarters in St. Paul. We intend to promptly disclose on our website should there be any amendments to, or waivers by the Board of Directors of, the Code of Conduct or the Code of Ethics for Senior Officers and Finance Associates.
The material appearing under the heading entitled Section 16(a) Beneficial Ownership Reporting Compliance located in the Proxy Statement is incorporated herein by reference.
The material appearing under the heading entitled Board of Directors located in the Proxy Statement pertaining to the identity of Audit Committee members and the designation of the audit committee financial expert is incorporated herein by reference.
Item 11. Executive Compensation
The material appearing under the heading entitled Executive Compensation located in the Proxy Statement is incorporated herein by reference. However, pursuant to Securities and Exchange Commission Regulation S-K, Item 402(a)(9), the material appearing under the headings entitled Report of the Compensation Committee on Executive Compensation and Comparison of Five Year Cumulative Total Return located in the Proxy Statement is not incorporated herein.
19
Item 12. Security Ownership of Certain Beneficial Owners and Management
The material appearing under the headings entitled Security Ownership located in the Proxy Statement is incorporated herein by reference. The holdings of Henkel Chemie VmbH and HC Investments, Inc. are subject to certain limitations with respect to the Companys voting securities as more fully described in the Companys Proxy Statement under the heading Stockholder Agreement, which is incorporated herein by reference.
The material appearing under the heading Executive Compensation pertaining to Equity Compensation Plan Information located in the Proxy Statement is incorporated herein by reference.
A total of 1,311,042 shares of Common Stock held by the Companys current directors and executive officers, some of whom may be affiliates of the Company, have been excluded from the computation of market value of the Companys Common Stock on the cover page of this Report. This total represents that portion of the shares reported as beneficially owned by directors and executive officers of the Company as of June 30, 2003, which are actually issued and outstanding.
Item 13. Certain Relationships and Related Transactions
The material appearing under the heading entitled Director Independence, located in the Proxy Statement pertaining to Stockholder Agreement and Related Party Transactions, as well as the paragraph relating to understandings concerning the election of directors between Henkel KGaA and the Company and the biographical material pertaining to Messrs. Stefan Hamelmann, Jochen Krautter and Ulrich Lehner, both located in the Proxy Statement under the heading Proposal to Elect Directors, are incorporated herein by reference.
The material appearing under the heading entitled Independent Auditors Fees located in the Proxy Statement is incorporated herein by reference.
20
Item 15. Exhibits , Financial Statement Schedules, and Reports on Form 8-K
I(1). The following financial statements of the Company, included in the Annual Report, are incorporated into Item 8 hereof.
(i) Consolidated Statement of Income for the years ended December 31, 2003, 2002 and 2001, Annual Report page 31.
(ii) Consolidated Balance Sheet at December 31, 2003, 2002 and 2001, Annual Report page 32.
(iii) Consolidated Statement of Cash Flows for the years ended December 31, 2003, 2002 and 2001, Annual Report page 33.
(iv) Consolidated Statement of Comprehensive Income and Shareholders Equity for the years ended December 31, 2003, 2002 and 2001, Annual Report page 34.
(v) Notes to Consolidated Financial Statements, Annual Report pages 35 through 50.
(vi) Report of Independent Auditors, Annual Report page 51.
I(2). The following financial statement schedule to the Companys financial statements listed in Item 15.I(1). for the years ended December 31, 2003, 2002 and 2001 located on page 32 hereof, and the Report of Independent Auditors on Financial Statement Schedule at page 30 hereof, are filed as part of this Report.
(i) Schedule II Valuation and Qualifying Accounts for the years ended December 31, 2003, 2002 and 2001.
All other schedules, for which provision is made in the applicable regulations of the Securities and Exchange Commission, are not required under the related instructions or are inapplicable and therefore have been omitted. All significant majority-owned subsidiaries are included in the filed consolidated financial statements.
21
II. The following documents are filed as exhibits to this Report. We will, upon request and payment of a fee not exceeding the rate at which copies are available from the Securities and Exchange Commission, furnish copies of any of the following exhibits to stockholders.
(3)A. Restated Certificate of Incorporation - Incorporated by reference to Exhibit (3) to our Current Report on Form 8-K dated May 9, 2003.
B. By-Laws, as amended through February 18, 1999 - Incorporated by reference to Exhibit (3)B of our Form 10-K Annual Report for the year ended December 31, 1998.
(4)A. Common Stock - see Exhibits (3)A and (3)B.
B. Form of Common Stock Certificate.
C. (i) Rights Agreement dated as of February 24, 1996 - Incorporated by reference to Exhibit (4) of our Current Report on Form 8-K dated February 24, 1996.
(ii) Amendment, dated November 5, 2001 to the Rights Agreement dated as of February 24, 1996 - Incorporated by reference to Exhibit (1) of our Form 8A/A filed November 6, 2001.
D. Second Amended and Restated Stockholders Agreement between Henkel KGaA and Ecolab Inc., dated November 30, 2001 - Incorporated by reference to Exhibit (4) of our Current Report on Form 8-K dated November 30, 2001.
E. Amended and Restated Indenture, dated as of January 9, 2001, between Ecolab Inc. and Bank One, NA (formerly known as The First National Bank of Chicago) as Trustee - Incorporated by reference to Exhibit (4)(A) of our Current Report on Form 8-K dated January 23, 2001.
F. Officers Certificate establishing terms and conditions of 6.875% Notes due February 1, 2011 - Incorporated by reference to Exhibit 4(B) of our Current Report on Form 8-K dated January 23, 2001.
G. Form of 6.875% Note due February 2, 2011 - Incorporated by reference to Exhibit 4(c) of our Current Report on Form 8-K dated January 23, 2001.
H. (i) Trust Deed, dated 7 February 2002, constituting 300,000,000 5.375% Notes due 2007 between Ecolab Inc. and JP Morgan Chase Bank, London Branch - Incorporated by reference to Exhibit (4)H(i) of our Form 10-K Annual Report for the year ended December 31, 2001.
22
(ii) Paying Agency Agreement, dated 7 February 2002, relating to 300,000,000 5.375% Notes due 2007 among Ecolab Inc., JPMorgan Chase Bank, London Branch, J. P. Morgan Bank Luxembourg S.A. and others - Incorporated by reference to Exhibit (4)H(ii) of our Form 10-K Annual Report for the year ended December 31, 2001.
Copies of other constituent instruments defining the rights of holders of our long-term debt are not filed herewith, pursuant to Section (b)(4)(iii) of Item 601 of Regulation S-K, because the aggregate amount of securities authorized under each of such instruments is less than 10% of our total assets on a consolidated basis. We will, upon request by the Securities and Exchange Commission, furnish to the Commission a copy of each such instrument.
(10)A. (i) Multicurrency Credit Agreement (Credit Agreement) dated as of September 29, 1993, as Amended and Restated as of December 13, 2000, among Ecolab Inc., the financial institutions party thereto from time to time, Citicorp USA, Inc. as Administrative Agent, Citibank International Plc, as Euro-Agent and Bank One, NA and Credit Suisse First Boston as Co-Agents - Incorporated by reference to Exhibit (10)A of our Current Report on Form 8-K dated January 23, 2001.
(ii) Australian Dollar Local Currency Addendum to the Credit Agreement, dated October 17, 1997 - Incorporated by reference to Exhibit (4)B of our Form 10-Q for the quarter ended September 30, 1997.
(iii) Australian Dollar Local Currency Addendum dated as of June 23, 1998 among Ecolab Finance PTY Limited, Ecolab Inc., Citibank, N.A., the Local Currency Agent named therein and the Local Currency Banks party thereto - Incorporated by reference to Exhibit (4)B of our Form 10-Q for the quarter ended June 30, 1998.
B. (i) Credit Agreement (364 Day Facility) dated December 7, 2001, among Ecolab Inc., the banks parties thereto (the Banks) and Citicorp USA, Inc. as Agent for the Banks - Incorporated by reference to Exhibit (99)B of our Current Report on Form 8-K dated November 30, 2001.
(ii) Amendment No. 1 to Credit Agreement (364 Day Facility) dated as of October 31, 2002, among Ecolab Inc., the bank parties thereto (the Banks) and Citicorp USA, Inc. as Agent for the Banks - Incorporated by reference to Exhibit (10)B(iii) of our Form 10-K for the year ended December 31, 2002.
(iii) Amendment No. 2 to Credit Agreement (364 Day Facility) dated as of October 30, 2003, among Ecolab Inc., the bank parties thereto (the Banks) and Citicorp USA, Inc. as Agent for the Banks.
C. Documents comprising global Commercial Paper Programs
(i) U.S. $200,000,000 Euro-Commercial Paper Programme
(a) Dealer Agreement dated as of 10 June 2003 among Ecolab Inc., Credit Suisse First Boston (Europe) Limited as Arranger, and Citibank International plc and Credit Suisse First Boston (Europe) Limited as
23
Dealers - Incorporated by reference to Exhibit (10)A(i)(a) of our Form 10-Q for the quarter ended June 30, 2003.
(b) Note Agency Agreement dated as of 10 June 2003 between Ecolab Inc. and Citibank, N.A. as Issue and Paying Agent. - Incorporated by reference to Exhibit (10)A(i)(b) our Form 10-Q for the quarter ended June 30, 2003.
(c) Deed of Covenant made as of 10 June 2003 by Ecolab Inc. - Incorporated by reference to Exhibit (10)A(i)(c) of our Form 10-Q for the quarter ended June 30, 2003.
(ii) U.S. $450,000,000 U.S. Commercial Paper Program
(a) Form of Commercial Paper Dealer Agreement for 4 (2) Program. Agreements have been executed with Salomon Smith Barney, Inc. and Banc One Capital Markets, Inc - Incorporated by reference to Exhibit (10)A(ii)(a) of our Form 10-Q for the quarter ended June 30, 2003.
(b) Issuing and Paying Agency Agreement dated as of July 10, 2000 between Ecolab Inc. and Bank One, National Association as Issuing and Paying Agent - Incorporated by reference to Exhibit (10)A(ii)(b) of our Form 10-Q for the quarter ended June 30, 2003.
(iii) AUD 200,000,000 Australian Commercial Paper and Medium Term Note Programme
(a) Dealer Agreement dated as of 10 July 1998 among Ecolab Finance Pty Limited as Issuer, Citisecurities Limited as Arranger, and the Dealers Parties thereto - Incorporated by reference to Exhibit (10)A(iii)(a) of our Form 10-Q for the quarter ended June 30, 2003.
(b) Guarantee and Negative Pledge made by our on 10 July 1998 - Incorporated by reference to Exhibit (10)A(iii)(b) of our Form 10-Q for the quarter ended June 30, 2003.
(c) Issuing and Paying Agency Agreement dated as of 10 July 1998 between Ecolab Finance Pty Limited as Issuer and Perpetual Trustee Company Limited as Agent - Incorporated by reference to Exhibit (10)A(iii)(c) of our Form 10-Q for the quarter ended June 30, 2003.
(d) MTN Program Master Note dated as of 10 July 1998 by Ecolab Finance Pty Limited - Incorporated by reference to Exhibit (10)A(iii)(d) of our Form 10-Q for the quarter ended June 30, 2003.
(e) Registry Services Deed dated as of 10 July 1998 between Ecolab Finance Pty Limited as Issuer and Perpetual Trustee Company as Registrar - Incorporated by reference to Exhibit (10)A(iii)(e) of our Form 10-Q for the quarter ended June 30, 2003.
D. Ecolab Inc. 1993 Stock Incentive Plan, as Amended and Restated as of May 12, 2000 - Incorporated by reference to Exhibit (10)D of our Form 10-K Annual Report for the year ended December 31, 2002.
24
E. Ecolab Inc. 1997 Stock Incentive Plan, as Amended and Restated as of August 18, 2000 - Incorporated by reference to Exhibit (10) of our Form 10-Q for the quarter ended September 30, 2000.
F. (i) 1988 Non-Employee Director Stock Option Plan as amended through February 23, 1991 - Incorporated by reference to Exhibit (10)D of our Form 10-K Annual Report for the year ended December 31, 1990.
(ii) Amendment to 1988 Non-Employee Director Stock Option Plan effective May 11, 2001 - Incorporated by reference to Exhibit (10)F(iii) of our Form 10-K Annual Report for the year ended December 31, 2002.
G. (i) 1995 Non-Employee Director Stock Option Plan - Incorporated by reference to Exhibit (10)D of our Form 10-K Annual Report for the year ended December 31, 1994.
(ii) Amendment No. 1 to 1995 Non-Employee Director Stock Option Plan effective February 25, 2000 - Incorporated by reference to Exhibit (10)E(ii) of our Form 10-K for the year ended December 31, 1999.
(iii) Amendment No. 2 to 1995 Non-Employee Director Stock Option Plan effective May 11, 2001 - Incorporated by reference to Exhibit (10)G(iii) of our Form 10-K Annual Report for the year ended December 31, 2002.
H. (i) Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan. Incorporated by reference to Exhibit (10) of our Form 10-Q for the quarter ended March 31, 2001.
(ii) Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan, as amended effective May 1, 2004.
I. Form of Director Indemnification Agreement. Substantially identical agreements are in effect as to each of our directors.
J. (i) Ecolab Executive Death Benefits Plan, as amended and restated effective March 1, 1994 - Incorporated by reference to Exhibit (10)J of our Form 10-K Annual Report for the year ended December 31, 1994. See also Exhibit (10)P hereof.
(ii) Amendment No. 1 to Ecolab Executive Death Benefits Plan - Incorporated by reference to Exhibit (10)H(ii) of our Form 10-K Annual Report for the year ended December 31, 1998.
(iii) Second Declaration of Amendment to Ecolab Executive Death Benefits Plan, effective March 1, 1998 - Incorporated by reference to Exhibit (10)H(iii) of our Form 10-K Annual Report for the year ended December 31, 1998.
K. Ecolab Executive Long-Term Disability Plan, as amended and restated effective January 1, 1994 - Incorporated by reference to Exhibit (10)K of our 10-K Annual Report for the year ended December 31, 1994. See also Exhibit (10)P hereof.
25
L. Ecolab Executive Financial Counseling Plan - Incorporated by reference to Exhibit (10)K of our Form 10-K Annual Report for the year ended December 31, 1992.
M. Ecolab Supplemental Executive Retirement Plan, as amended and restated effective January 1, 2003.
N. Ecolab Mirror Savings Plan, as amended and restated effective as of March 1, 2002 - Incorporated by reference to Exhibit (10)N of our Form 10-K Annual Report for the year ended December 31, 2002.
O. Ecolab Mirror Pension Plan, as amended and restated effective as of January 1, 2003 - Incorporated by reference to Exhibit (10)B of our Form 10-Q for the quarter ended June 30, 2003. See also Exhibit (10)P hereof.
P. Ecolab Inc. Administrative Document for Non-Qualified Benefit Plans, as amended and restated effective as of January 1, 2003.
Q. 1999 Ecolab Inc. Management Performance Incentive Plan - Incorporated by reference to Exhibit (10)O of our Form 10-K Annual Report for the year ended December 31, 1998.
R. Ecolab Inc. Change in Control Severance Compensation Policy, effective February 22, 2002 - Incorporated by reference to Exhibit (10)R of our Form 10-K Annual Report for the year ended December 31, 2002.
S. (i) Master Agreement, dated as of December 7, 2000, between Ecolab Inc. and Henkel KGaA - Incorporated by reference to Exhibit 18 of HC Investments, Inc.s and Henkel KGaAs Amendment No. 5 to Schedule 13D dated December 14, 2000.
(ii) Amendment No. 1 to the Master Agreement, dated December 7, 2000, between Ecolab Inc. and Henkel KGaA-Incorporated by reference to Exhibit (10) of our Form 10-Q for the quarter ended September 30, 2001.
(iii) Intellectual Property Agreement dated November 30, 2001, between Ecolab and Henkel KGaA-Incorporated by reference to Exhibit (10) of our Current Report on Form 8-K dated November 30, 2001.
T. Description of Ecolab Inc. Management Incentive Plan - Incorporated by reference to Exhibit (10)R of our Form 10-K for the year ended December 31, 2001.
U. (i) Hiring Letter of Bruno Deschamps - Incorporated by reference to Exhibit (10)T of our Form 10-K for the year ended December 31, 2000.
(ii) Separation Agreement between the Company and Bruno Deschamps effective March 11, 2002 - Incorporated by reference to Exhibit (10) of our Form 10-Q for the quarter ended March 31, 2002.
V. Ecolab Inc. 2002 Stock Incentive Plan - Incorporated by reference to Exhibit (10) of our Form 10-Q for the quarter ended June 30, 2002.
(13) Those portions of our Annual Report to Stockholders for the year ended December 31, 2003 which are incorporated by reference into Parts I, II and IV hereof.
26
(21) List of Subsidiaries as of February 27, 2004.
(23) Consent of Independent Accountants at page 31 hereof is filed as a part hereof.
(24) Powers of Attorney.
(31) Rule 13a-14(a) Certifications.
(32) Section 1350 Certifications.
(99) A. Ecolab Code of Conduct.
B. Code of Ethics for Senior Officers and Finance Associates.
EXECUTIVE COMPENSATION PLANS AND ARRANGEMENTS
Included in the preceding list of exhibits are the following management contracts or compensatory plans or arrangements:
Exhibit No. |
|
Description |
|
|
|
(10)D. |
|
Ecolab Inc. 1993 Stock Incentive Plan. |
|
|
|
(10)E. |
|
Ecolab Inc. 1997 Stock Incentive Plan. |
|
|
|
(10)F. |
|
1988 Non-Employee Director Stock Option Plan. |
|
|
|
(10)G. |
|
1995 Non-Employee Director Stock Option Plan. |
|
|
|
(10)H. |
|
Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan. |
|
|
|
(10)I. |
|
Form of Director Indemnification Agreement. |
|
|
|
(10)J. |
|
Ecolab Executive Death Benefits Plan. |
|
|
|
(10)K. |
|
Ecolab Executive Long-Term Disability Plan. |
|
|
|
(10)L. |
|
Ecolab Executive Financial Counseling Plan. |
|
|
|
(10)M. |
|
Ecolab Supplemental Executive Retirement Plan. |
|
|
|
(10)N. |
|
Ecolab Mirror Savings Plan. |
|
|
|
(10)O. |
|
Ecolab Mirror Pension Plan. |
|
|
|
(10)P. |
|
Ecolab Inc. Administrative Document for Non-Qualified Benefit Plans. |
|
|
|
(10)Q. |
|
1999 Ecolab Inc. Management Performance Incentive Plan. |
|
|
|
(10)R. |
|
Ecolab Inc. Change in Control Severance Compensation Policy. |
|
|
|
(10)T. |
|
Ecolab Management Incentive Plan. |
|
|
|
(10)U. |
|
Hiring Letter and Separation Agreement of Bruno Deschamps. |
|
|
|
(10)V. |
|
Ecolab Inc. 2002 Stock Incentive Plan. |
27
III. Reports on Form 8-K:
We filed one Current Report on Form 8-K during the quarter ended December 31, 2003, on October 17, 2003 to announce under Item 5 that our Board of Directors authorized the repurchase of up to 10,000,000 shares of common stock to fund stock incentive plans and for general corporate purposes. Subsequent to December 31, 2003, we filed two Current Reports on Form 8-K, dated February 26 and February 28, 2004, to report under Item 5 the appointment of three new members of Ecolabs Board of Directors and to report the announcement of a leadership transition plan.
28
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, Ecolab Inc. has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on the 5 th day of March, 2004.
|
ECOLAB INC. |
||
|
(Registrant) |
||
|
|
|
|
|
By |
/s/ Allan L. Schuman |
|
|
|
Allan L. Schuman |
|
|
|
Chairman of the Board
and
|
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of Ecolab Inc. and in the capacities indicated, on the 5 th day of March, 2004.
/s/ Allan L. Schuman |
|
Chairman of the Board and |
|
Allan L. Schuman |
|
Chief Executive Officer
|
|
|
|
|
|
/s/ Steven L. Fritze |
|
Executive Vice President and |
|
Steven L. Fritze |
|
Chief Financial Officer
|
|
|
|
|
|
/s/ Daniel J. Schmechel |
|
Vice President and Controller |
|
Daniel J. Schmechel |
|
(Principal Accounting Officer) |
|
|
|
|
|
/s/ Lawrence T. Bell |
|
Directors |
|
Lawrence T. Bell |
|
|
|
|
|
|
|
as attorney-in-fact for:
|
|
|
|
|
|
|
|
Directors not signing:
|
|
|
|
29
REPORT OF INDEPENDENT AUDITORS
ON FINANCIAL STATEMENT SCHEDULE
To the Shareholders and Directors of Ecolab Inc.:
Our audits of the consolidated financial statements referred to in our report dated February 26, 2004 appearing in the 2003 Annual Report to Shareholders of Ecolab Inc. (which report and consolidated financial statements are incorporated by reference in this Annual Report on Form 10-K) also included an audit of the financial statement schedule listed in Item 15.I(2).(i) of this Form 10-K. In our opinion, this financial statement schedule presents fairly, in all material respects, the information set forth therein when read in conjunction with the related consolidated financial statements.
|
|
|
|
/s/ PricewaterhouseCoopers LLP |
|
|
|
|
PricewaterhouseCoopers LLP |
Minneapolis, Minnesota
February 26, 2004
30
CONSENT OF INDEPENDENT ACCOUNTANTS
We hereby consent to the incorporation by reference in the Registration Statements of Ecolab Inc. on Form S-8 (Registration Nos. 2-60010; 2-74944; 33-1664; 33-41828; 2-90702; 33-18202; 33-55986; 33-56101; 333-95043; 333-109890; 33-26241; 33-34000; 33-56151; 333-18627; 333-109891; 33-39228; 33-56125; 333-70835; 33-60266; 333-95041; 33-65364; 333-18617; 333-79449; 333-40239; 333-95037; 333-50969; 333-58360; and 333-97927) of our report dated February 26, 2004 relating to the consolidated financial statements of Ecolab Inc. as of December 31, 2003, 2002 and 2001 and for the years then ended, which appears in the 2003 Annual Report to Shareholders of Ecolab Inc., which is incorporated by reference in this Annual Report on Form 10-K of Ecolab Inc. We also consent to the inclusion in this Annual Report on Form 10-K of our report dated February 26, 2004 relating to the financial statement schedule of Ecolab Inc. as of December 31, 2003, 2002 and 2001 and for the years then ended, which also appears in this Form 10-K.
|
|
|
|
/s/ PricewaterhouseCoopers LLP |
|
|
|
|
PricewaterhouseCoopers LLP |
Minneapolis, Minnesota
March 5, 2004
31
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS
ECOLAB INC.
(In Thousands)
COL. A |
|
COL. B |
|
COL. C |
|
COL. D |
|
COL. E |
|
|||||||
|
|
|
|
Additions |
|
|
|
|
|
|||||||
Description |
|
Balance at
|
|
Charged to
|
|
Charged
|
|
Deductions (B) |
|
Balance
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Allowance for Doubtful Accounts: |
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Year Ended December 31, 2003 |
|
$ |
35,995 |
|
$ |
18,403 |
|
$ |
3,669 |
|
$ |
(14,056 |
) |
$ |
44,011 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Year Ended December 31, 2002 |
|
$ |
30,297 |
|
$ |
17,220 |
|
$ |
2,232 |
|
$ |
(13,754 |
) |
$ |
35,995 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Year Ended December 31, 2001 |
|
$ |
15,330 |
|
$ |
10,941 |
|
$ |
12,527 |
|
$ |
(8,501 |
) |
$ |
30,297 |
|
(A) Included the effects of changes in currency translation and business acquisition, including Henkel-Ecolab in 2001
(B) Uncollectible accounts charged off, net of recovery of accounts previously written off.
32
EXHIBIT INDEX
The following documents are filed as exhibits to this Report.
Exhibit No. |
|
|
|
Document |
|
Method of Filing |
||
|
|
|
|
|
|
|
||
(3) |
|
A. |
|
|
|
Restated Certificate of Incorporation. |
|
Incorporated by reference to Exhibit (3) to our Current Report on Form 8-K dated May 9, 2003. |
|
|
|
|
|
|
|
|
|
|
|
B. |
|
|
|
By-Laws, as amended through February 18, 1999. |
|
Incorporated by reference to Exhibit (3)B of our Form 10-K Annual Report, for the year ended December 31, 1998. |
|
|
|
|
|
|
|
|
|
(4) |
|
A. |
|
|
|
Common Stock. |
|
See Exhibits (3)A and (3)B. |
|
|
|
|
|
|
|
|
|
|
|
B. |
|
|
|
Form of Common Stock Certificate. |
|
Filed herewith electronically. |
|
|
|
|
|
|
|
|
|
|
|
C. |
|
(i) |
|
Rights Agreement dated as of February 24, 1996. |
|
Incorporated by reference to Exhibit (4) of our Current Report on Form 8-K dated February 24, 1996. |
|
|
|
|
|
|
|
|
|
|
|
|
|
(ii) |
|
Amendment, dated November 5, 2001, to the Rights Agreement dated as of February 24, 1996. |
|
Incorporated by reference to Exhibit (1) of our Form 8A/A filed November 6, 2001. |
|
|
|
|
|
|
|
|
|
|
|
D. |
|
|
|
Second Amended and Restated Stockholders Agreement between Henkel KGaA and Ecolab Inc., dated November 30, 2001. |
|
Incorporated by reference to Exhibit (4) of our Current Report on Form 8-K dated November 30, 2001. |
Exhibit No. |
|
|
|
Document |
|
Method of Filing |
||
|
|
E. |
|
|
|
Amended and Restated Indenture dated as of January 9, 2001 between Ecolab Inc. and Bank One, N.A. (formerly known as The First National Bank of Chicago) as Trustee. |
|
Incorporated by reference to Exhibit (4)(A) of our Current Report on Form 8-K dated January 23, 2001. |
|
|
|
|
|
|
|
|
|
|
|
F. |
|
|
|
Officers Certificate establishing terms and conditions of 6.875% Notes due February 1, 2011. |
|
Incorporated by reference to Exhibit 4(B) of our Current Report on Form 8-K dated January 23, 2001. |
|
|
|
|
|
|
|
|
|
|
|
G. |
|
|
|
Form of 6.875% Note due February 2, 2011. |
|
Incorporated by reference to Exhibit 4(c) of our Current Report on Form 8-K dated January 23, 2001. |
|
|
|
|
|
|
|
|
|
|
|
H. |
|
(i) |
|
Trust Deed dated 7 February 2002, constituting 300,000,000 5.375% Notes due 2007 between Ecolab Inc. and JPMorgan Chase Bank, London Branch. |
|
Incorporated by reference to Exhibit (4)H(i) of our Form 10-K Annual Report for the year ended December 31, 2001. |
|
|
|
|
|
|
|
|
|
|
|
|
|
(ii) |
|
Paying Agency Agreement, dated 7 February 2002, relating to 300,000,000 5.375% Note due 2007 among Ecolab Inc., JPMorgan Chase Bank, London Branch, J.P. Morgan Bank Luxembourg S.A. and others. |
|
Incorporated by reference to Exhibit (4)H(ii) of our Form 10-K Annual Report for the year ended December 31, 2001. |
|
|
|
|
|
|
|
|
|
(10) |
|
A. |
|
(i) |
|
Multicurrency Credit Agreement (Credit Agreement) dated as of September 29, 1993, as Amended and Restated as of December 13, 2000, among Ecolab Inc., the financial institutions party thereto, Citicorp USA, Inc. as Administrative Agent, Citibank International Plc, as Euro-Agent and Bank One, NA and Credit Suisse First Boston as Co-Agents. |
|
Incorporated by reference to Exhibit (10)A of our Current Report on Form 8-K dated January 23, 2001. |
Exhibit No. |
|
|
|
Document |
|
Method of Filing |
||
|
|
|
|
(ii) |
|
Australian Dollar Local Currency Addendum to the Credit Agreement, dated October 17, 1997. |
|
Incorporated by reference to Exhibit (4)B of our Form 10-Q for the quarter ended September 30, 1997. |
|
|
|
|
|
|
|
|
|
|
|
|
|
(iii) |
|
Australian Dollar Local Currency Addendum dated as of June 23, 1998 among Ecolab Finance PTY Limited, Ecolab Inc., Citibank, N.A., the Local Currency Agent named therein and the Local Currency Banks party thereto. |
|
Incorporated by reference to Exhibit (4)B of our Form 10-Q for the quarter ended June 30, 1998. |
|
|
|
|
|
|
|
|
|
|
|
B. |
|
(i) |
|
Credit Agreement (364 Day Facility) dated December 7, 2001 among Ecolab Inc., the Banks and Citicorp USA, Inc. |
|
Incorporated by reference to Exhibit (99)B of our Form 8-K for the quarter ended November 30, 2001. |
|
|
|
|
|
|
|
|
|
|
|
|
|
(ii) |
|
Amendment No. 1 to Credit Agreement (364 Day Facility) dated as of October 31, 2002, among Ecolab Inc., the bank parties thereto (the Banks) and Citicorp USA, Inc. as Agent for the Banks. |
|
Incorporated by reference to Exhibit (10)B(iii) of our Form 10-K for the year ended December 31, 2002. |
|
|
|
|
|
|
|
|
|
|
|
|
|
(iii) |
|
Amendment No. 2 to Credit Agreement (364 Day Facility) dated as of October 30, 2003, among Ecolab Inc., the bank parties thereto (the Banks) and Citicorp USA, Inc. as Agent for the Banks. |
|
Filed herewith electronically. |
|
|
|
|
|
|
|
|
|
|
|
C. |
|
|
|
Documents comprising global Commercial Paper Programs. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(i) |
|
U.S. $200,000,000 Euro-Commercial Paper Programme. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) Dealer Agreement dated as of 10 June 2003 among Ecolab Inc., Credit Suisse First Boston (Europe) Limited as Arranger, and Citibank International plc and Credit Suisse First Boston (Europe) Limited as Dealers. |
|
Incorporated by reference to Exhibit (10)A(i)(a) of our Form 10-Q for the quarter ended June 30, 2003. |
Exhibit No. |
|
|
|
Document |
|
Method of Filing |
||
|
|
|
|
|
|
(b) Note Agency Agreement dated as of 10 June 2003 between Ecolab Inc. and Citibank, N.A. as Issue and Paying Agent. |
|
Incorporated by reference to Exhibit (10)A(i)(b) our Form 10-Q for the quarter ended June 30, 2003. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(c) Deed of Covenant made as of 10 June 2003 by Ecolab Inc. |
|
Incorporated by reference to Exhibit (10)A(i)(c) of our Form 10-Q for the quarter ended June 30, 2003. |
|
|
|
|
|
|
|
|
|
|
|
|
|
(ii) |
|
U.S. $450,000,000 U.S. Commercial Paper Program. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) Form of Commercial Paper Dealer Agreement for 4 (2) Program. Agreements have been executed with Salomon Smith Barney, Inc. and Banc One Capital Markets, Inc. |
|
Incorporated by reference to Exhibit (10)A(ii)(a) of our Form 10-Q for the quarter ended June 30, 2003. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(b) Issuing and Paying Agency Agreement dated as of July 10, 2000 between Ecolab Inc. and Bank One, National Association as Issuing and Paying Agent. |
|
Incorporated by reference to Exhibit (10)A(ii)(b) of our Form 10-Q for the quarter ended June 30, 2003. |
|
|
|
|
|
|
|
|
|
|
|
|
|
(iii) |
|
AUD 200,000,000 Australian Commercial Paper and Medium Term Note Programme. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) Dealer Agreement dated as of 10 July 1998 among Ecolab Finance Pty Limited as Issuer, Citisecurities Limited as Arranger, and the Dealers Parties thereto. |
|
Incorporated by reference to Exhibit (10)A(iii)(a) of our Form 10-Q for the quarter ended June 30, 2003. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(b) Guarantee and Negative Pledge made by our on 10 July 1998. |
|
Incorporated by reference to Exhibit (10)A(iii)(b) of our Form 10-Q for the quarter ended June 30, 2003. |
Exhibit No. |
|
|
|
Document |
|
Method of Filing |
||
|
|
|
|
|
|
(c) Issuing and Paying Agency Agreement dated as of 10 July 1998 between Ecolab Finance Pty Limited as Issuer and Perpetual Trustee Company Limited as Agent. |
|
Incorporated by reference to Exhibit (10)A(iii)(c) of our Form 10-Q for the quarter ended June 30, 2003. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(d) MTN Program Master Note dated as of 10 July 1998 by Ecolab Finance Pty Limited. |
|
Incorporated by reference to Exhibit (10)A(iii)(d) of our Form 10-Q for the quarter ended June 30, 2003. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(e) Registry Services Deed dated as of 10 July 1998 between Ecolab Finance Pty Limited as Issuer and Perpetual Trustee Company as Registrar. |
|
Incorporated by reference to Exhibit (10)A(iii)(e) of our Form 10-Q for the quarter ended June 30, 2003. |
|
|
|
|
|
|
|
|
|
|
|
D. |
|
|
|
Ecolab Inc. 1993 Stock Incentive Plan, as amended and restated as of May 12, 2000. |
|
Incorporated by reference to Exhibit (10)D of our Form 10-K Annual Report for the year ended December 31, 2002. |
|
|
|
|
|
|
|
|
|
|
|
E. |
|
|
|
Ecolab Inc. 1997 Stock Incentive Plan, as Amended and Restated as of August 18, 2000. |
|
Incorporated by reference to Exhibit (10) of our Form 10-Q for the quarter ended September 30, 2000. |
|
|
|
|
|
|
|
|
|
|
|
F. |
|
(i) |
|
1988 Non-Employee Director Stock Option Plan as amended through February 23, 1991. |
|
Incorporated by reference to Exhibit (10)D of our Form 10-K Annual Report for the year ended December 31, 1990. |
Exhibit No. |
|
|
|
Document |
|
Method of Filing |
||
|
|
|
|
(ii) |
|
Amendment to 1988 Non-Employee Director Stock Option Plan effective May 11, 2001. |
|
Incorporated by reference to Exhibit (10)F(iii) of our Form 10-K Annual Report for the year ended December 31, 2002. |
|
|
|
|
|
|
|
|
|
|
|
G. |
|
(i) |
|
1995 Non-Employee Director Stock Option Plan. |
|
Incorporated by reference to Exhibit (10)D of our Form 10-K Annual Report for the year ended December 31, 1994. |
|
|
|
|
|
|
|
|
|
|
|
|
|
(ii) |
|
Amendment No. 1 to 1995 Non-Employee Director Stock Option Plan effective February 25, 2000. |
|
Incorporated by reference to Exhibit (10)E(ii) of our Form 10-K for the year ended December 31, 1999. |
|
|
|
|
|
|
|
|
|
|
|
|
|
(iii) |
|
Amendment No. 2 to 1995 Non-Employee Director Stock Option Plan effective May 11, 2001. |
|
Incorporated by reference to Exhibit (10)G(iii) of our Form 10-K Annual Report for the year ended December 31, 2002. |
|
|
|
|
|
|
|
|
|
|
|
H. |
|
(i) |
|
Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan. |
|
Incorporated by reference to Exhibit (10) of our Form 10-Q for the quarter ended March 31, 2001. |
|
|
|
|
|
|
|
|
|
|
|
|
|
(ii) |
|
Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan, as amended effective May 1, 2004. |
|
Filed herewith electronically. |
|
|
|
|
|
|
|
|
|
|
|
I. |
|
|
|
Form of Director Indemnification Agreement. Substantially identical agreements are in effect as to each director of Ecolab Inc. |
|
Filed herewith electronically. |
Exhibit No. |
|
|
|
Document |
|
Method of Filing |
||
|
|
J. |
|
(i) |
|
Ecolab Executive Death Benefits Plan, as amended and restated effective March 1, 1994. |
|
Incorporated by reference to Exhibit (10)J of our 10-K Annual Report for the year ended December 31, 1994. See also Exhibit (10)P hereof. |
|
|
|
|
|
|
|
|
|
|
|
|
|
(ii) |
|
Amendment No. 1 to Ecolab Executive Death Benefits Plan. |
|
Incorporated by reference to Exhibit (10)H(ii) of our 10-K Annual Report for the year ended December 31, 1998. |
|
|
|
|
|
|
|
|
|
|
|
|
|
(iii) |
|
Second Declaration of Amendment to Ecolab Executive Death Benefits Plan, effective March 1, 1998. |
|
Incorporated by reference to Exhibit (10)H(iii) of our 10-K Annual Report for the year ended December 31, 1998. |
|
|
|
|
|
|
|
|
|
|
|
K. |
|
|
|
Ecolab Executive Long-Term Disability Plan, as amended and restated effective January 1, 1994. |
|
Incorporated by reference to Exhibit (10)K of our 10-K Annual Report for the year ended December 31, 1994. See also Exhibit (10)P hereof. |
|
|
|
|
|
|
|
|
|
|
|
L. |
|
|
|
Ecolab Executive Financial Counseling Plan. |
|
Incorporated by reference to Exhibit (10)K of our Form 10-K Annual Report for the year ended December 31, 1992. |
|
|
|
|
|
|
|
|
|
|
|
M. |
|
|
|
Ecolab Supplemental Executive Retirement Plan, as amended and restated effective January 1, 2003. |
|
Filed herewith electronically. |
|
|
|
|
|
|
|
|
|
|
|
N. |
|
|
|
Ecolab Mirror Savings Plan, as amended and restated effective March 1, 2002. |
|
Incorporated by reference to Exhibit (10)N of our Form 10-K Annual Report for the year ended December 31, 2002. |
Exhibit No. |
|
|
|
Document |
|
Method of Filing |
||
|
|
O. |
|
|
|
Ecolab Mirror Pension Plan, as amended and restated effective as of January 1, 2003. |
|
Incorporated by reference to Exhibit (10)B of our Form 10-Q for the quarter ended June 30, 2003. See also Exhibit (10)P hereof. |
|
|
|
|
|
|
|
|
|
|
|
P. |
|
|
|
Ecolab Inc. Administrative Document for Non-Qualified Benefit Plans, as amended and restated effective as of January 1, 2003. |
|
Filed herewith electronically. |
|
|
|
|
|
|
|
|
|
|
|
Q. |
|
|
|
1999 Ecolab Inc. Management Performance Incentive Plan. |
|
Incorporated by reference to Exhibit (10)O of our Form 10-K Annual Report for the year ended December 31, 1998. |
|
|
|
|
|
|
|
|
|
|
|
R. |
|
|
|
Ecolab Inc. Change in Control Severance Compensation Policy, effective February 22, 2002. |
|
Incorporated by reference to Exhibit (10)R of our Form 10-K Annual Report for the year ended December 31, 2002. |
|
|
|
|
|
|
|
|
|
|
|
S. |
|
(i) |
|
Master Agreement, dated as of December 7, 2000, between Ecolab Inc. and Henkel KGaA. |
|
Incorporated by reference to Exhibit 18 of HC Investments, Inc.s and Henkel KGaAs Amendment No. 5 to Schedule 13D dated December 14, 2000. |
|
|
|
|
|
|
|
|
|
|
|
|
|
(ii) |
|
Amendment No. 1 to the Master Agreement, dated December 7, 2000, between Ecolab Inc. and Henkel KGaA. |
|
Incorporated by reference to Exhibit (10) of our Form 10-Q for the quarter ended September 30, 2001. |
|
|
|
|
|
|
|
|
|
|
|
|
|
(iii) |
|
Intellectual Property Agreement dated November 30, 2001, between Ecolab Inc. and Henkel KGaA. |
|
Incorporated by reference to Exhibit (10) of our Current Report on Form 8-K dated November 30, 2001. |
Exhibit No. |
|
|
|
Document |
|
Method of Filing |
||
|
|
T. |
|
|
|
Description of Ecolab Inc. Management Incentive Plan. |
|
Incorporated by reference to Exhibit (10)R of our Form 10-K for the year ended December 31, 2001. |
|
|
|
|
|
|
|
|
|
|
|
U. |
|
(i) |
|
Hiring Letter of Bruno Deschamps. |
|
Incorporated by reference to Exhibit (10)T of our Form 10-K for the year ended December 31, 2000. |
|
|
|
|
|
|
|
|
|
|
|
|
|
(ii) |
|
Separation Agreement between Ecolab Inc. and Bruno Deschamps effective March 11, 2002. |
|
Incorporated by reference to Exhibit (10) of our Form 10-Q for the quarter ended March 31, 2002. |
|
|
|
|
|
|
|
|
|
|
|
V. |
|
|
|
Ecolab Inc. 2002 Stock Incentive Plan. |
|
Incorporated by reference to Exhibit (10) of our Form 10-Q for the quarter ended June 30, 2002. |
|
|
|
|
|
|
|
|
|
(13) |
|
|
|
|
|
Those portions of our Annual Report to Stockholders for the year ended December 31, 2003 which are incorporated by reference into Parts I, II and IV hereof. |
|
Filed herewith electronically. |
|
|
|
|
|
|
|
|
|
(21) |
|
|
|
|
|
List of Subsidiaries as of February 27, 2004. |
|
Filed herewith electronically. |
|
|
|
|
|
|
|
|
|
(23) |
|
|
|
|
|
Consent of Independent Accountants at page 31 hereof is filed as a part hereof. |
|
See page 31 hereof. |
|
|
|
|
|
|
|
|
|
(24) |
|
|
|
|
|
Powers of Attorney. |
|
Filed herewith electronically. |
|
|
|
|
|
|
|
|
|
(31) |
|
|
|
|
|
Rule 13a-14(a) Certifications. |
|
Filed herewith electronically. |
|
|
|
|
|
|
|
|
|
(32) |
|
|
|
|
|
Section 1350 Certifications. |
|
Filed herewith electronically. |
|
|
|
|
|
|
|
|
|
(99) |
|
A. |
|
|
|
Ecolab Code of Conduct. |
|
Filed herewith electronically. |
|
|
|
|
|
|
|
|
|
|
|
B. |
|
|
|
Code of Ethics for Senior Officers and Finance Associates. |
|
Filed herewith electronically. |
Number
NCU
Common Stock
Par Value $1.00
[Graphic]
Shares
Incorporated under the laws of the State of Delaware
[Logo]
CUSIP 278865 10 0
See Reverse for Certain Definitions
ECOLAB INC.
This Certifies that
[SPECIMEN]
is the owner of Fully Paid and Non Assessable Shares of the Common Stock of Ecolab Inc. transferable on the books of the Corporation by the holder hereof in person or by duly authorized attorney upon surrender of this certificate properly endorsed. This certificate is not valid unless countersigned by the Transfer Agent and registered by the Registrar.
Witness the facsimile seal of the Corporation and the facsimile signatures of its duly authorized officers.
[Seal]
Dated:
/s/ A. L. Schuman |
|
|
Chairman of the Board |
||
|
||
/s/ L. T. Bell |
|
|
Secretary |
||
|
||
Countersigned and Registered: |
||
EquiServe Trust Company, N.A., |
||
By |
||
Transfer Agent and Registrar. |
||
Authorized Signature. |
||
ECOLAB INC .
The corporation will furnish, without charge, to each stockholder who so requests, a printed statement of the powers, designations, preferences and relative, participating, optional or other special rights of each class of stock or series thereof which the corporation is authorized to issue and the qualifications, limitations or restrictions of such preferences and/or rights. Requests may be directed to the Secretary of ECOLAB INC. at its principal office, or the Transfer Agent named on the face of this certificate.
This Certificate also evidences and entitles the holder hereof to certain Rights as set forth in the Rights Agreement between Ecolab Inc. (the Company) and First Chicago Trust Company of New York (the Rights Agent) dated as of February 24, 1996, as the same may be amended from time to time (the Rights Agreement), the terms of which are hereby incorporated herein by reference and a copy of which is on file at the principal offices of the Company. Under certain circumstances, as set forth in the Rights Agreement, such Rights will be evidenced by separate certificates and will no longer be evidenced by this certificate. The Company will mail to the holder of this certificate a copy of the Rights Agreement, as in effect on the date of mailing, without charge promptly after receipt of a written request therefor. Under certain circumstances set forth in the Rights Agreement, Rights issued to, or held by, any Person who is, was or becomes an Acquiring Person or an Adverse Person or any Affiliate or Associate thereof (as such terms are defined in the Rights Agreement), whether currently held by or on behalf of such Person or by any subsequent holder, may become null and void.
The following abbreviations, when used in the inscription on the face of this certificate, shall be construed as though they were written out in full according to applicable laws or regulations:
For value received, hereby sell, assign and transfer unto
Please insert Social Security or other identifying number of assignee |
|
|
||||
|
|
|
||||
|
|
|
||||
Please print or typewrite name and address including postal zip code of assignee |
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
Shares of the capital stock |
|
|||
represented by the within Certificate, and do hereby irrevocably constitute |
|
|
||||
and appoint |
|
|
|
|
||
|
|
|
||||
|
|
|
||||
Attorney to transfer the said stock on the books of the within-named Corporation with full |
|
|||||
power of substitution in the premises. |
|
|
||||
Dated, |
|
|
||
|
||||
|
||||
|
|
|
||
NOTICE: The signature to this assignment must correspond with the name as written upon the face of the Certificate, in every particular, without alteration, or enlargement, or any change whatever.
EXHIBIT (10)B(iii)
AMENDMENT NO. 2
to
CREDIT AGREEMENT (364 Day Facility)
Dated as of October 30, 2003
This AMENDMENT NO. 2 TO CREDIT AGREEMENT ( Amendment ), dated as of October 30, 2003, is entered into by and among Ecolab Inc., a Delaware corporation (the Borrower ), the financial institutions party hereto (the Banks ), and Citicorp USA, Inc. ( Citicorp ), as administrative agent (the Agent ) for the Banks. Each capitalized term used herein and not defined herein shall have the meaning ascribed thereto in the below-defined Credit Agreement.
PRELIMINARY STATEMENT
The Borrower, the Banks and the Agent are parties to the Credit Agreement (364 Day Facility) dated as of December 7, 2001 (as the same may be amended, restated, supplemented or otherwise modified from time to time, the Credit Agreement ). The Borrower, the Banks and the Agent have agreed to amend the Credit Agreement pursuant to the terms of this Amendment.
SECTION 1. Amendments to the Credit Agreement . Effective as of the date hereof, subject to the satisfaction of the condition precedent set forth in Section 2 below, the Credit Agreement is hereby amended as follows:
1.1 The definition of Stated Termination Date in Section 1.01 is hereby amended by deleting October 30, 2003 and substituting October 28, 2004 therefor.
1.2 Clause (iii) of Section 9.02(a) is hereby amended and restated in its entirety as follows:
(iii) if to the Agent, at its address at Bank Loan Syndications, Two Penns Way, Suite 200, New Castle, Delaware 19720, Attention: Lisa Rodriguez, Telecopier No. 212-994-0961, with a copy to Citicorp Securities, Inc., 388 Greenwich Street, New York City, New York 10013, Attention: Carolyn Sheridan, Telecopier No. 212-816-8185;
1.3 Section 9.13 is hereby amended to insert the following sentence at the end thereof:
Notwithstanding anything to the contrary set forth herein, e ach party hereto (and each officer, director, employee, accountant, attorney, advisor, agent and representative of each such party) may disclose to any and all Persons, without limitation of any kind, the U.S. tax treatment and U.S. tax structure of the transactions evidenced hereby and all materials of any kind (including opinions and other tax analyses) that are provided to any of them relating to such U.S. tax treatment and U.S. tax
structure.
1.4 Schedule I is hereby deleted in its entirety and replaced with Schedule I hereto.
1.5 Schedule II is hereby deleted in its entirety and replaced with Schedule II hereto.
SECTION 2. Condition Precedent . This Amendment shall become effective and be deemed effective as of the date hereof (or if such items are not received until a later date, on such later date) upon the Agents receipt of duly executed originals of this Amendment from the Borrower and each Bank.
SECTION 3. Covenants, Representations and Warranties of the Borrower .
3.1 Upon the effectiveness of this Amendment, the Borrower hereby reaffirms all covenants, representations and warranties made by it in the Credit Agreement, as amended hereby, and agrees that all such covenants, representations and warranties shall be deemed to have been re-made as of the effective date of this Amendment.
3.2 The Borrower hereby represents and warrants that (i) this Amendment constitutes a legal, valid and binding obligation of the Borrower, enforceable against the Borrower in accordance with its terms, except as enforceability thereof may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws relating to or affecting creditors rights generally and by the effect of general principles of equity and (ii) upon the effectiveness of this Amendment, no Event of Default or Default shall exist with respect to the Borrower.
SECTION 4. Reference to and Effect on the Credit Agreement .
4.1 Upon the effectiveness of this Amendment, each reference in the Credit Agreement to this Agreement, hereunder, hereof, herein or words of like import shall mean and be a reference to the Credit Agreement, as amended hereby, and each reference to the Credit Agreement in any other document, instrument or agreement executed and/or delivered in connection with the Credit Agreement shall mean and be a reference to the Credit Agreement as amended hereby.
4.2 Except as specifically amended above, the Credit Agreement, the Notes and all other documents, instruments and agreements executed and/or delivered in connection therewith shall remain in full force and effect and are hereby ratified and confirmed.
4.3 The execution, delivery and effectiveness of this Amendment shall not operate as a waiver of any right, power or remedy of any party under the Credit Agreement, the Notes or any other document, instrument or agreement executed in connection therewith, nor constitute a waiver of any provision contained therein, except as specifically set forth herein.
2
SECTION 5. Execution in Counterparts . This Amendment may be executed in any number of counterparts and by different parties hereto in separate counterparts, each of which when so executed and delivered shall be deemed to be an original and all of which taken together shall constitute one and the same instrument.
SECTION 6. Governing Law . This Amendment shall be governed by, and construed in accordance with, the laws of the State of New York.
SECTION 7. Headings . Section headings in this Amendment are included herein for convenience of reference only and shall not constitute a part of this Amendment for any other purpose.
The remainder of this page is intentionally blank.
3
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed by their respective officers thereunto duly authorized, as of the date first above written.
|
ECOLAB INC. |
||
|
|
|
|
|
By: |
/s/ Mark D. Vangsgard |
|
|
|
Name: Mark D. Vangsgard |
|
|
|
Title: Vice President and Treasurer |
|
|
|
|
|
|
CITICORP USA, INC., as Administrative Agent |
||
|
|
|
|
|
By: |
/s/ Carolyn A. Sheridan |
|
|
|
Name: Carolyn A. Sheridan |
|
|
|
Title: Managing Director & Vice President |
|
Banks |
|||||||||
|
|
|
||||||||
|
CITICORP USA, INC . |
|||||||||
|
By: |
/s/ Carolyn A. Sheridan |
|
|||||||
|
|
Name: Carolyn A. Sheridan |
||||||||
|
|
Title: Managing Director & Vice President |
||||||||
|
|
|
||||||||
|
JPMORGAN CHASE BANK |
|||||||||
|
By: |
/s/ Stacey L. Haimes |
|
|||||||
|
|
Name: Stacey L. Haimes |
||||||||
|
|
Title: Vice President |
||||||||
|
|
|
||||||||
|
CREDIT SUISSE FIRST BOSTON |
|||||||||
|
Cayman Islands Branch |
|||||||||
|
By: |
/s/ Karl Studer |
|
|||||||
|
|
Name: Karl Studer |
||||||||
|
|
Title: Director |
||||||||
|
|
|
||||||||
|
By: |
/s/ Cedric Evard |
|
|||||||
|
|
Name: Cedric Evard |
||||||||
|
|
Title: Assistant Vice President |
||||||||
|
|
|
||||||||
|
BANK ONE, NA (Main Office Chicago) |
|||||||||
|
By: |
/s/ Jenny A. Gilpin |
|
|||||||
|
|
Name: Jenny A. Gilpin |
||||||||
|
|
Title: Managing Director |
||||||||
|
|
|
||||||||
|
WELLS FARGO BANK, |
|||||||||
|
NATIONAL ASSOCIATION |
|||||||||
|
By: |
/s/ James D. Heinz |
|
|||||||
|
|
Name: James D. Heinz |
||||||||
|
|
Title: Senior Vice President |
||||||||
|
|
|
||||||||
|
By: |
/s/ Allison S. Gelfman |
|
|||||||
|
|
Name: Allison S. Gelfman |
||||||||
|
|
Title: Vice President |
||||||||
|
|
|
||||||||
|
WACHOVIA BANK, |
|||||||||
|
NATIONAL ASSOCIATION |
|||||||||
|
By: |
/s/ Steven L. Hipsman |
|
|||||||
|
|
Name: Steven L. Hipsman |
||||||||
|
|
Title: Director |
||||||||
|
|
|
||||||||
|
BANK OF AMERICA, N.A. |
|||||||||
|
By: |
/s/ Wendy J. Gorman |
|
|||||||
|
|
Name: Wendy J. Gorman |
||||||||
|
|
Title: Managing Director |
||||||||
|
|
|
||||||||
|
BARCLAYS BANK PLC |
|||||||||
|
By: |
/s/ Nicholas Bell |
|
|||||||
|
|
Name: Nicholas Bell |
||||||||
|
|
Title: Director |
||||||||
SCHEDULE I
Applicable Lending Offices and Notice Addresses
CITICORP USA, INC.
Notice Address:
Citicorp USA, Inc.
c/o Citicorp Securities, Inc.
388 Greenwich Street
New York City, New York 10013
Attn: Carolyn Sheridan
Telecopier No.: 212-816-8185
Domestic Lending Office and Eurodollar Lending Office:
Citicorp USA, Inc.
Bank Loan Syndications
Two Penns Way, Suite 200
New Castle, Delaware 19720
Attn: Lisa Rodriguez
Telecopier No.: 212-994-0961
JPMORGAN CHASE BANK
Notice Address:
JPMorgan Chase Bank
227 West Monroe Street, 27 th Floor
Chicago,
Illinois 60606
Attn: Laura Born
Telecopier No.: 312-541-3441
Confirmation
No.: 312-541-3379
E-mail:
laura born@jpmorgan.com
Domestic Lending Office and Eurodollar Lending Office:
JPMorgan
Chase Bank
1111 Fanin, 10
th
Floor
Houston, TX 77002
Attn: Danette Espinoza
Telecopier No.: 713-750-2782
WELLS FARGO BANK, NATIONAL ASSOCIATION
Notice Address and Domestic Lending Office:
Wells
Fargo Bank, National Association
Sixth & Marquette MAC N305-031
Minneapolis, MN 55479
Attn: Ethel Philips
Telecopier No.: 612-667-4145
and to: Allison Gelfman
Telecopier No.: 612-667-4145
E-Mail:
allison.s.gelfman@wellsfargo.com
Eurodollar Lending Office:
Wells
Fargo Bank, National Association
Sixth & Marquette MAC N305-031
Minneapolis, MN 55479
Attn: Ethel Philips
Telecopier No.: 612-667-4145
and to: Allison Gelfman
Telecopier No.: 612-667-4145
CREDIT SUISSE FIRST BOSTON
Notice Address:
Eleven Madison Avenue
New York, NY 10010
Attn: Karl Studer, Corporate Banking
Telecopier: 212-743-1894
E-Mail: karl.studer@csfb.com
Domestic Lending Office and Eurodollar Lending Office:
Credit Suisse First
Boston
One Madison Avenue
New York, New York 10010
Attn: Ed Markowski
and to: Hazel Leslie
Telecopier No.: 212-538-6851
(With a copy to the Notice Address)
BANK ONE, NA
Notice Address:
Bank One, NA
Suite 0173, 14th Floor
1 Bank One Plaza
Chicago, Illinois 60670-0324
Attn: Jenny Gilpin
Telecopier No.: 312-732-3888
E-Mail:
jenny gilpin@bankone.com
Domestic Lending Office and Eurodollar Lending Office:
Bank One, NA
1 Bank One Plaza
Chicago, Illinois 60670
Attn: Deanna Lee
Telecopier No.: 312-732-4303
WACHOVIA BANK, NATIONAL ASSOCIATION
Notice Address:
Wachovia Bank, N.A.
191 Peachtree Street
Mail Code GA8050
Atlanta, Georgia 30303
Attn: Steven Hipsman
Ms. Teresa Howard (Operations/Administration)
Telecopier No.: 404-332-4048 (Credit
Matters)
404-332-1118
(Operations/Administration)
E-Mail: stevenhipsman@wachovia.com
Domestic Lending Office and Eurodollar Lending Office:
Wachovia Bank, N.A.
201 South College Street
Attn: Sharon Gibson
Telecopier No.: 704-715-0094
BANK OF AMERICA, N.A.
Notice Address:
Bank of America, N.A.
100 North Tryon Street
Charlotte, North
Carolina 28255-0001
Attn: Lawrence Saunders
Telecopier No.: 704-386-1447
E-Mail:
lawrence.saunders@bankofamerica.com
With a copy to:
Bank of America, N.A.
335 Madison Avenue, 5 th Floor
New York, New York 10017
Attn: Colleen Briscoe
Telecopier No.: 212-503-7878
E-Mail: colleen.m.briscoe@bankofamerica.com
Domestic Lending Office and Eurodollar Lending Office:
Bank of America, N.A.
101 North Tryon Street
Charlotte, North
Carolina 28255-0001
Attn: Curtis Lancy
Telecopier No.: 888-969-9252
BARCLAYS BANK PLC
Notice Address:
Administrative Matters
Barclays Bank PLC
200 Park Avenue, 4
th
Floor
New York, New York 10188
Attn: David Barton
Telecopier No.: 212-412-7511
E-Mail: Davide.Barton@barcap.com
Operations Matters
Barclays Bank PLC
222 Broadway - 7 th Floor
New York, New York 10038
Attn: Eddie Cotto
Telecopier No: 212-412-5306
E-Mail: eddie.cotto@barcap.com
Domestic Lending Office and Eurodollar Lending Office:
Barclays Bank PLC
200 Park Avenue
New York, New York 10188
(Notices to be addressed as specified above)
SCHEDULE II
Commitments
Institution |
|
Commitment |
|
|
Citicorp USA, Inc. |
|
$ |
32,500,000 |
|
JPMorgan Chase Bank |
|
$ |
32,500,000 |
|
Credit Suisse First Boston |
|
$ |
30,000,000 |
|
Bank One, NA (Main Office Chicago) |
|
$ |
20,000,000 |
|
Wells Fargo Bank, National Association |
|
$ |
20,000,000 |
|
Wachovia Bank, N.A. |
|
$ |
20,000,000 |
|
Bank of America, N.A. |
|
$ |
10,000,000 |
|
Barclays Bank PLC |
|
$ |
10,000,000 |
|
Total |
|
$ |
175,000,000 |
|
EXHIBIT (10)H(ii)
ECOLAB INC.
2001 NON-EMPLOYEE DIRECTOR STOCK OPTION AND
DEFERRED COMPENSATION PLAN
(as amended effective as of May 1, 2004)
2
3
A Qualified Director may be granted from time to time one or more options to purchase that number of whole Shares as determined by the Board in its sole discretion (Periodic Options). Periodic Options will be deemed to be granted as of the date specified in the grant resolution of the Board. The terms of the Periodic Options are set forth in Section 9.
4
5
6
7
8
9
Notwithstanding anything in the Plan to the contrary, if a Participant is determined by the Board, acting in its sole discretion, to have committed any action which would constitute Cause as defined in Section 15.8, irrespective of whether such action or the Boards determination occurs before or after such Participant ceases to serve as a director of the Company, all rights of the Participant under the Plan attributable to unexercised Periodic Options granted under Section 8 and any agreements evidencing a Periodic Option then held by the Participant will terminate and be forfeited without notice of any kind. Benefits attributable to amounts credited to a Participants Account pursuant to Sections 4 and 5 and any earnings credited with respect to such amounts pursuant to Sections 6.1 and 6.2 will not be forfeited.
10
11
Notwithstanding any other provision of the Plan or any agreements entered into pursuant to the Plan to the contrary, neither the Company nor the Trustee is required to issue or distribute any Shares under the Plan, and a Participant or distributee may not sell, assign, transfer or otherwise dispose of Shares issued or distributed pursuant to the Plan, unless (a) there is in effect with respect to such Shares a registration statement under the Securities Act and any applicable securities laws of a state or foreign jurisdiction or an exemption from such registration under the Securities Act and applicable state or foreign securities laws, and (b) there has been obtained any other consent, approval or permit from any other regulatory body which the Company, in its sole discretion, deems necessary or advisable. The Company or the Trustee may condition such issuance, distribution, sale or transfer upon the receipt of any representations or agreements from the parties involved, and the placement of any legends on certificates representing Shares, as may be deemed necessary or advisable by the Company in order to comply with such securities law or other restrictions.
12
The definitions set forth in this Section 15 apply unless the context otherwise indicates.
13
14
15
16
17
18
19
20
EXHIBIT (10)I
INDEMNIFICATION AGREEMENT
AGREEMENT, effective as of , , between Ecolab Inc., a Delaware corporation (the Company), and (the Director), a director of the Company;
WHEREAS, in recognition of Directors need for substantial protection against personal liability in order to enhance Directors service to the Company in an effective manner and Directors reliance on the provisions of the By - Laws requiring indemnification of the Director under certain circumstances, and in part to provide Director with specific contractual assurance that the protection promised by such By - Laws will be available to Director (regardless of, among other things, any amendment to or revocation of such By - Laws or any change in the composition of the Companys Board of Directors or acquisition transaction relating to the Company), the Company wishes to provide in this Agreement for the indemnification of and the advancing of expenses to Director to the full extent (whether partial or complete) permitted by law and as set forth in this Agreement, and, to the extent insurance is maintained, for the continued coverage of Director under the Companys directors and officers liability insurance policies.
NOW THEREFORE, in consideration of the premises and of Director agreeing to serve or continuing to serve the Company directly or, at its request, with another enterprise, and intending to be legally bound hereby, the parties hereto agree as follows:
1. Basic Indemnification Arrangement .
(a) In the event Director was, is or becomes a party to or witness or other participant in, or is threatened to be made a party to or witness or other participant in, a Claim by reason of (or arising in part out of) an Indemnifiable Event, the Company shall indemnify Director to the fullest extent permitted by law as soon as practicable but in any event no later than 30 days after written demand is presented to the Company, against any and all Expenses, judgments, fines, penalties and amounts paid in settlement of such Claim. If so requested by Director, the Company shall advance (within ten business days of such written request) any and all Expenses to Director (an Expense Advance). Notwithstanding anything in this Agreement to the contrary, and except as provided in Section 3, prior to a Change in Control Director shall not be entitled to indemnification pursuant to this Agreement in connection with any Claim initiated by Director against the Company or any director or officer of the Company unless the Company has joined in or consented to the initiation of such Claim.
(b) Notwithstanding the foregoing, (i) the obligations of the Company under Section 1(a) shall be subject to the condition that the Reviewing Party shall not have determined (in a written opinion, in any case in which the special independent counsel referred to in Section 2 hereof is involved) that Director would not be permitted to be
indemnified under applicable law, and (ii) the obligation of the Company to make an Expense Advance pursuant to Section 1(a) shall be subject to the condition that, if, when and to the extent that the Reviewing Party determines that Director would not be permitted to be so indemnified under applicable law, the Company shall be entitled to be reimbursed by Director (who hereby agrees to reimburse the Company) for all such amounts theretofore paid; provided, however, that if Director has commenced legal proceedings in a court of competent jurisdiction to secure a determination that Director should be indemnified under applicable law, any determination made by the Reviewing Party that Director would not be permitted to be indemnified under applicable law shall not be binding and Director shall not be required to reimburse the Company for any Expense Advance until a final judicial determination is made with respect thereto (as to which all rights of appeal there from have been exhausted or lapsed). If there has not been a Change in Control, the Reviewing Party shall be selected by the Board of Directors, and if there has been such a Change in Control, the Reviewing Party shall be the special independent counsel referred to in Section 2 hereof. If there has been no determination by the Reviewing Party or if the Reviewing Party determines that Director substantively would not be permitted to be indemnified in whole or in part under applicable law, Director shall have the right to commence litigation in any court in the states of Minnesota or Delaware having subject matter jurisdiction thereof and in which venue is proper seeking an initial determination by the court or challenging any such determination by the Reviewing Party or any aspect thereof, and the Company hereby consents to service of process and to appear in any such proceeding. Any determination by the Reviewing Party otherwise shall be conclusive and binding on the Company and Director.
2. Change in Control .
The Company agrees that if there is a Change in Control of the Company, then with respect to all matters thereafter arising concerning the rights of Director to indemnity payments and Expense Advances under this Agreement or any other agreement or Company By - Law now or hereafter in effect relating to Claims for Indemnifiable Events, the Company shall seek legal advice only from special independent counsel selected by Director and approved by the Company (which approval shall not be unreasonably withheld), and who has not otherwise performed services for the Company within the last five years (other than in connection with such matters) or Director. Such counsel, among other things, shall render its written opinion to the Company and Director as to whether and to what extent the Director would be permitted to be indemnified under applicable law. The Company agrees to pay the reasonable fees of the special, independent counsel referred to above and to fully indemnify such counsel against any and all expenses (including attorneys fees), claims, liabilities and damages arising out of or relating to this Agreement or its engagement pursuant hereto.
2
3. Indemnification for Additional Expenses .
The Company shall indemnify Director against any and all expenses (including attorneys fees) and, if requested by Director, shall (within ten business days of such written request) advance such expenses to Director, which are incurred by Director in connection with any claim asserted against or action brought by Director for (i) indemnification or advance payment of Expenses by the Company under this Agreement or any other agreement or Company By-Law now or hereafter in effect relating to Claims for Indemnifiable Events and/or (ii) recovery under any directors and officers liability insurance policies maintained by the Company, regardless of whether Director ultimately is determined to be entitled to such indemnification, advance expense payment or insurance recovery, as the case may be.
4. Partial Indemnity, Etc.
If Director is entitled under any provision of this Agreement to indemnification by the Company of some or a portion of the Expenses, judgments, fines, penalties and amounts paid in settlement of a Claim but not, however, for all of the total amount thereof, the Company shall nevertheless indemnify Director for the portion thereof to which Director is entitled. Moreover, notwithstanding any other provision of this Agreement, to the extent that Director has been successful on the merits or otherwise in defense of any or all Claims relating in whole or in part to an Indemnifiable Event or in defense of any issue or matter therein, including dismissal without prejudice, Director shall be indemnified against all Expenses incurred in connection therewith. In connection with any determination by the Reviewing Party or otherwise as to whether Director is entitled to be indemnified hereunder the burden of proof shall be on the Company to establish that Director is not so entitled.
5. No Presumption .
For purposes of this Agreement, the termination of any action, suit or proceeding by judgment, order, settlement (whether with or without court approval) or conviction, or upon a plea of nolo contendere, or its equivalent, shall not create a presumption that Director did not meet any particular standard of conduct or have any particular belief or that a court has determined that indemnification is not permitted by applicable law.
6. Non - exclusivity, Etc.
The rights of the Director hereunder shall be in addition to any other rights Director may have under the Companys By - Laws or the Delaware General Corporation Law or otherwise. To the extent that a change in the Delaware General Corporation Law (whether by statute or judicial decision), or the Companys By - Laws, permits greater indemnification by agreement than would be afforded currently under the Companys By - Laws and this
3
Agreement, it is the intent of the parties hereto that Director shall enjoy by this Agreement the greater benefits so afforded by such change.
7. Liability Insurance .
To the extent the Company maintains an insurance policy or policies providing directors and officers liability insurance, Director shall be covered by such policy or policies, in accordance with its or their terms, to the maximum extent of the coverage available for any Company director.
8. Certain Definitions:
(a) Change in Control : For purposes of this Agreement, a Change in Control shall be deemed to have occurred if at any time any of the following events shall occur:
(i) any person, as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended (the Exchange Act) (other than the Company, any trustee or other fiduciary holding securities under any employee benefit plan of the Company, or any corporation owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of stock of the Company), is or becomes the beneficial owner (as defined in Rule 13d - 3 under the Exchange Act), directly or indirectly of securities of the Company representing 25% or more of the combined voting power of the Companys then outstanding securities, other than in a transaction arranged or approved by the Board of Directors of the Company (the Board) prior to its occurrence; provided, however, that if any such person shall become the beneficial owner, directly or indirectly, of securities of the Company representing 34% or more of the combined voting power of the Companys then outstanding securities, a Change in Control shall be deemed to occur whether or not any or all of such beneficial ownership is obtained in a transaction arranged or approved by the Board prior to its occurrence, and other than in a transaction in which such person shall have executed a written agreement with the Company (and approved by the Board) on or prior to the date on which such person becomes the beneficial owner of 25% or more of the combined voting power of the Companys then outstanding securities, which agreement imposes one or more limitations on the amount of such persons beneficial ownership of shares of Common Stock (Shareholder Agreement), if, and so long as, such Shareholder Agreement (or any amendment thereto approved by the Board provided that no such amendment shall cure any prior breach of such Agreement or any amendment thereto) continues to be binding on such person and such person is in compliance (as determined by the Board in its discretion) with the terms of such Shareholder Agreement (including such amendment); provided, however, that if any such person shall become the beneficial owner directly or indirectly, of securities of the Company representing 50% or more of the combined voting power of the Companys then
4
outstanding securities, a Change in Control shall be deemed to occur whether or not such beneficial ownership was held in compliance with a binding Shareholder Agreement;
(ii) during any period of two consecutive years (not including any period prior to the execution of this Agreement), individuals who at the beginning of such period constitute the Board, and any new director (other than a director designated by a person who has entered into an agreement with the Company to effect a transaction which would constitute a Change in Control pursuant to clause (i), (iii) or (iv) of this Section 8(a)) whose election by the Board or nomination for election by the Companys stockholders was approved by a vote of at least two - thirds of the directors then still in office who either were directors at the beginning of the period or whose election or nomination for election was previously so approved, cease for any reason to constitute at least a majority thereof;
(iii) the stockholders of the Company approve a merger or consolidation of the Company with any other corporation, other than (i) a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than 80% of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation or (ii) a merger or consolidation effected to implement a recapitalization of the Company (or similar transaction) in which no person acquires a percentage of the combined voting power of the Companys then outstanding securities which would constitute a Change in Control pursuant to Section 8(a)(i).
(iv) the stockholders of the Company approve a plan of complete liquidation of the Company or an agreement for the sale or disposition by the Company of all or substantially all of the Companys assets.
(b) Claim : any threatened, pending or completed action, suit or proceeding, or any inquiry or investigation whether conducted by the Company or any other party, whether civil, criminal, administrative, or investigative.
(c) Expenses : include attorneys fees and all other costs, expenses and obligations paid or incurred in connection with investigating, defending, being a witness in or participating in (including on appeal), or preparing to defend, be a witness in or participate in any Claim relating to any Indemnifiable Event.
(d) Indemnifiable Event : any event or occurrence related to the fact that Director is or was a director, officer, employee, agent or fiduciary of the Company, or is or was serving at the request of the Company as a director, officer, employee, trustee, agent or
5
fiduciary of another corporation, partnership, joint venture, employee benefit plan, trust or other enterprise, or by reason of anything done or not done by Director in any such capacity.
(e) Reviewing Party : any appropriate person or body consisting of a member or members of the Companys Board of Directors or any other person or body appointed by the Board (including the special independent counsel referred to in Section 2) who is not a party to the particular Claim for which Director is seeking indemnification.
(f) Voting Securities : any securities of the Company which vote generally in the election of directors.
9. Amendments and Waiver .
No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by both of the parties hereto. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions hereof (whether or not similar) nor shall such waiver constitute a continuing waiver.
10. Subrogation .
In the event of payment under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of recovery of Director, who shall execute all papers required and shall do everything that may be necessary to secure such rights, including the execution of such documents necessary to enable the Company effectively to bring suit to enforce such rights.
11. No Duplication of Payments .
The Company shall not be liable under this Agreement to make any payment in connection with any claim made against Director to the extent Director has otherwise actually received payment (under any insurance policy, By - Law or otherwise) of the amounts otherwise indemnifiable hereunder.
12. Binding Effect, Etc.
This Agreement shall be binding upon and inure to the benefit of and be enforceable by the parties hereto and their respective successors, assigns, including any direct or indirect successor by purchase, merger, consolidation or otherwise to all or substantially all of the business and/or assets of the Company, spouses, heirs, and personal and legal representatives. This Agreement shall continue in effect regardless of whether Director continues to serve as a director (or in one of the capacities enumerated in Section 8(d) hereof) of the Company or of any other enterprise at the Companys request.
6
13. Severability .
The provisions of this Agreement shall be severable in the event that any of the provisions hereof (including any provision within a single section, paragraph or sentence) are held by a court of competent jurisdiction to be invalid, void or otherwise unenforceable, and the remaining provisions shall remain enforceable to the fullest extent permitted by law.
14. Governing Law .
This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Delaware applicable to contracts made and to be performed in such state without giving effect to the principles of conflicts of laws.
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the day and year first above written.
|
|
ECOLAB INC. |
|
|
|
|
|
|
|
|
|
Director |
|
By: |
|
|
|
|
|
7
EXHIBIT (10)M
ECOLAB
SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN
(As Amended and Restated Effective as of January 1, 2003)
WHEREAS, the Company previously established the Ecolab Supplemental Executive Retirement Plan (the Plan) to provide additional retirement benefits in consideration of services performed and to be performed by certain participants for the Company and certain related corporations.
NOW, THEREFORE, pursuant to Section 1.3 of the Plan and Section 5.1 of the Ecolab Inc. Administrative Document for Non-Qualified Benefit Plans, the Company hereby amends and restates the Plan in its entirety to read as follows:
Words and phrases used herein with initial capital letters which are defined in the Pension Plan or the Administrative Document are used herein as so defined, unless otherwise specifically defined herein or the context clearly indicates otherwise. The following words and phrases when used in this Plan with initial capital letters shall have the following respective meanings, unless the context clearly indicates otherwise:
2
3
(a) = one-twelfth (1/12th) of the Executives Final Average Compensation, multiplied by two percent (2%) for each of the Executives Years of Benefit Service (up to a maximum of 30), reduced by (i) the Pension Benefit, (ii) the Mirror Pension Benefit, (iii) fifty percent (50%) of the Primary Insurance Amount, and (iv) the Savings Plan Benefit; and
(b) = the difference between (i) one-twelfth (1/12th) of the Executives Final Average Compensation, and (ii) one-twelfth (1/12 th ) of the Executives Annual Compensation for the Plan Year in which the Executive commenced employment with the Controlled Group, multiplied by one percent (1%) for each of the Executives Years of Past Service Credit (if any).
For purposes of subsection (1)(b)(ii), if the Executive was not an Employee for the entire Plan Year, his Annual Compensation for such Plan Year shall be annualized based on the number of days employed by the Controlled Group out of a Plan Year of 365 days.
4
6
7
8
IN WITNESS WHEREOF, Ecolab Inc. has executed this Supplemental Executive Retirement Plan and has caused its corporate seal to be affixed this 11 th day of November, 2003.
|
ECOLAB INC. |
|||
|
|
|
||
|
|
|
||
|
By: |
/s/Steven L. Fritze |
|
|
|
|
Steven L. Fritze |
||
|
|
Senior Vice President and |
||
|
|
Chief Financial Officer |
||
|
|
|
||
(Seal) |
|
|
||
|
|
|
||
Attest: |
|
|
||
|
|
|
||
|
|
|
||
/s/Lawrence T. Bell |
|
|
|
|
Lawrence T. Bell |
|
|
||
Senior Vice President,
|
|
|
||
9
EXHIBIT A
ACTUARIAL ASSUMPTIONS
FOR SERP BENEFITS AND
SERP PRE-RETIREMENT BENEFITS
1. Interest Rate: |
|
|
|
|
|
A. For Lump Sum |
|
The interest rate will be 125% of the 10-year Treasury rate for the month of October preceding the Plan Year (i.e., January 1) (1) in which the retirement or other termination of employment is effective if the SERP Benefit is to commence immediately following such retirement or termination of employment or (2) in which the distribution becomes payable if the payment is to be deferred. |
|
|
|
B. General Actuarial Equivalence |
|
7.5% except as provided in item 4 below. |
|
|
|
2. Mortality General Actuarial Equivalence |
|
1971 Group Annuity Table. |
|
|
|
3. Annuity Values Weighted General Actuarial Equivalence |
|
75% male, 25% female. |
|
|
|
4. Lump Sum Early Commencement: |
|
If payment is in the form of a single lump sum, the lump sum interest shall be based on the lump sum interest rate defined in item 1 above, and the early retirement benefit immediate annuity amount as determined under Section 3.3(2). |
10
EXHIBIT B
PRIMARY SOCIAL SECURITY BENEFITS
(A) For purposes of the Plan, an Executives monthly primary social security benefit is the estimated social security benefit amount, under the Old Age and Survivors Insurance Benefit Act of the United States in effect on the first day of the calendar year during which the Executive terminates his employment, which the Executive is receiving, or would be entitled to receive, commencing at his attainment of age 65, whether or not he applies for, or actually receives, such benefits.
(B) The amounts determined under section (A) hereof shall be based upon the following assumptions:
(1) except as otherwise provided in clause (5) hereof, the Executive is assumed to have participated in social security starting at the later of age 22 or January 1, 1951;
(2) except as otherwise provided in clause (5) hereof, the Executives compensation on which his social security benefit is based shall be assumed to be that resulting from applying a decrease for years prior to the mid-year of the years on which the Executives Final Average Compensation is based, and an increase for years following such mid-year, at the same rates as the national average total wages for adjusting earnings as used in computing social security benefits, as published by the Social Security Administration for each such year, with the rate for the last published year being used for any years subsequent to such last published year;
(3) except as otherwise provided in clause (5) hereof, the taxable wage base, the factors for indexing wages, and the table or formula used to determine the estimated monthly primary social security benefit amount will be assumed to remain constant following the Executives termination of employment;
(4) except as otherwise provided in clause (5) hereof, for an Executive whose employment terminates prior to his attainment of age 65, it shall be assumed that he earned no compensation from the date of termination of his employment to his attainment of age 65;
(5) for an Executive whose benefit is based, in whole or part, upon the continuing accrual of Years of Benefit Service during the period of his Disability, it shall be assumed that, during the period for which he accrues Years of Benefit Service under those sections, he continued to earn Annual Compensation at the same rate as during the Plan Year in which he became Disabled; provided, however, that, in the event the Executive is receiving, or is entitled to receive, a primary social security disability benefit, the amount of such benefit shall be deemed to be his primary social security benefit for purposes of the Plan, in lieu of the amount otherwise determined under this Exhibit B;
(C) an Executive who, for any reason, is not a participant in the United States social security benefit program shall be deemed to participate fully in such program for purposes of determining the Executives primary social security benefit.
(D) An Executives primary social security benefit may be determined by reference to a schedule based upon pay brackets, provided such schedule is prepared in accordance with the foregoing provisions of this Exhibit B.
11
EXHIBIT C
SAVINGS PLAN BENEFIT
The Savings Plan Benefit shall be one-twelfth (1/12th) of the annual benefit, determined by the Administrator, that would be provided by Employer Contributions to the Ecolab Savings Plan (formerly the EL Thrift Plan) (hereafter the Savings Plan) made on or prior to July 1, 1994, if the Executives benefit under the Savings Plan as of July 1, 1994 were paid commencing at the Executives attainment of age 65 on a straight life annuity basis (based on an interest rate of 4.25% and the 1984 Unisex Pension Mortality Table shifted forward one year) and assuming (1) that the Employers contributed to the Savings Plan on the Executives behalf from (a) the later of January 1, 1977 or the date of the Executives first eligibility for participation in the Savings Plan until (b) the earlier of the Executives Retirement or July 1, 1994, an annual amount equal to three percent (3%) of the Executives actual Annual Compensation; provided, however, that the three percent (3%) shall be reduced by the amount, if any, which could not be contributed in each year by reason of the maximum contributions limitations of Code Section 415 and the maximum compensation limitations of Code Section 401(a)(17), and (2) that such Employer contributions to the Savings Plan on behalf of the Executive accumulated earnings at an annual rate of eight percent (8%) for all periods prior to January 1, 1991, and for each calendar year thereafter until the earlier of the Executives attainment of age 65 or December 31, 1993, at an interest rate established annually by the Administrator based on the PBGCs immediate annuity rate as of the December 31 of the immediately preceding year, and for the period from January 1, 1994 until the attainment of age 65, at an interest rate of 4.25% (the December 1993 PBGC immediate rate).
12
EXHIBIT (10)P
ECOLAB
INC.
ADMINISTRATIVE DOCUMENT FOR NON-QUALIFIED BENEFIT PLANS
(As Amended and Restated Effective as of January 1, 2003)
Ecolab Inc. (the Company) hereby amends and completely restates this Administrative Document (the Administrative Document) which provides for the administration of the non-qualified benefit plans listed on Exhibit A hereto (collectively, the Plans and individually, a Plan) which have been established by the Company for purposes of providing benefits to certain management and highly compensated employees who perform management and professional functions for the Company and certain related entities. This Administrative Document is incorporated by reference in and is a part of each of the Plans.
Words and phrases used in this Administrative Document and in the Plans with initial capital letters which are defined in the Pension Plan are used in this Administrative Document and in the Plans as so defined, unless otherwise specifically defined herein or in the Plans or the context clearly indicates otherwise. Words and phrases used in this Administrative Document with initial capital letters which are defined in the Plans are used herein as so defined. The following words and phrases when used in this Administrative Document or in the Plans with initial capital letters shall have the following respective meanings, unless the context clearly indicates otherwise or a particular Plan provides differently with respect to its own provisions:
(1) any person as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended (Exchange Act) (other than the Company, any trustee or other fiduciary holding securities under any employee benefit plan of the Company, or any corporation owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of stock of the Company), is or becomes, including pursuant to a tender or exchange offer for shares of the common stock of the Company (Common Stock) pursuant to which purchases are made, the beneficial owner (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing 25% or more of the combined voting power of the Companys then outstanding securities, other than in a transaction arranged or approved by the Board of Directors of the Company (the Board) prior to its occurrence; provided, however, that if any such person will become the beneficial owner, directly or indirectly, of securities of the Company representing 34% or more of the combined voting power of the Companys then outstanding securities, a Change in Control will be deemed to occur whether or not any or all of such beneficial ownership is obtained in a transaction arranged or approved by the Board prior to its occurrence, and other than in a transaction in which such person will have executed a written agreement with the Company (and approved by the Board) on or prior to the date on which such person becomes the beneficial owner of 25% or more of the combined voting power of the Companys then outstanding securities, which agreement imposes one or more limitations on the amount of such persons beneficial ownership of shares of Common Stock, if, and so long as, such agreement (or any amendment thereto approved by the Board provided that no such amendment will cure any prior breach of such agreement or any amendment thereto) continues to be binding on such person and such person is in compliance (as determined by the Board in its sole discretion) with the terms of such agreement (including such amendment); provided, however that if any such person will become the beneficial owner, directly or indirectly, of securities of the Company representing 50% or more of the combined voting power of the Companys then outstanding securities, a Change in Control will be deemed to occur whether or not such beneficial ownership was held in compliance with such a binding agreement, and provided further that the provisions if this Subsection (1) shall not be applicable to a transaction in which a corporation becomes the owner of all the Companys outstanding securities in a transaction which complies with the provisions of Subsection (3) of this Section (e.g., a reverse triangular merger); or
(2) during any thirty-six consecutive calendar months, individuals who constitute the Board on the first day of such period or any new director (other than a director whose initial assumption of office is in connection with an actual or threatened election contest including, but not limited to, a consent solicitation, relating to the election of directors of the Company) whose appointment or election by the Board or nomination for election by the Companys stockholders was approved or recommended by a vote of at least two-thirds (2/3) of the directors then still in office who were either directors on the first day of such period, or whose appointment, election or nomination for election was previously so approved or recommended, shall cease for any reason to constitute at least a majority thereof; or
(3) there is consummated a merger or consolidation of the Company or any direct or indirect subsidiary of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior to such merger or consolidation continuing to represent (either by remaining
2
outstanding or by being converted into voting securities of the surviving entity or any parent thereof) more than 50% of the combined voting power of the securities of the Company or such surviving entity or any parent thereof outstanding immediately after such merger or consolidation, and in which no person (as defined under Subsection (1) above) acquires 50% or more of the combined voting power of the securities of the Company or such surviving entity or parent thereof outstanding immediately after such merger or consolidation; or
(4) the stockholders of the Company approve a plan of complete liquidation or dissolution of the Company or there is consummated an agreement for the sale or disposition by the Company of all or substantially all of the Companys assets, other than a sale or disposition by the Company of all or substantially all of the Companys assets to an entity, more than 50% of the combined voting power of the voting securities of which are owned by stockholders of the Company in substantially the same proportions as their ownership of the Company immediately prior to such sale.
3
4
5
6
7
8
9
IN WITNESS WHEREOF, Ecolab Inc. has executed this Administrative Document and has caused its corporate seal to be affixed this 11 th day of November, 2003.
|
ECOLAB INC. |
||
|
|
||
|
|
|
|
|
By: |
/s/ Steven L. Fritze |
|
|
|
Steven L. Fritze |
|
|
|
Senior Vice President
and
|
|
|
|
|
|
|
|
|
|
(Seal) |
|
|
|
|
|
|
|
|
|
|
|
Attest: |
|
|
|
|
|
|
|
|
|
|
|
/s/ Lawrence T. Bell |
|
|
|
Lawrence T. Bell |
|
|
|
Senior Vice President,
|
|
|
|
10
EXHIBIT A
1. Ecolab Executive Death Benefits Plan
2. Ecolab Executive Long-Term Disability Plan
3. Ecolab Mirror Pension Plan
4. Ecolab Supplemental Executive Retirement Plan
5. Ecolab Mirror Savings Plan
11
Exhibit 13
financial discussion
OVERVIEW FOR 2003
This Financial Discussion should be read in conjunction with the information on Forward-Looking Statements and Risk Factors found at the end of the Financial Discussion.
Despite being faced with continuing challenges from the global economic environment, we delivered a very strong financial performance in 2003. Our ability to leverage our wide range of offerings resulted in double-digit earnings per share growth, strong operating cash flow, a healthy return on investment and an improved balance sheet for 2003. We continue to successfully implement our Circle the Customer Circle the Globe growth strategy to generate strong financial results.
Several important items impacted our financial results in 2003.
Operating Performance
We continued to find new markets in which to grow our business. Strong sales growth in Kay resulted from servicing the developing fast-casual restaurant market segment and food retail business. Professional Products introduced the first solid-based product offering for surgical instrument cleaning in the acute care market segment. Our International locations continue to expand the successful Pest Elimination business to new geographies.
We made appropriate decisions to improve the profitability of certain business units. We have exited low-margin accounts within Professional Products, Textile Care and areas in Europe. This has negatively impacted sales growth in 2003.
We continued to invest in future growth during 2003. This included investing in our sales-and-service force and in acquiring such businesses as Adams Healthcare. We also made investments to improve the service efficiency of GCS Service. While GCS Service had lower sales and an operating loss in 2003, we have better positioned the business for the long term.
Our sales associates grew our business by gaining new independent and chain accounts, as well as growing business at existing customers.
We faced competition in our markets and we countered with our innovative product offerings and our superior customer service.
Financial Performance
Operating cash flow in 2003 continued to be very strong and allowed us to make acquisitions, pay down $108 million of debt, reacquire over $227 million of our common stock and make $75 million in additional voluntary contributions to our U.S. pension plan.
Currency translation had a positive impact on our financial results in 2003, adding approximately $12 million to net income.
An improvement in our annual effective income tax rate from 39.8 percent in 2002 to 38.1 percent in 2003 added approximately $7 million to net income. The acquisition of our former European joint venture business at the end of fiscal year 2001 has allowed us to have a more tax efficient structure.
The combination of all of these factors helped us exceed all three of our long-term financial objectives in 2003. These objectives are (i) 15 percent growth in diluted income per common share, (ii) 20 percent return on beginning shareholders equity and (iii) an investment grade or A rated balance sheet. Specifically, here is what we accomplished:
Diluted net income per share was $1.06 for 2003, up 33 percent from $0.80 in 2002. Included in 2003 net income is a gain of $11.1 million, or $6.7 million net of tax, from the sale of an equity investment. For 2002, net income includes (i) a transitional impairment charge of $4.0 million after tax ($0.02 per diluted share) from the adoption of Statement of Financial Accounting Standards (SFAS) No. 142, (ii) a one-time gain of $3.5 million after tax from benefit plan changes, (iii) special charges of $32.4 million after-tax related to restructuring activities and the integration of our European operations and (iv) a gain of $1.9 million after tax ($0.01 per diluted share) from discontinued operations. These items are of a non-recurring nature and are not necessarily indicative of future operating results.
Return on beginning shareholders equity was 25 percent for 2003 compared with 24 percent in 2002. The items discussed above affected the return for 2002. Adjusting for these items, return on beginning shareholders equity was 27 percent. This was the twelfth consecutive year we exceeded our long-term financial objective of a 20 percent return on beginning shareholders equity.
We maintained our debt rating within the A categories of the major rating agencies during 2003.
As a result of our continued strong financial performance and related stock price increases, on June 6, 2003, we paid a two-for-one stock split in the form of a 100 percent stock dividend to shareholders of record on May 23, 2003. All per share, shares outstanding and market price data have been adjusted to reflect the stock split.
2004 Expectations
We expect to acquire additional businesses which fit with our Circle the Customer Circle the Globe growth strategy.
We remain concerned about the possible adverse impact of global terrorism, unforeseen hostilities and public health epidemics on the sensitive travel and tourism industries.
We expect currency translation to have a favorable impact on 2004 but to a lesser extent than we experienced in 2003.
20
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
In May 2002, the Securities & Exchange Commission (SEC) issued a proposed rule: Disclosure in Managements Discussion and Analysis about the Application of Critical Accounting Policies . Although the SEC has not issued a final rule yet, the following discussion has been prepared on the basis of the guidelines in the SEC rule proposal. If adopted as proposed, the rule would require disclosures connected with estimates a company makes in applying its accounting policies. However, such discussion would be limited to critical accounting estimates, or those that management believes meet two criteria in the proposal: First, the accounting estimate must require a company to make assumptions about matters that are highly uncertain at the time the accounting estimate is made. Second, different estimates that the company reasonably could have used for the accounting estimate in the current period, or changes in the accounting estimate that are reasonably likely to occur from period to period, must have a material impact on the presentation of the companys financial condition, changes in financial condition or results of operations. Besides estimates that meet the critical estimate criteria, the company makes many other accounting estimates in preparing its financial statements and related disclosures. All estimates, whether or not deemed critical, affect reported amounts of assets, liabilities, revenues and expenses as well as disclosures of contingent assets and liabilities. Estimates are based on experience and other information available prior to the issuance of the financial statements. Materially different results can occur as circumstances change and additional information becomes known, even from estimates not deemed critical under the SEC rule proposal.
Revenue Recognition
We recognize revenue as services are performed or on product sales at the time title transfers to the customer. We record estimated reductions to revenue for customer programs and incentive offerings including pricing arrangements, promotions and other volume-based incentives at the time of sale. If market conditions were to decline, we may increase customer incentive offerings, which could reduce sales and gross profit margins at the time the incentive is offered.
Valuation Allowances and Accrued Liabilities
We estimate sales returns and allowances by analyzing historical returns and credits, and apply these trend rates to the most recent 12 months sales data to calculate estimated reserves for future credits. We estimate the allowance for doubtful accounts by analyzing accounts receivable balances by age, applying historical trend rates to the most recent 12 months sales, less actual write-offs to date. In addition, our estimates also include separately providing for 100 percent of specific customer balances when it is deemed probable that the balance is uncollectible. Actual results could differ from these estimates under different assumptions.
Estimates used to record liabilities related to pending litigation and environmental claims are based on our best estimate of probable future costs. We record the amounts that represent the points in the range of estimates that we believe are most probable or the minimum amounts when no amount within the range is a better estimate than any other amount. Potential insurance reimbursements are not anticipated in our accruals for environmental liabilities. While the final resolution of litigation and environmental contingencies could result in amounts different than current accruals, and therefore have an impact on our consolidated financial results in a future reporting period, we believe the ultimate outcome will not have a significant effect on our consolidated results of operations, financial position or cash flows.
Actuarially Determined Liabilities
The measurement of our pension and postretirement benefit obligations are dependent on a variety of assumptions determined by management and used by our actuaries. These assumptions affect the amount and timing of future contributions and expenses.
The assumptions used in developing the required estimates include discount rate, projected salary and health care cost increases, expected return or earnings on assets, retirement rates and mortality rates. The discount rate assumption is based on the investment yields available at year-end on corporate long-term bonds rated AA. Projected salary and health care cost increases are based on our long-term actual experience, the near-term outlook and assumed inflation. The expected return on plan assets reflects asset allocations, investment strategies and the views of investment managers over a long-term perspective. Retirement and mortality rates are based primarily on actual plan experience. The effects of actual results differing from our assumptions are accumulated and amortized over future periods and, therefore, generally affect our recognized expense in future periods. For 2003, our discount rates and projected salary increases used to determine our pension and postretirement obligations were lower than in 2002, while our expected return on plan assets remained unchanged.
We are self-insured in North America for most workers compensation, general liability and automotive liability losses, subject to per occurrence and aggregate annual liability limitations. We are insured for losses in excess of these limitations. We are also self-insured for health care claims for eligible participating employees, subject to certain deductibles and limitations. We determine our liabilities for claims incurred but not reported on an actuarial basis. A change in these assumptions would cause reported results to differ.
Income Taxes
Judgment is required to determine the annual effective income tax rate, deferred tax assets and liabilities and any valuation allowances recorded against net deferred tax assets. Our effective income tax rate is based on annual income, statutory tax rates and tax planning opportunities available in the various jurisdictions in which we operate. We establish liabilities or reserves when we believe that certain positions are likely to be challenged by authorities and we may not succeed, despite our belief that our tax return positions are fully supportable. We adjust these reserves in light of changing facts and circumstances, such as the progress of a tax audit. Our annual effective income tax rate includes the impact of reserve provisions and changes to reserves that we consider appropriate. This annual rate is then applied to our quarterly operating results. In the event that there is a significant one-time item recognized in our operating results, the tax attributable to that item would be separately calculated and recorded in the same period as the one-time item.
Tax regulations require items to be included in our tax returns at different times than the items are reflected in our financial statements. As a result, the effective income tax rate reflected in our financial statements differs from that reported in our tax returns. Some of these differences are permanent, such as expenses that are not deductible on our tax return, and some are temporary differences, such as depreciation expense. Temporary differences create deferred tax assets and liabilities. Deferred tax assets generally represent items that can be used as a
21
tax deduction or credit in our tax return in future years for which we have already recorded the tax benefit in our income statement. We establish valuation allowances for our deferred tax assets when the amount of expected future taxable income is not likely to support the utilization of the deduction or credit. Deferred tax liabilities generally represent items for which we have already taken a deduction in our tax return, but have not yet recognized that tax benefit in our financial statements. We have not recognized any deferred tax liabilities on undistributed international earnings because if those earnings were remitted to the United States, we believe any applicable income taxes would be substantially offset by available foreign tax credits.
A number of years may elapse before a particular tax matter, for which we have established a reserve, is audited and finally resolved. The number of tax years with open tax audits varies depending on the tax jurisdiction. In the United States, the Internal Revenue Service is currently examining our tax returns for 1999 through 2001. While it is often difficult to predict the final outcome or the timing of resolution of any particular tax matter, we believe that our reserves reflect the probable outcome of known tax contingencies. Unfavorable settlement of any particular issue would require the use of cash. Favorable resolution could result in reduced income tax expense reported in the financial statements in the future. Our tax reserves are generally presented in the balance sheet within other non-current liabilities.
Long-Lived and Intangible Assets
We periodically review our long-lived and intangible assets for impairment and assess whether significant events or changes in business circumstances indicate that the carrying value of the assets may not be recoverable. This could occur when the carrying amount of an asset exceeds the anticipated future undiscounted cash flows expected to result from the use of the asset and its eventual disposition. The amount of the impairment loss to be recorded, if any, is calculated as the excess of the assets carrying value over its estimated fair value. We also periodically reassess the estimated remaining useful lives of our long-lived assets. Changes to estimated useful lives would impact the amount of depreciation and amortization expense recorded in earnings. We have experienced no significant changes in the carrying value of our long-lived assets.
Statement of Financial Accounting Standards (SFAS) No. 142, Goodwill and Other Intangible Assets , requires that goodwill and certain intangible assets be assessed for impairment using fair value measurement techniques. Specifically, goodwill impairment is determined using a two-step process. Both the first step of determining the fair value of a reporting unit and the second step of determining the fair value of individual assets and liabilities of a reporting unit (including unrecognized intangible assets) are judgmental in nature and often involve the use of significant estimates and assumptions. Estimates of fair value are primarily determined using discounted cash flows, market comparisons and recent transactions. These valuation methodologies use significant estimates and assumptions, which include projected future cash flows (including timing), discount rate reflecting the risk inherent in future cash flows, perpetual growth rate, and determination of appropriate market comparables. Of the total goodwill included in our consolidated balance sheet, 15 percent is recorded in our U.S. Cleaning & Sanitizing reportable segment, 6 percent in our U.S. Other Services segment and 79 percent in our International Cleaning & Sanitizing segment.
In 2002, SFAS No. 142 became effective and as a result, we ceased to amortize goodwill in 2002. We were required to perform an initial impairment review of our goodwill at the beginning of 2002 under the guidelines of SFAS No. 142. The result of testing goodwill for impairment was a non-cash charge of $4.0 million after-tax ($0.02 per share). All of the impairment charge related to our Africa/Export operations due to the difficult economic environment in that region. We have continued to review our goodwill for impairment on an annual basis for all reporting units, including businesses reporting losses such as GCS Service, under the guidelines of SFAS No. 142.
Functional Currencies
In preparing the consolidated financial statements, we are required to translate the financial statements of our foreign subsidiaries from the currency in which they keep their accounting records, generally the local currency, into United States dollars. Assets and liabilities of these operations are translated at the exchange rates in effect at each fiscal year end. The translation adjustments related to assets and liabilities that arise from the use of differing exchange rates from period to period are included in accumulated other comprehensive income (loss) in shareholders equity. Income statement accounts are translated at the average rates of exchange prevailing during the year. We evaluate our International operations based on fixed rates of exchange; however, the different exchange rates from period to period impact the amount of reported income from our consolidated operations.
OPERATING RESULTS
Consolidated
(thousands, except per share) |
|
2003 |
|
2002 |
|
2001 |
|
|||
|
|
|
|
|
|
|
|
|||
Net sales |
|
$ |
3,761,819 |
|
$ |
3,403,585 |
|
$ |
2,320,710 |
|
Operating income |
|
$ |
482,658 |
|
$ |
395,866 |
|
$ |
318,179 |
|
Income |
|
|
|
|
|
|
|
|||
Continuing operations before change in accounting |
|
$ |
277,348 |
|
$ |
211,890 |
|
$ |
188,170 |
|
Change in accounting |
|
|
|
(4,002 |
) |
|
|
|||
Discontinued operations |
|
|
|
1,882 |
|
|
|
|||
Net income |
|
$ |
277,348 |
|
$ |
209,770 |
|
$ |
188,170 |
|
|
|
|
|
|
|
|
|
|||
Diluted income per common share |
|
|
|
|
|
|
|
|||
Continuing operations before change in accounting |
|
$ |
1.06 |
|
$ |
0.81 |
|
$ |
0.72 |
|
Change in accounting |
|
|
|
(0.02 |
) |
|
|
|||
Discontinued operations |
|
|
|
0.01 |
|
|
|
|||
Net income |
|
$ |
1.06 |
|
$ |
0.80 |
|
$ |
0.72 |
|
Our consolidated net sales reached $3.8 billion for 2003, an increase of 11 percent over net sales of $3.4 billion in 2002. Excluding acquisitions and divestitures, consolidated net sales increased 10 percent. Changes in currency translation positively impacted the consolidated sales growth rate by 6 percentage points, primarily due to the strength of the euro against the U.S. dollar. Sales also benefited from aggressive new account sales, new products and selling more to existing customers.
22
|
|
2003 |
|
2002 |
|
2001 |
|
|
|
|
|
|
|
|
|
Gross profit as a percent of net sales |
|
50.9 |
% |
50.4 |
% |
51.7 |
% |
Selling, general & administrative expenses as a percent of net sales |
|
38.1 |
% |
37.7 |
% |
38.0 |
% |
Our consolidated gross profit margin in 2003 increased over 2002. In 2002, cost of sales included $9.0 million of restructuring costs. If these costs were excluded, the gross profit margin for 2002 would have been 50.7 percent. The increase in the margin for 2003 also benefited from business mix and cost reduction actions, partially offset by poor results in GCS Service during 2003.
Selling, general and administrative expenses for 2003 increased as a percentage of sales over 2002. The increase in the 2003 expense ratio is primarily due to an increase in sales-and-service investments, rising insurance costs, increased headcount and health care costs and startup expenses related to legal entity restructuring, partially offset by cost savings initiatives.
In the first quarter of 2002, we approved plans to undertake restructuring cost-saving actions. Restructuring savings were approximately $31 million and $16 million in 2003 and 2002, respectively. Most of these savings were reinvested in the business.
(thousands) |
|
2003 |
|
2002 |
|
2001 |
|
|||
|
|
|
|
|
|
|
|
|||
Operating income |
|
$ |
482,658 |
|
$ |
395,866 |
|
$ |
318,179 |
|
Operating income as a percent of net sales |
|
12.8 |
% |
11.6 |
% |
13.7 |
% |
|||
Operating income for 2003 increased 22 percent over 2002. Excluding special charges in 2002 of $46 million, operating income in 2003 increased 9 percent over 2002. Adjusting for special charges, operating income in 2002 would have been 13.0 percent of net sales. The decline in 2003 operating income margins from this level reflects increased headcount and benefit costs and investments in the sales force partially offset by favorable sales volume increases and cost reduction initiatives.
Our net income was $277 million in 2003 as compared to $210 million in 2002, an increase of 32 percent. Net income in 2003 included a gain on the sale of an equity investment of $6.7 million after tax and a reduction in previously recorded restructuring expenses of $0.8 million after tax, offset by a write-off of $1.7 million of goodwill related to an international business sold in 2003. Net income in 2002 included a gain from discontinued operations of $1.9 million after tax, offset by special charges of $28.9 million after tax and a SFAS No. 142 transitional impairment charge of $4.0 million after tax. These items are of a non-recurring nature and are not necessarily indicative of future operating results. If these items are excluded from both 2003 and 2002, net income increased 13 percent for 2003. This improvement in net income reflected good fixed-rate operating income growth in our International segment, particularly in Europe. Currency translation also positively impacted net income by approximately $12 million due primarily to the strength of the euro against the U.S. dollar. The comparison of net income also benefited from a lower effective income tax rate in 2003 which was the result of cost savings initiatives, a lower overall international rate and improved international mix. Excluding the items of a non-recurring nature previously mentioned, net income for 2003 was 7.2 percent of net sales, up slightly from 7.1 percent in 2002.
2002 compared with 2001
Our consolidated net sales reached $3.4 billion for 2002, an increase of 47 percent over net sales of $2.3 billion in 2001. Business acquisitions, primarily the acquisition of the European joint venture, contributed to the overall sales growth for 2002. Excluding acquisitions, primarily the European joint venture, consolidated net sales increased 4 percent in 2002. Sales growth was experienced in most of our divisions. Changes in currency translation negatively impacted the consolidated sales growth rate by approximately 1 percentage point for 2002. Sales results reflected aggressive selling efforts, the benefits of investments in sales force training and productivity tools and new products, which were partially offset by the poor economic environment.
Our consolidated gross profit margin in 2002 decreased from 2001. Cost of sales included restructuring costs of $9.0 million for the year ended December 31, 2002. Excluding these restructuring charges, the gross profit margin would have been 50.7 percent for 2002. The gross profit margin was also negatively affected by the acquisition and consolidation of the European joint venture. The gross profit margin for 2001 on a pro forma basis (reflecting the European joint venture on a consolidated basis) was 50.2 percent. Our gross profit margin benefited from product mix improvements and cost reduction actions.
Selling, general and administrative expenses as a percent of sales for 2002 decreased when compared to 2001. The selling, general and administrative expense ratio on a pro forma basis (reflecting the consolidation of our European joint venture and the elimination of goodwill amortization) for 2001 was 37.5 percent. The increase in 2002 over the prior year pro forma expense ratio is partially due to stronger sales, which resulted in higher commissions and incentive-based compensation. This increase was partially offset by tight cost controls and savings related to restructuring activities in 2002.
During the first quarter of 2002, management approved various restructuring and other cost-saving actions, including costs to integrate our European operations, to streamline and improve our global operations. These actions resulted in pre-tax charges of approximately $51.8 million ($32.4 million after tax) in 2002. These charges were partially offset by a curtailment gain of $5.8 million ($3.5 million after tax) attributable to certain benefit plan changes. The restructuring included (i) a reduction of our global workforce during 2002, (ii) the closing of several facilities, (iii) the discontinuance of selected product lines and (iv) other actions. The expected cost savings related to restructuring activities began in 2002. Restructuring savings were approximately $16 million ($10 million after tax) in 2002. We have reinvested most of these savings in our business. Further details related to these restructuring expenses are included in Note 3 of the notes to consolidated financial statements.
Operating income for 2002 increased by 24 percent over 2001. Excluding special charges of $46 million, operating income for 2002 was 13.0 percent of net sales. This compared to 2001 pro forma operating income (reflecting the consolidation of our European joint venture and elimination of goodwill amortization) of $404 million, or 12.7 percent of net sales. This comparison of operating income margins reflects tight cost controls, savings from cost reduction initiatives and the sale of new products.
In addition to continuing operations, a legal issue related to the disposal of a business in 1992 was resolved during 2002, resulting in
23
the recognition of a gain from discontinued operations of approximately $1.9 million (net of income tax benefit of $1.1 million) or $0.01 per diluted share.
Our net income for 2002 was $210 million. Net income included restructuring charges of $32.4 million after tax, a curtailment gain of $3.5 million after tax, a gain from discontinued operations of $1.9 million after tax and a SFAS No. 142 transitional impairment charge of $4.0 million after tax. Excluding these items, our net income for 2002 increased 28 percent over net income of $188 million in 2001. This improvement reflected good operating income growth in most of our divisions, the additional operating income generated by the acquisition of the European joint venture and the elimination of goodwill amortization. This was partially offset by higher net interest expense due to increased borrowings primarily to finance our acquisition of the European joint venture. Currency translation benefited diluted net income by $0.01 per share for 2002. As a percentage of net sales, net income for 2002 was 6.2 percent. Excluding the items of a nonrecurring nature previously mentioned, net income for 2002 was 7.1 percent of net sales, down from 8.1 percent in 2001 due to the addition of the European joint venture.
OPERATING SEGMENT PERFORMANCE
Our operating segments have similar products and services and we are organized to manage our operations geographically. Our operating segments have been aggregated into three reportable segments: United States Cleaning & Sanitizing, United States Other Services, and International Cleaning & Sanitizing. We evaluate the performance of our International operations based on fixed management rates of currency exchange. Therefore, International sales and operating income totals, as well as the International financial information included in this financial discussion, are based on translation into U.S. dollars at the fixed currency exchange rates used by management for 2003. All other accounting policies of the reportable segments are consistent with accounting principles generally accepted in the United States of America and the accounting policies of the company described in Note 2 of the notes to consolidated financial statements. Additional information about our reportable segments is included in Note 16 of the notes to consolidated financial statements.
Sales by Operating Segment
(thousands) |
|
2003 |
|
2002 |
|
2001 |
|
|||
|
|
|
|
|
|
|
|
|||
Net sales |
|
|
|
|
|
|
|
|||
United States |
|
|
|
|
|
|
|
|||
Cleaning & Sanitizing |
|
$ |
1,694,323 |
|
$ |
1,615,171 |
|
$ |
1,548,882 |
|
Other Services |
|
320,444 |
|
308,329 |
|
273,020 |
|
|||
Total United States |
|
2,014,767 |
|
1,923,500 |
|
1,821,902 |
|
|||
International Cleaning & Sanitizing |
|
1,560,557 |
|
1,497,935 |
|
474,089 |
|
|||
Total |
|
3,575,324 |
|
3,421,435 |
|
2,295,991 |
|
|||
Effect of foreign currency translation |
|
186,495 |
|
(17,850 |
) |
24,719 |
|
|||
Consolidated |
|
$ |
3,761,819 |
|
$ |
3,403,585 |
|
$ |
2,320,710 |
|
The following chart presents the comparative percentage change in net sales for each of our operating segments for 2003 and 2002 (excluding Europe in 2002). European operations have been excluded in the percent change for 2002 since they were consolidated for the first time in 2002, making the percentage comparison not meaningful.
Sales Growth Information
|
|
Percent Change from Prior Year |
|
||
|
|
2003 |
|
2002 |
|
|
|
|
|
|
|
Net sales |
|
|
|
|
|
United States Cleaning & Sanitizing |
|
|
|
|
|
Institutional |
|
5 |
% |
6 |
% |
Kay |
|
12 |
|
9 |
|
Textile Care |
|
(10 |
) |
3 |
|
Professional Products |
|
9 |
|
(4 |
) |
Water Care Services |
|
4 |
|
(3 |
) |
Vehicle Care |
|
4 |
|
3 |
|
Food & Beverage |
|
3 |
|
1 |
|
Total United States Cleaning & Sanitizing |
|
5 |
% |
4 |
% |
United States Other Services |
|
|
|
|
|
Pest Elimination |
|
11 |
% |
7 |
% |
GCS Service |
|
(7 |
) |
19 |
|
Total United States Other Services |
|
4 |
% |
13 |
% |
Total United States |
|
5 |
% |
6 |
% |
International Cleaning & Sanitizing |
|
|
|
|
|
Europe |
|
4 |
% |
|
% |
Asia Pacific |
|
3 |
|
2 |
|
Latin America |
|
7 |
|
9 |
|
Canada |
|
4 |
|
8 |
|
Other |
|
21 |
|
25 |
|
Total International Cleaning & Sanitizing (excluding Europe in 2002) |
|
4 |
% |
7 |
% |
Consolidated (excluding Europe in 2002) |
|
11 |
% |
5 |
% |
Sales of our United States Cleaning & Sanitizing operations were $1.7 billion in 2003 and increased 5 percent over net sales of $1.6 billion in 2002. Business acquisitions had no effect on the growth in sales for 2003. Sales benefited from good growth in our Kay and Professional Products operations, which were partially offset by lower sales in Textile Care. The increase in our Institutional division reflected its continued efforts to generate new accounts, the successful introduction of new products and improved customer service. Trends in the foodservice, hospitality and healthcare industries were challenging in early 2003 but showed signs of improvement late in the year. Kay's sales increase reflects solid growth in its food retail services business and to quickservice restaurants as well as through the introduction of new products and programs. Textile Care sales decreased, particularly to distributors, due
24
to soft industry demand and strong competition within the industry. Textile Care is focusing on improving its service and reestablishing its relationships with distributors in an effort to increase sales growth. Textile Care is also continuing to take a selective approach to new customers to ensure they meet our profit guidelines. Sales of Professional Products increased due to strong gains in the healthcare market offsetting the continuing phase-out of the specialty business. Our introduction of the first solid-based product offering to the acute care market in the second quarter of 2003 helped drive the sales growth in the healthcare market. Professional Products janitorial sales were also positively impacted in 2003 by a long-term supply agreement that began in December 2002. Effective January 2004, our Professional Products division was reorganized to better serve janitorial and healthcare customers by splitting the Professional Products division into two divisions, Professional Products and Healthcare. Our Food & Beverage sales were driven by improved retention and corporate account growth in the dairy, soft drink, meat and poultry and food markets. This increase was partially offset by a decrease in agricultural sales due to overall market weakness. Water Care Services had good growth in sales to the food and beverage, hospitality, healthcare and commercial accounts due to solid gains in new customer accounts. Vehicle Care sales were again driven by new business with major oil companies and successful new product introductions.
Sales of our United States Other Services operations increased 4 percent to $320 million in 2003, from $308 million in 2002. Business acquisitions had no effect on the growth in sales for 2003. Pest Eliminations sales in 2003 reflected strong growth in both contract sales, due to the addition of new large accounts, and non-contract services, due to the aggressive efforts of the sales force. GCS Service sales decreased in 2003 due to service interruptions caused by the restructuring of field operations and the transition to a new centralized administration center, which began operation in 2003. In an effort to increase sales going forward, GCS Service implemented productivity improvement measures in the fourth quarter of 2003.
Management rate sales for our International Cleaning & Sanitizing segment were $1.6 billion for 2003, an increase of 4 percent over sales in 2002. Excluding the effects of acquisitions and divestitures, sales increased 3 percent. Sales in Europe, excluding the effects of acquisitions and divestitures, increased 2 percent. Successful new housekeeping and Ecotemp programs were partially offset by a weak European economy and strong competition. We are focusing on expanding our Pest Elimination business in Europe through acquisitions such as the Terminix operations in the United Kingdom, which was purchased in December 2002, and Nigiko with operations in France, acquired in January 2004. We expect to leverage the success of this business in the United States to become a global provider of pest elimination services. The increase in Asia Pacific was driven by Japan, New Zealand and Northeast Asia. In Japan, sales to chain restaurants and resort hotel customers improved and New Zealand is showing strong growth in its pest elimination services business. In Northeast Asia, Korea's growth was propelled by strong Institutional sales while China experienced excellent growth in its Food & Beverage sales. Good growth in these areas was partially offset by a sales decline in Australia due to soft Food & Beverage and Water Care business. Sales in Latin America, excluding acquisitions, grew 6 percent in 2003 and most Latin America countries experienced good growth except Venezuela, where a country-wide strike at the beginning of 2003 resulted in virtually no sales for the first two fiscal months of 2003. Mexico, the Caribbean and Central America all had double-digit sales growth in 2003. Growth in Latin America is being fueled by good growth in food retail programs, a demand for improved sanitation and expansion of pest elimination services. Sales in Canada increased due to continued focus on obtaining new customers and selling additional solutions to existing customers, partially offset by the impact of the Severe Acute Respiratory Syndrome (SARS) outbreak in Canada.
25
Operating Income by Operating Segment
(thousands) |
|
2003 |
|
2002 |
|
2001 |
|
|||
|
|
|
|
|
|
|
|
|||
Operating income |
|
|
|
|
|
|
|
|||
United States |
|
|
|
|
|
|
|
|||
Cleaning & Sanitizing |
|
$ |
285,212 |
|
$ |
271,838 |
|
$ |
246,936 |
|
Other Services |
|
21,031 |
|
33,051 |
|
29,338 |
|
|||
Total United States |
|
306,243 |
|
304,889 |
|
276,274 |
|
|||
International Cleaning & Sanitizing |
|
159,866 |
|
138,373 |
|
44,575 |
|
|||
Total |
|
466,109 |
|
443,262 |
|
320,849 |
|
|||
Corporate |
|
(4,834 |
) |
(46,008 |
) |
(4,938 |
) |
|||
Effect of foreign currency translation |
|
21,383 |
|
(1,388 |
) |
2,268 |
|
|||
Consolidated |
|
$ |
482,658 |
|
$ |
395,866 |
|
$ |
318,179 |
|
|
|
|
|
|
|
|
|
|||
Operating income as a percent of net sales |
|
|
|
|
|
|
|
|||
United States |
|
|
|
|
|
|
|
|||
Cleaning & Sanitizing |
|
16.8 |
% |
16.8 |
% |
15.9 |
% |
|||
Other Services |
|
6.6 |
|
10.7 |
|
10.7 |
|
|||
Total |
|
15.2 |
|
15.9 |
|
15.2 |
|
|||
International Cleaning & Sanitizing |
|
10.2 |
|
9.2 |
|
9.4 |
|
|||
Consolidated |
|
12.8 |
% |
11.6 |
% |
13.7 |
% |
Operating income of our United States Cleaning & Sanitizing operations increased 5 percent in 2003. Operating income as a percent of sales remained the same in 2003 as 2002 due to the investments in developing the sales force and higher operating costs being offset by cost savings initiatives. We added 100 sales-and-service associates to our United States Cleaning & Sanitizing operations during 2003.
Operating income of United States Other Services operations decreased 36 percent. As a percentage of net sales, operating income decreased significantly as well. Pest Elimination had strong operating income growth, while GCS Service results reflected an operating loss. Strong growth in both contract and non-contract services, coupled with tight expense control, has helped fuel Pest Eliminations growth. GCS Service results reflected an operating loss due to a decrease in sales resulting from operational issues encountered with a transition to a centralized administration center and the related costs invested in this initiative. This lost revenue adversely impacted operating income due to the relatively fixed nature of GCS Services expenses. During 2003, we added 95 sales-and-service associates to our United States Other Services operations.
Operating income of our International Cleaning & Sanitizing operations rose 16 percent in 2003 at management rates. Excluding the effects of acquisitions and divestitures, operating income increased 13 percent. Our international operating income margin also increased in 2003 over 2002. Operating income as a percent of net sales excluding acquisitions and divestitures was 10.7 in 2003 versus 9.7 in 2002. This result was due to good operating income growth and margin improvement in our European, Asia Pacific and Canadian businesses. Operating income growth was also good in Latin America. The primary reason for these significant improvements was due to the successful introduction of new products and programs as well as careful cost management. We added 80 sales-and-service associates to our International Cleaning & Sanitizing operations during 2003.
Operating income margins of our International operations are less than those realized for our U.S. operations. The lower International margins are due to (i) higher costs of importing raw materials and finished goods, (ii) the additional costs caused by the difference in scale of International operations where many operating locations are smaller in size and (iii) the additional cost of operating in numerous and diverse foreign jurisdictions. Proportionately larger investments in sales, technical support and administrative personnel are also necessary in order to facilitate the growth of our International operations.
2002 compared with 2001
Sales of our United States Cleaning & Sanitizing operations were $1.6 billion in 2002 and increased 4 percent over net sales of $1.5 billion in 2001. Business acquisitions had no effect on the growth in sales for 2002. Sales benefited from good growth in sales of U.S. Institutional and Kay operations. U.S. Institutional operations sales growth during 2002 reflected good growth driven primarily by the non-travel portion of the business. Trends in sales to the travel-related business also showed improvement over the course of 2002. Sales of Kays U.S. operations increased over 2001 with strong growth in both its food retail business and sales to the quickservice market. Textile Care sales increased from 2001 due to increased sales to existing customers as well as sales to new customers. Professional Products sales decreased in 2002 due to both a decline in the core sales of the Janitorial market and a decrease in the non-core specialty business reflecting a planned restructuring of the JaniSource business. Professional Products sales, however, were positively impacted at the end of 2002 due to a long-term supply agreement that became effective in December 2002. Water Care Services sales decreased from 2001 due to customer cost cutting and consolidations. Water Care also continued to exit non-core markets. Vehicle Care sales growth for 2002 was primarily due to new business with major oil companies as well as new product introductions. Food & Beverage sales increased slightly from 2001 with good growth in sales to the dairy, beverage and meat & poultry markets which were partially offset by weak agricultural sales.
Sales of United States Other Services operations increased 13 percent to $308 million in 2002, from $273 million in 2001. Excluding the effects of business acquisitions, sales increased 4 percent for 2002. Pest Eliminations sales in 2002 included strong growth in non-contract services, and were partially offset by a slowdown in the growth of contract services. GCS Service sales growth increased over 2001, reflecting the continued expansion of its operations through acquisitions and a focus on integrating past acquisitions. Excluding the effects of businesses acquired, GCS Service sales decreased 1 percent for 2002. The results reflected the divisions focus on standardizing operating procedures and the impact of the hospitality slowdown on the GCS business. United States Other Services also includes modest sales from the addition of EcoSure operations in January 2002.
Management rate-based sales of our International Cleaning & Sanitizing operations reached $1.5 billion for 2002, an increase of 216 percent over sales of $0.5 billion in 2001. International Cleaning & Sanitizing includes European sales of $1.0 billion for 2002. Prior to 2002, we included the results of our former European joint venture operations in our financial statements using the equity method of accounting. Excluding Europes sales, International Cleaning & Sanitizing sales growth was 7 percent for 2002. Excluding all business acquisitions and divestitures, sales also increased 7 percent in 2002. European sales, although not consolidated prior to 2002, increased 8 percent over 2001 due to good growth in sales to the food and beverage markets and European acquisitions. For the Asia Pacific region, Japan, New Zealand
26
and China showed good sales growth for the year while Australias sales declined due to the sale of its Hygiene Services business. Asia Pacifics sales increased 3 percent in 2002, excluding business acquisitions and divestitures. The increase in Asia Pacific sales was primarily from the institutional and food and beverage markets. Latin America sales increased 7 percent in 2002, excluding business acquisitions, with good growth in all countries except Venezuela due to the economic impact of the devaluation of its currency. Sales in Canada increased over the prior year due to good growth in sales to the institutional market.
Operating income of our United States Cleaning & Sanitizing operations was $272 million in 2002, an increase of 10 percent from operating income of $247 million in 2001. As a percentage of net sales, operating income increased from 15.9 percent in 2001 to 16.8 percent in 2002. The improvement in reported operating income margins reflected tight cost controls, savings from cost reduction initiatives, the sale of new products and the impact of adopting SFAS No. 142. Operating income in 2001 does not reflect the effect of SFAS No. 142, and thus includes amortization expenses related to goodwill of $10.6 million. If the provisions of SFAS No. 142 had been applied retroactively to January 1, 2001, operating income for our United States Cleaning & Sanitizing operations would have increased 6 percent and the operating income margin for our U.S. Cleaning & Sanitizing operations would have been 16.6 percent for 2001. We added 105 sales-and-service associates to our United States Cleaning & Sanitizing operations during 2002.
Operating income of our United States Other Services operations increased 13 percent to $33 million in 2002. The operating income margin for United States Other Services was 10.7 percent for both 2002 and 2001. Operating income in 2001 does not reflect the effect of SFAS No. 142 and includes $1.9 million of amortization expense related to goodwill. Excluding acquisitions and the effects of SFAS No. 142, operating income increased 3 percent over 2001. Excluding acquisitions and including the pro forma effects of SFAS No. 142 on 2001, the operating income margin for United States Other Services was 11.4 percent for both 2002 and 2001. Pest Elimination had strong operating income growth due to increased productivity and cost controls. Operating income for GCS Service declined due to investments in the divisions infrastructure and systems. During 2002, we added 75 sales-and-service associates to our United States Other Services operations.
Operating income of our International Cleaning & Sanitizing operations rose 210 percent to $138 million in 2002 from operating income of $45 million in 2001. The International operating income margin decreased from 9.4 percent in 2001 to 9.2 percent in 2002. Operating income in 2001 does not reflect the effect of SFAS No. 142 and includes $5.3 million of amortization expense related to goodwill. Excluding acquisitions and including the pro forma effects of SFAS No. 142 on 2001, operating income increased 15 percent over 2001. Excluding acquisitions (primarily Europe) and including the pro forma effects on SFAS No. 142 on 2001, the operating income margin for International increased to 10.3 percent of net sales from 9.6 percent in 2001. Significant operating income growth and margin improvement from Asia Pacific, Latin America and Canada contributed to the increase. We added 510 sales-and-service associates to our International Cleaning & Sanitizing operations, including Europe, during 2002.
Henkel-Ecolab
Prior to November 30, 2001, we operated cleaning and sanitizing businesses in Europe through a 50 percent economic interest in the Henkel-Ecolab joint venture. On November 30, 2001, we purchased from Henkel KGaA the remaining 50 percent interest of Henkel-Ecolab that we did not already own. Additional details related to this purchase are included in Note 5 of the notes to consolidated financial statements.
We consolidated Henkel-Ecolabs operations effective with the November 30,2001 acquisition date and the end of Henkel-Ecolabs fiscal year for 2001. Because we consolidate our International operations on the basis of their November 30 fiscal year ends, Henkel-Ecolabs balance sheet was consolidated with our balance sheet as of year-end 2001. The income statement for the European operations was consolidated with our operations beginning in 2002.
Corporate
Our corporate operating expenses totaled $4.8 million in 2003, compared with $46.0 million in 2002 and $4.9 million in 2001.
Corporate operating expense in 2003 included a write-off of $1.7 million of goodwill related to an International business sold in 2003, $1.4 million of income for reductions in restructuring accruals and $4.5 million of expense for postretirement death benefits for retired executives. In 2002, the amount in corporate operating expense included restructuring and merger integration costs of $51.8 million, which were partially offset by a curtailment gain of $5.8 million related to benefit plan changes. Prior to 2002, corporate operating expense included overhead costs directly related to the European joint venture. In 2002 and 2003, these expenses were included in our International Cleaning & Sanitizing operating segment.
Interest and Income Taxes
Net interest expense for 2003 was $45 million, an increase of 3 percent over net interest expense of $44 million in 2002. The increase was primarily due to our euro-denominated debt and the strength of the euro against the U.S. dollar partially offset by lower debt levels.
Net interest expense of $44 million for 2002 increased 54 percent over net interest expense of $28 million in 2001. This increase was primarily due to higher debt levels incurred at year-end 2001 to finance the acquisition of the remaining 50 percent interest of our European joint venture which we did not already own.
Our effective income tax rate was 38.1 percent for 2003, compared with effective income tax rates of 39.8 percent and 40.5 percent in 2002 and 2001, respectively. Excluding the effects of the gain on the sale of an equity investment and the effect of special charges, the effective income tax rate was 38.0 percent for 2003. Excluding the effects of special charges in 2002, the estimated annual effective income tax rate was 39.5 percent. The reduction in the 2003 effective income tax rate was primarily due to a lower overall international rate and favorable international mix, as well as the tax savings opportunities that were available after the companys acquisition of its European operations at the end of fiscal year 2001. The decrease in 2002 from prior years was principally due to the adoption of SFAS No. 142 at the beginning of 2002, which eliminated the amortization of goodwill and related income tax effects. Overall effective rates on International operations were higher in 2002 than in prior years, principally due to the addition of the European joint venture. This was partially offset by lower state income tax rates in 2002.
27
FINANCIAL POSITION
Our debt continued to be rated within the A categories by the major rating agencies during 2003. Significant changes in our financial position during 2003 and 2002 included the following:
Total assets reached $3.2 billion at December 31, 2003, an increase of 13 percent over total assets of $2.9 billion at year-end 2002. Approximately $290 million of this increase was related to the strengthening of foreign currencies, primarily the euro. For example, 87 percent of the increase in accounts receivable was related to currency. The increase in goodwill in 2003 over 2002 was almost entirely related to currency. Other assets also increased significantly in 2003 due to a $75 million contribution to fund our U.S. pension plan.
In the liability section of the balance sheet, short-term debt was down significantly due to strong operating cash flow, which allowed us to pay down approximately $94 million of our short-term debt. Income taxes payable increased in 2003 over 2002 due to higher current income tax expense for 2003 as compared to 2002 and lower income tax payments made during the year compared to the prior year. Long-term debt also increased in 2003 due to currency as a large portion of our debt is denominated in euros.
During 2002 total assets increased to $2.9 billion from $2.5 billion at year-end 2001. Accounts receivable increased 8 percent over year end 2001, primarily due to the effect of business acquisitions during 2002, as well as due to the effect of exchange rates. Other assets also increased significantly from year-end 2001 due to payments totaling approximately $125 million to fund our U.S. pension plan during 2002. Other current liabilities increased from year-end 2001 primarily due to an increase in restructuring accruals and due to the effect of exchange rates.
Total debt was $675 million at December 31, 2003 and decreased from total debt of $700 million at year-end 2002. This decrease in total debt during 2003 was principally due to debt repayments made during the year, which were partially offset by the increase in debt due to the strengthening of foreign currencies, primarily the euro, during 2003. As of December 31,2003 the ratio of total debt to capitalization was 34 percent, down from 39 percent at year-end 2002 and 46 percent at year-end 2001. The lower debt to capitalization rate in 2003 and 2002 was due to debt repayments made during those years and increasing shareholders equity levels.
CASH FLOWS
Cash provided by operating activities reached a new record high of $529 million for 2003, an increase from $423 million in 2002 and $364 million in 2001. The operating cash flow for 2003 increased over 2002 due to higher sales in 2003 and a lower contribution to the pension plan compared to 2002. Operating cash flows for 2003 were also higher than 2002 due to reduced payments on restructuring liabilities and lower estimated tax payments due to tax benefits on options exercised during 2003. The increase in operating cash flows for 2002 over 2001 reflected the additional cash flows from businesses acquired, primarily the European joint venture, as well as the improvement in accounts receivable and days sales outstanding. Historically, we have had strong operating cash flows and we anticipate this will continue. We expect to continue to use this cash flow to acquire new businesses, repurchase our common stock, invest in merchandising equipment and other capital assets and pay down debt.
Cash flows used for investing activities included capital expenditures of $212 million in 2003, $213 million in 2002 and $158 million in 2001. Worldwide additions of merchandising equipment, primarily cleaning and sanitizing product dispensers, accounted for approximately 70 percent of each years capital expenditures. Merchandising equipment is depreciated over 3 to 7 year lives. Cash used for businesses acquired included Adams Healthcare in 2003, Terminix Ltd. and Kleencare Hygiene in 2002 and Henkel-Ecolab in 2001.
Financing cash flow activity included cash used to reacquire shares and pay dividends and cash provided and used through our debt arrangements. Share repurchases totaled $227 million in 2003, $9 million in 2002 and $32 million in 2001. These repurchases were funded with operating cash flows and cash from the exercise of employee stock options. In October 2003, we announced a new authorization to repurchase up to 10 million additional shares of Ecolab common stock for the purpose of offsetting the dilutive effect of shares issued for stock option exercises and incentives and general corporate purposes.
In 2003, we increased our annual dividend rate for the twelfth consecutive year. We have paid dividends on our common stock for 67 consecutive years. Cash dividends declared per share of common stock, by quarter, for each of the last three years were as follows:
|
|
First
|
|
Second
|
|
Third
|
|
Fourth
|
|
Year |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||
2003 |
|
$ |
0.0725 |
|
$ |
0.0725 |
|
$ |
0.0725 |
|
$ |
0.0800 |
|
$ |
0.2975 |
|
2002 |
|
0.0675 |
|
0.0675 |
|
0.0675 |
|
0.0725 |
|
0.2750 |
|
|||||
2001 |
|
0.0650 |
|
0.0650 |
|
0.0650 |
|
0.0675 |
|
0.2625 |
|
|||||
28
LIQUIDITY AND CAPITAL RESOURCES
We currently expect to fund all of the requirements which are reasonably foreseeable for 2004, including new program investments, scheduled debt repayments, dividend payments, possible acquisitions and share repurchases from operating activities, cash reserves and short-term borrowings. In the event of a significant acquisition, funding may occur through additional long-term borrowings. Cash provided by operating activities reached an all time high of $529 million in 2003. While cash flows could be negatively affected by a decrease in revenues, we do not believe that our revenues are highly susceptible, over the short run, to rapid changes in technology within our industry. We have a $450 million U.S. commercial paper program and a 200 million Australian dollar commercial paper program. In June 2003, we established a $200 million European commercial paper program to provide a source of funding for our European and other international acquisitions and working capital requirements. All three programs are rated A-1 by Standard & Poors and P-1 by Moodys. To support our commercial paper programs and other general business funding needs, we maintain a $275 million multi-year committed credit agreement which expires in December 2005 and a $175 million 364 day credit facility which expires in October 2004. We can draw directly on both credit facilities on a revolving credit basis. As of December 31, 2003, approximately $36 million of these credit facilities were committed to support outstanding commercial paper, leaving $414 million available for other uses. In January 2004, we issued 85 million euro (approximately $109 million at the date of the transaction) of commercial paper primarily to finance acquisitions subsequent to year-end. In addition, we have other committed and uncommitted credit lines of approximately $200 million with major international banks and financial institutions to support our general funding needs. Additional details on our credit facilities are included in Note 7 of the notes to consolidated financial statements.
During 2003, we voluntarily contributed $75 million to our U.S. pension plan. In making this contribution, we considered the normal growth in accrued plan benefits, the impact of lower year-end discount rates on the plan liability, our intent to improve the projected benefit obligation funding ratio and the 29 percent actual asset return on our pension plan in 2003. Our contributions to the pension plan did not have a material effect on our consolidated results of operations, financial condition or liquidity. We do not expect expense for our U.S. pension plan to increase significantly for 2004.
As described further in Note 5 of the consolidated financial statements, Henkel KGaA owns 28.2 percent of our common stock outstanding at December 31, 2003. In a December 2003 filing, Henkel reported that it may sell a portion or all of its holdings of Ecolab common stock and/or its holdings of common stock of The Clorox Company, or a combination of both, in connection with refinancing their pending acquisition of The Dial Corporation. Any dispositions by Henkel of any shares of Ecolab common stock would be done in accordance with the stockholders agreement between Henkel and Ecolab, including our right of first refusal, and applicable law.
We do not have relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purposes entities, which are sometimes established for the purpose of facilitating off-balance sheet financial arrangements or other contractually narrow or limited purposes. As such, we are not exposed to any financing, liquidity, market or credit risk that could arise if we had engaged in such relationships.
A schedule of our obligations under various long-term debt agreements and operating leases with noncancelable terms in excess of one year are summarized in the following table:
(thousands) |
|
Payments due by Period |
|
|||||||||||||
Contractual obligations |
|
Total |
|
Less
|
|
1-3
|
|
3-5
|
|
More
|
|
|||||
Long-term debt |
|
$ |
608,394 |
|
$ |
3,953 |
|
$ |
82,135 |
|
$ |
367,021 |
|
$ |
155,285 |
|
Operating leases |
|
138,525 |
|
35,726 |
|
51,136 |
|
29,392 |
|
22,271 |
|
|||||
Total contractual cash obligations |
|
$ |
746,919 |
|
$ |
39,679 |
|
$ |
133,271 |
|
$ |
396,413 |
|
$ |
177,556 |
|
We lease sales and administrative office facilities, distribution center facilities, computers and other equipment under longer-term operating leases. Vehicle leases are generally shorter in duration. The U.S. vehicle leases have guaranteed residual value requirements that have historically been satisfied by the proceeds on the sale of the vehicles. No amounts have been recorded for these guarantees in the table above as we believe that the potential recovery of value from the vehicles when sold will be greater than the residual value guarantee.
We do not have significant unconditional purchase obligations, or significant other commercial commitments, such as commitments under lines of credit, standby letters of credit, guarantees, standby repurchase obligations or other commercial commitments.
We are in compliance with all covenants and other requirements of our credit agreements and indentures. Additionally, we do not have any rating triggers that would accelerate the maturity dates of our debt.
A downgrade in our credit rating could limit or preclude our ability to issue commercial paper under our current programs. A credit rating downgrade could also adversely affect our ability to renew existing, or negotiate new credit facilities in the future and could increase the cost of these facilities. Should this occur, we could seek additional sources of funding, including issuing term notes or bonds. In addition, we have the ability at our option to draw upon our $450 million committed credit facilities prior to their termination.
MARKET RISK
We enter into contractual arrangements (derivatives) in the ordinary course of business to manage foreign currency exposure and interest rate risks. We do not enter into derivatives for trading purposes. Our use of derivatives is subject to internal policies that provide guidelines for control, counterparty risk and ongoing monitoring and reporting and is designed to reduce the volatility associated with movements in foreign exchange and interest rates on our income statement.
We enter into forward contracts, swaps and foreign currency options to hedge certain intercompany financial arrangements, and to hedge against the effect of exchange rate fluctuations on transactions related to cash flows and net investments denominated in currencies other than U.S. dollars. At December 31, 2003, we had approximately $239 million of foreign currency forward exchange contracts with face amounts denominated primarily in euros.
We manage interest expense using a mix of fixed and floating rate debt. To help manage borrowing costs, we may enter into interest rate swap agreements. Under these arrangements, we agree to exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. At year-end 2003, we had an interest rate swap that converts approximately euro 78 million (approximately $94 million U.S. dollars) of our Euronote debt from a fixed interest rate to a floating or variable
29
interest rate. This swap agreement is effective until February 2007. We also have an interest rate swap agreement on 50 million Australian dollars (approximately $36 million U.S. dollars) of Australian floating rate debt. This agreement is effective through November 2004 and has a fixed annual pay rate of approximately 6 percent. In September 2003, we entered into an interest rate swap agreement that converts $30 million of the 7.19% senior notes from a fixed interest rate to a floating or variable interest rate. This agreement is effective until January 2006.
Based on a sensitivity analysis (assuming a 10 percent adverse change in market rates) of our foreign exchange and interest rate derivatives and other financial instruments, changes in exchange rates or interest rates would not materially affect our financial position and liquidity. The effect on our results of operations would be substantially offset by the impact of the hedged items.
SUBSEQUENT EVENTS
In January 2004, we acquired Nigiko, a Paris-based provider of commercial pest elimination services throughout France. Nigiko pest elimination has annual sales of approximately $55 million. These operations will become part of our International Cleaning & Sanitizing operations in 2004.
In February 2004, we acquired Daydots International, a Texas-based provider of food safety products. Daydots has annual sales of approximately $22 million. These operations will become part of our U.S. Cleaning & Sanitizing operations in 2004.
FORWARD-LOOKING STATEMENTS AND RISK FACTORS
This financial discussion and other portions of this Annual Report to Shareholders contain various Forward-Looking Statements within the meaning of the Private Securities Litigation Reform Act of 1995. These include expectations concerning business progress and expansion, business acquisitions, currency translation, cash flows, debt repayments, susceptibility to changes in technology, global economic conditions and liquidity requirements. These statements, which represent our expectations or beliefs concerning various future events, are based on current expectations. Therefore, they involve a number of risks and uncertainties that could cause actual results to differ materially from those of such Forward-Looking Statements. These risks and uncertainties include the vitality of the foodservice, hospitality and travel industries; restraints on pricing flexibility due to competitive factors and customer and vendor consolidations; changes in oil or raw material prices or unavailability of adequate and reasonably priced raw materials; the occurrence of capacity constraints or the loss of a key supplier; the effect of future acquisitions or divestitures or other corporate transactions; our ability to achieve plans for past acquisitions; the costs and effects of complying with: (i) laws and regulations relating to the environment and to the manufacture, storage, distribution, efficacy and labeling of our products and (ii) changes in tax, fiscal, governmental and other regulatory policies; economic factors such as the worldwide economy, interest rates and currency movements, including, in particular, our exposure to foreign currency risk; the occurrence of (a) litigation or claims, (b) the loss or insolvency of a major customer or distributor, (c) war, (d) natural or manmade disasters (including acts of terrorism or hostilities which impact our markets) and, (e) severe weather conditions or public health epidemics affecting the foodservice, hospitality and travel industries; loss of, or changes in, executive management; our ability to continue product introductions and technological innovations; and other uncertainties or risks reported from time-to-time in our reports to the Securities and Exchange Commission. In addition, we note that our stock price can be affected by fluctuations in quarterly earnings. There can be no assurances that our earnings levels will meet investors expectations. We undertake no duty to update our Forward-Looking Statements.
30
consolidated statement of income
Year ended December 31 (thousands, except per share) |
|
2003 |
|
2002 |
|
2001 |
|
|||
|
|
|
|
|
|
|
|
|||
Net sales |
|
$ |
3,761,819 |
|
$ |
3,403,585 |
|
$ |
2,320,710 |
|
Operating expenses |
|
|
|
|
|
|
|
|||
Cost of sales (including special charges (income) of ($76) in 2003, $8,977 in 2002 and ($566) in 2001) |
|
1,845,202 |
|
1,687,597 |
|
1,120,254 |
|
|||
Selling, general and administrative expenses |
|
1,433,551 |
|
1,283,091 |
|
881,453 |
|
|||
Special charges |
|
408 |
|
37,031 |
|
824 |
|
|||
Operating income |
|
482,658 |
|
395,866 |
|
318,179 |
|
|||
Gain on sale of equity investment |
|
11,105 |
|
|
|
|
|
|||
Interest expense, net |
|
45,345 |
|
43,895 |
|
28,434 |
|
|||
Income from continuing operations before income taxes and equity in earnings of Henkel-Ecolab |
|
448,418 |
|
351,971 |
|
289,745 |
|
|||
Provision for income taxes |
|
171,070 |
|
140,081 |
|
117,408 |
|
|||
Equity in earnings of Henkel-Ecolab |
|
|
|
|
|
15,833 |
|
|||
Income from continuing operations before cumulative effect of change in accounting |
|
277,348 |
|
211,890 |
|
188,170 |
|
|||
Cumulative effect of change in accounting |
|
|
|
(4,002 |
) |
|
|
|||
Gain from discontinued operations |
|
|
|
1,882 |
|
|
|
|||
Net income |
|
$ |
277,348 |
|
$ |
209,770 |
|
$ |
188,170 |
|
|
|
|
|
|
|
|
|
|||
Basic income per common share |
|
|
|
|
|
|
|
|||
Income from continuing operations before change in accounting |
|
$ |
1.07 |
|
$ |
0.82 |
|
$ |
0.74 |
|
Change in accounting |
|
|
|
(0.02 |
) |
|
|
|||
Gain from discontinued operations |
|
|
|
0.01 |
|
|
|
|||
Net income |
|
$ |
1.07 |
|
$ |
0.81 |
|
$ |
0.74 |
|
Diluted income per common share |
|
|
|
|
|
|
|
|||
Income from continuing operations before change in accounting |
|
$ |
1.06 |
|
$ |
0.81 |
|
$ |
0.72 |
|
Change in accounting |
|
|
|
(0.02 |
) |
|
|
|||
Gain from discontinued operations |
|
|
|
0.01 |
|
|
|
|||
Net income |
|
$ |
1.06 |
|
$ |
0.80 |
|
$ |
0.72 |
|
|
|
|
|
|
|
|
|
|||
Weighted-average common shares outstanding |
|
|
|
|
|
|
|
|||
Basic |
|
259,454 |
|
258,147 |
|
254,832 |
|
|||
Diluted |
|
262,737 |
|
261,574 |
|
259,855 |
|
The accompanying notes are an integral part of the consolidated financial statements.
31
consolidated balance sheet
December 31 (thousands, except per share) |
|
2003 |
|
2002 |
|
2001 |
|
|||
|
|
|
|
|
|
|
|
|||
ASSETS |
|
|
|
|
|
|
|
|||
Current assets |
|
|
|
|
|
|
|
|||
Cash and cash equivalents |
|
$ |
85,626 |
|
$ |
49,205 |
|
$ |
41,793 |
|
Accounts receivable, net |
|
626,002 |
|
553,154 |
|
514,074 |
|
|||
Inventories |
|
309,959 |
|
291,506 |
|
279,785 |
|
|||
Deferred income taxes |
|
75,820 |
|
71,147 |
|
53,781 |
|
|||
Other current assets |
|
52,933 |
|
50,925 |
|
40,150 |
|
|||
Total current assets |
|
1,150,340 |
|
1,015,937 |
|
929,583 |
|
|||
Property, plant and equipment, net |
|
736,797 |
|
680,265 |
|
644,323 |
|
|||
Goodwill, net |
|
797,211 |
|
695,700 |
|
596,925 |
|
|||
Other intangible assets, net |
|
203,859 |
|
188,670 |
|
178,951 |
|
|||
Other assets, net |
|
340,711 |
|
285,335 |
|
175,218 |
|
|||
Total assets |
|
$ |
3,228,918 |
|
$ |
2,865,907 |
|
$ |
2,525,000 |
|
|
|
|
|
|
|
|
|
|||
LIABILITIES AND SHAREHOLDERS EQUITY |
|
|
|
|
|
|
|
|||
Current liabilities |
|
|
|
|
|
|
|
|||
Short-term debt |
|
$ |
70,203 |
|
$ |
160,099 |
|
$ |
233,393 |
|
Accounts payable |
|
212,287 |
|
205,665 |
|
199,772 |
|
|||
Compensation and benefits |
|
190,386 |
|
184,239 |
|
132,720 |
|
|||
Income taxes |
|
59,829 |
|
12,632 |
|
18,887 |
|
|||
Other current liabilities |
|
319,237 |
|
291,193 |
|
243,180 |
|
|||
Total current liabilities |
|
851,942 |
|
853,828 |
|
827,952 |
|
|||
Long-term debt |
|
604,441 |
|
539,743 |
|
512,280 |
|
|||
Postretirement health care and pension benefits |
|
249,906 |
|
207,596 |
|
183,281 |
|
|||
Other liabilities |
|
227,203 |
|
164,989 |
|
121,135 |
|
|||
Shareholders equity (common stock, par value $1.00 per share; shares outstanding: 2003 257,417; 2002 129,940 and 2001 127,900) |
|
1,295,426 |
|
1,099,751 |
|
880,352 |
|
|||
Total liabilities and shareholders equity |
|
$ |
3,228,918 |
|
$ |
2,865,907 |
|
$ |
2,525,000 |
|
The accompanying notes are an integral part of the consolidated financial statements.
32
consolidated statement of cash flows
Year ended December 31 (thousands) |
|
2003 |
|
2002 |
|
2001 |
|
|||
|
|
|
|
|
|
|
|
|||
OPERATING ACTIVITIES |
|
|
|
|
|
|
|
|||
Net income |
|
$ |
277,348 |
|
$ |
209,770 |
|
$ |
188,170 |
|
Cumulative effect of change in accounting |
|
|
|
4,002 |
|
|
|
|||
Gain from discontinued operations |
|
|
|
(1,882 |
) |
|
|
|||
Income from continuing operations |
|
277,348 |
|
211,890 |
|
188,170 |
|
|||
Adjustments to reconcile income from continuing operations to cash provided by operating activities: |
|
|
|
|
|
|
|
|||
Depreciation |
|
201,512 |
|
194,840 |
|
128,020 |
|
|||
Amortization |
|
28,144 |
|
28,588 |
|
34,970 |
|
|||
Deferred income taxes |
|
42,455 |
|
49,923 |
|
(2,950 |
) |
|||
Gain on sale of equity investment |
|
(11,105 |
) |
|
|
|
|
|||
Equity in earnings of Henkel-Ecolab |
|
|
|
|
|
(15,833 |
) |
|||
Henkel-Ecolab royalties and dividends |
|
|
|
|
|
23,928 |
|
|||
Special charges asset disposals |
|
1,684 |
|
6,180 |
|
(566 |
) |
|||
Other, net |
|
1,837 |
|
1,835 |
|
(1,373 |
) |
|||
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|||
Accounts receivable |
|
(5,547 |
) |
78 |
|
20,570 |
|
|||
Inventories |
|
(2,902 |
) |
(3,567 |
) |
(8,014 |
) |
|||
Other assets |
|
(39,224 |
) |
(141,926 |
) |
(26,049 |
) |
|||
Accounts payable |
|
(13,329 |
) |
(8,860 |
) |
(7,451 |
) |
|||
Other liabilities |
|
48,326 |
|
84,345 |
|
31,059 |
|
|||
Cash provided by operating activities |
|
529,199 |
|
423,326 |
|
364,481 |
|
|||
|
|
|
|
|
|
|
|
|||
INVESTING ACTIVITIES |
|
|
|
|
|
|
|
|||
Capital expenditures |
|
(212,035 |
) |
(212,757 |
) |
(157,937 |
) |
|||
Property disposals |
|
8,502 |
|
6,788 |
|
3,027 |
|
|||
Capitalized software expenditures |
|
(8,951 |
) |
(4,490 |
) |
|
|
|||
Businesses acquired and investments in affiliates |
|
(31,726 |
) |
(62,825 |
) |
(469,804 |
) |
|||
Sale of businesses and assets |
|
27,130 |
|
|
|
|
|
|||
Cash used for investing activities |
|
(217,080 |
) |
(273,284 |
) |
(624,714 |
) |
|||
|
|
|
|
|
|
|
|
|||
FINANCING ACTIVITIES |
|
|
|
|
|
|
|
|||
Net issuances (repayments) of notes payable |
|
(94,412 |
) |
(368,834 |
) |
204,218 |
|
|||
Long-term debt borrowings |
|
5,959 |
|
261,039 |
|
149,817 |
|
|||
Long-term debt repayments |
|
(13,270 |
) |
(1,257 |
) |
(16,283 |
) |
|||
Reacquired shares |
|
(227,145 |
) |
(8,894 |
) |
(32,164 |
) |
|||
Cash dividends on common stock |
|
(75,413 |
) |
(69,583 |
) |
(66,456 |
) |
|||
Exercise of employee stock options |
|
126,615 |
|
45,531 |
|
19,356 |
|
|||
Other, net |
|
(313 |
) |
(1,746 |
) |
(975 |
) |
|||
Cash provided by (used for) financing activities |
|
(277,979 |
) |
(143,744 |
) |
257,513 |
|
|||
|
|
|
|
|
|
|
|
|||
Effect of exchange rate changes on cash |
|
2,281 |
|
1,114 |
|
548 |
|
|||
|
|
|
|
|
|
|
|
|||
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS |
|
36,421 |
|
7,412 |
|
(2,172 |
) |
|||
Cash and cash equivalents, beginning of year |
|
49,205 |
|
41,793 |
|
43,965 |
|
|||
Cash and cash equivalents, end of year |
|
$ |
85,626 |
|
$ |
49,205 |
|
$ |
41,793 |
|
The accompanying notes are an integral part of the consolidated financial statements.
33
consolidated statement of comprehensive income and shareholders equity
(thousands) |
|
Common
|
|
Additional
|
|
Retained
|
|
Deferred
|
|
Accumulated
|
|
Treasury
|
|
Total |
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
BALANCE DECEMBER 31, 2000 |
|
$ |
148,170 |
|
$ |
283,587 |
|
$ |
899,959 |
|
$ |
(7,895 |
) |
$ |
(89,075 |
) |
$ |
(477,739 |
) |
$ |
757,007 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Net income |
|
|
|
|
|
188,170 |
|
|
|
|
|
|
|
188,170 |
|
|||||||
Foreign currency translation |
|
|
|
|
|
|
|
|
|
(5,962 |
) |
|
|
(5,962 |
) |
|||||||
Other comprehensive loss |
|
|
|
|
|
|
|
|
|
(586 |
) |
|
|
(586 |
) |
|||||||
Comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
|
181,622 |
|
|||||||
Cash dividends declared |
|
|
|
|
|
(67,080 |
) |
|
|
|
|
|
|
(67,080 |
) |
|||||||
Stock options, including tax benefits |
|
1,564 |
|
34,985 |
|
|
|
|
|
|
|
|
|
36,549 |
|
|||||||
Stock awards, net issuances |
|
|
|
880 |
|
|
|
14 |
|
|
|
(180 |
) |
714 |
|
|||||||
Business acquisitions |
|
|
|
|
|
|
|
|
|
|
|
(501 |
) |
(501 |
) |
|||||||
Reacquired shares |
|
|
|
|
|
|
|
|
|
|
|
(32,164 |
) |
(32,164 |
) |
|||||||
Amortization |
|
|
|
|
|
|
|
4,205 |
|
|
|
|
|
4,205 |
|
|||||||
BALANCE DECEMBER 31, 2001 |
|
149,734 |
|
319,452 |
|
1,021,049 |
|
(3,676 |
) |
(95,623 |
) |
(510,584 |
) |
880,352 |
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Net income |
|
|
|
|
|
209,770 |
|
|
|
|
|
|
|
209,770 |
|
|||||||
Foreign currency translation |
|
|
|
|
|
|
|
|
|
20,500 |
|
|
|
20,500 |
|
|||||||
Other comprehensive income |
|
|
|
|
|
|
|
|
|
67 |
|
|
|
67 |
|
|||||||
Minimum pension liability |
|
|
|
|
|
|
|
|
|
(1,052 |
) |
|
|
(1,052 |
) |
|||||||
Comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
|
229,285 |
|
|||||||
Cash dividends declared |
|
|
|
|
|
(71,156 |
) |
|
|
|
|
|
|
(71,156 |
) |
|||||||
Stock options, including tax benefits |
|
2,216 |
|
64,617 |
|
|
|
|
|
|
|
|
|
66,833 |
|
|||||||
Stock awards, net issuances |
|
|
|
2,139 |
|
|
|
(827 |
) |
|
|
(658 |
) |
654 |
|
|||||||
Business acquisitions |
|
|
|
|
|
|
|
|
|
|
|
(116 |
) |
(116 |
) |
|||||||
Reacquired shares |
|
|
|
|
|
|
|
|
|
|
|
(8,894 |
) |
(8,894 |
) |
|||||||
Amortization |
|
|
|
|
|
|
|
2,793 |
|
|
|
|
|
2,793 |
|
|||||||
BALANCE DECEMBER 31, 2002 |
|
151,950 |
|
386,208 |
|
1,159,663 |
|
(1,710 |
) |
(76,108 |
) |
(520,252 |
) |
1,099,751 |
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Net income |
|
|
|
|
|
277,348 |
|
|
|
|
|
|
|
277,348 |
|
|||||||
Foreign currency translation |
|
|
|
|
|
|
|
|
|
90,601 |
|
|
|
90,601 |
|
|||||||
Other comprehensive loss |
|
|
|
|
|
|
|
|
|
(865 |
) |
|
|
(865 |
) |
|||||||
Minimum pension liability |
|
|
|
|
|
|
|
|
|
(9,530 |
) |
|
|
(9,530 |
) |
|||||||
Comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
|
357,554 |
|
|||||||
Cash dividends declared |
|
|
|
|
|
(77,132 |
) |
|
|
|
|
|
|
(77,132 |
) |
|||||||
Stock options, including tax benefits |
|
3,596 |
|
136,941 |
|
|
|
|
|
|
|
|
|
140,537 |
|
|||||||
Stock awards, net issuances |
|
|
|
604 |
|
|
|
(253 |
) |
|
|
(43 |
) |
308 |
|
|||||||
Reacquired shares |
|
|
|
|
|
|
|
|
|
|
|
(227,145 |
) |
(227,145 |
) |
|||||||
Amortization |
|
|
|
|
|
|
|
1,553 |
|
|
|
|
|
1,553 |
|
|||||||
Stock dividend |
|
154,738 |
|
(154,738 |
) |
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
BALANCE DECEMBER 31, 2003 |
|
$ |
310,284 |
|
$ |
369,015 |
|
$ |
1,359,879 |
|
$ |
(410 |
) |
$ |
4,098 |
|
$ |
(747,440 |
) |
$ |
1,295,426 |
|
COMMON STOCK ACTIVITY
|
|
2003 |
|
2002 |
|
2001 |
|
||||||
Year ended December 31 (shares) |
|
Common Stock |
|
Treasury Stock |
|
Common Stock |
|
Treasury Stock |
|
Common Stock |
|
Treasury Stock |
|
Shares, beginning of year |
|
151,950,428 |
|
(22,010,334 |
) |
149,734,067 |
|
(21,833,949 |
) |
148,169,930 |
|
(21,009,195 |
) |
Stock options |
|
3,595,961 |
|
|
|
2,216,361 |
|
|
|
1,564,137 |
|
|
|
Stock awards, net issuances |
|
|
|
12,241 |
|
|
|
25,065 |
|
|
|
21,382 |
|
Business acquisitions |
|
|
|
|
|
|
|
(2,672 |
) |
|
|
(15,017 |
) |
Reacquired shares |
|
|
|
(6,666,861 |
) |
|
|
(198,778 |
) |
|
|
(831,119 |
) |
Stock dividend |
|
154,737,694 |
|
(24,202,607 |
) |
|
|
|
|
|
|
|
|
Shares, end of year |
|
310,284,083 |
|
(52,867,561 |
) |
151,950,428 |
|
(22,010,334 |
) |
149,734,067 |
|
(21,833,949 |
) |
The accompanying notes are an integral part of the consolidated financial statements.
34
notes to consolidated financial statements
NOTE 1 NATURE OF BUSINESS
Ecolab Inc. (the company) develops and markets premium products and services for the hospitality, foodservice, institutional and industrial markets. The company provides cleaning, sanitizing, pest elimination, maintenance and repair products, systems and services primarily to hotels and restaurants; healthcare and educational facilities; quickservice (fast-food and convenience stores) units; grocery stores; commercial and institutional laundries; light industry; dairy plants and farms; food and beverage processors; pharmaceutical and cosmetic facilities and the vehicle wash industry.
NOTE 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Principles of Consolidation
The consolidated financial statements include the accounts of the company and all majority-owned subsidiaries. Prior to November 30, 2001, the company accounted for its investment in Henkel-Ecolab under the equity method of accounting. As discussed further in Note 5, on November 30, 2001, the company acquired the remaining 50 percent interest of the European joint venture that it did not previously own, and Henkel-Ecolab became a wholly-owned subsidiary of the company. Because the company consolidates its international operations on the basis of their November 30 fiscal year ends, the balance sheet of the European operations was consolidated with the companys balance sheet beginning with year-end 2001. The income statement for the European operations was consolidated with the companys operations beginning in 2002. International subsidiaries are included in the financial statements on the basis of their November 30 fiscal year-ends to facilitate the timely inclusion of such entities in the companys consolidated financial reporting. All intercompany transactions and profits are eliminated in consolidation.
Foreign Currency Translation
Financial position and results of operations of the companys international subsidiaries generally are measured using local currencies as the functional currency. Assets and liabilities of these operations are translated at the exchange rates in effect at each fiscal year end. The translation adjustments related to assets and liabilities that arise from the use of differing exchange rates from period to period are included in accumulated other comprehensive income (loss) in shareholders equity. The cumulative translation gain as of year-end 2003 was $16,064,000. The cumulative translation loss as of year-end 2002 and 2001 was $74,537,000 and $95,037,000, respectively. Income statement accounts are translated at the average rates of exchange prevailing during the year. The different exchange rates from period to period impact the amount of reported income from the companys international operations.
Cash and Cash Equivalents
Cash equivalents include highly-liquid investments with a maturity of three months or less when purchased.
Inventory Valuations
Inventories are valued at the lower of cost or market. Domestic chemical inventory costs are determined on a last-in, first-out (lifo) basis. LIFO inventories represented 29 percent, 30 percent and 29 percent of consolidated inventories at year-end 2003, 2002 and 2001, respectively. All other inventory costs are determined on a first-in, first-out (fifo) basis.
Property, Plant and Equipment
Property, plant and equipment are stated at cost. Merchandising equipment consists principally of various systems that dispense the companys cleaning and sanitizing products and dishwashing machines. The dispensing systems are accounted for on a mass asset basis, whereby equipment is capitalized and depreciated as a group and written off when fully depreciated. Depreciation is charged to operations using the straight-line method over the assets estimated useful lives ranging from 5 to 50 years for buildings, 3 to 7 years for merchandising equipment and 3 to 11 years for machinery and equipment.
Goodwill and Other Intangible Assets
Goodwill and other intangible assets arise principally from business acquisitions. Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired. Other intangible assets include primarily customer relationships, trademarks, patents and other technology. Other intangible assets are amortized on a straight-line basis over their estimated economic lives. The weighted-average useful life of other intangible assets was 12 years as of December 31, 2003.
The straight-line method of amortization reflects an appropriate allocation of the cost of the intangible assets to earnings in proportion to the amount of economic benefits obtained by the company in each reporting period. Total amortization expense related to other intangible assets during the years ended December 31, 2003, 2002 and 2001 was approximately $21.2 million, $16.9 million and $5.1 million, respectively. As of December 31, 2003, future estimated amortization expense related to amortizable other identifiable intangible assets for each of the next five years will be:
(thousands) |
|
|
|
|
|
|
|
|
|
|
|
2004 |
|
|
$ |
21,341 |
|
2005 |
|
|
19,696 |
|
|
2006 |
|
|
19,236 |
|
|
2007 |
|
|
18,692 |
|
|
2008 |
|
|
17,266 |
|
|
Long-Lived Assets
The company periodically reviews its long-lived assets for impairment and assesses whether significant events or changes in business circumstances indicate that the carrying value of the assets may not be recoverable. An impairment loss is recognized when the carrying amount of an asset exceeds the anticipated future undiscounted cash flows expected to result from the use of the asset and its eventual disposition. The amount of the impairment loss to be recorded, if any, is calculated by the excess of the assets carrying value over its fair value.
35
Revenue Recognition
The company recognizes revenue as services are performed or on product sales at the time title transfers to the customer. The company records estimated reductions to revenue for customer programs and incentive offerings, including pricing arrangements, promotions and other volume-based incentives at the time of sale.
Income Per Common Share
The computations of the basic and diluted income from continuing operations per share amounts were as follows:
(thousands, except per share) |
|
2003 |
|
2002 |
|
2001 |
|
|||
|
|
|
|
|
|
|
|
|||
Income from continuing operations before change in accounting |
|
$ |
277,348 |
|
$ |
211,890 |
|
$ |
188,170 |
|
|
|
|
|
|
|
|
|
|||
Weighted-average common shares outstanding |
|
|
|
|
|
|
|
|||
Basic |
|
259,454 |
|
258,147 |
|
254,832 |
|
|||
Effect of dilutive stock options and awards |
|
3,283 |
|
3,427 |
|
5,023 |
|
|||
Diluted |
|
262,737 |
|
261,574 |
|
259,855 |
|
|||
|
|
|
|
|
|
|
|
|||
Income from continuing operations before change in accounting per common share |
|
|
|
|
|
|
|
|||
Basic |
|
$ |
1.07 |
|
$ |
0.82 |
|
$ |
0.74 |
|
Diluted |
|
$ |
1.06 |
|
$ |
0.81 |
|
$ |
0.72 |
|
All number of share and per share data for all periods presented have been adjusted to reflect the two-for-one stock split described in Note 9.
Restricted stock awards of approximately 52,800 shares for 2003, 203,550 shares for 2002 and 347,100 shares for 2001 were excluded from the computation of basic weighted-average shares outstanding because such shares were not yet vested at those dates.
Stock options to purchase approximately 4.3 million shares for 2003, 8.4 million shares for 2002 and 7.9 million shares for 2001 were not dilutive and, therefore, were not included in the computations of diluted common shares outstanding.
Stock-Based Compensation
The company measures compensation cost for its stock incentive and option plans using the intrinsic value-based method of accounting.
Had the company used the fair value-based method of accounting to measure compensation expense for its stock incentive and option plans and charged compensation cost against income, over the vesting periods, based on the fair value of options at the date of grant, net income and the related basic and diluted per common share amounts for 2003,2002 and 2001 would have been reduced to the pro forma amounts in the following table:
(thousands, except per share) |
|
2003 |
|
2002 |
|
2001 |
|
|||
|
|
|
|
|
|
|
|
|||
Net income, as reported |
|
$ |
277,348 |
|
$ |
209,770 |
|
$ |
188,170 |
|
Add: Stock-based employee compensation expense included in reported net income, net of tax |
|
941 |
|
1,688 |
|
2,542 |
|
|||
Deduct: Total stock-based employee compensation expense under fair value - based method, net of tax |
|
(17,699 |
) |
(15,145 |
) |
(13,172 |
) |
|||
Pro forma net income |
|
$ |
260,590 |
|
$ |
196,313 |
|
$ |
177,540 |
|
|
|
|
|
|
|
|
|
|||
Basic net income per common share |
|
|
|
|
|
|
|
|||
As reported |
|
$ |
1.07 |
|
$ |
0.81 |
|
$ |
0.74 |
|
Pro forma |
|
1.00 |
|
0.76 |
|
0.70 |
|
|||
|
|
|
|
|
|
|
|
|||
Diluted net income per common share |
|
|
|
|
|
|
|
|||
As reported |
|
1.06 |
|
0.80 |
|
0.72 |
|
|||
Pro forma |
|
$ |
0.99 |
|
$ |
0.75 |
|
$ |
0.68 |
|
Note 10 to the consolidated financial statements contains the significant assumptions used in determining the underlying fair value of options.
Comprehensive Income
For the company, comprehensive income includes net income, foreign currency translation adjustments, minimum pension liabilities, gains and losses on derivative instruments designated and effective as cash flow hedges and nonderivative instruments designated and effective as foreign currency net investment hedges that are charged or credited to the accumulated other comprehensive income (loss) account in shareholders equity.
Derivative Instruments and Hedging Activities
The company uses foreign currency forward contracts, interest rate swaps and foreign currency debt to manage risks generally associated with foreign exchange rates, interest rates and net investments in foreign operations. The company does not hold derivative financial instruments of a speculative nature. On the date that the company enters into a derivative contract, it designates the derivative as (1) a hedge of (a) the fair value of a recognized asset or liability or (b) an unrecognized firm commitment (a fair value hedge), (2) a hedge of (a) a forecasted transaction or (b) the variability of cash flows that are to be received or paid in connection with a recognized asset or liability (a cash flow
36
hedge); or (3) a foreign-currency fair-value or cash flow hedge (a foreign currency hedge). The company formally documents all relationships between hedging instruments and hedged items, as well as its risk-management objective and strategy for undertaking various hedge transactions. The company also formally assesses (both at the hedges inception and on an ongoing basis) whether the derivatives that are used in hedging transactions have been highly effective in offsetting changes in the fair value or cash flows of hedged items and whether those derivatives may be expected to remain highly effective in future periods. When it is determined that a derivative is not (or has ceased to be) highly effective as a hedge, the company will discontinue hedge accounting prospectively. The company believes that on an ongoing basis its portfolio of derivative instruments will generally be highly effective as hedges. Hedge ineffectiveness during the years ended December 31, 2003, 2002 and 2001 was not significant.
All of the companys derivatives are recognized on the balance sheet at their fair value. The earnings impact resulting from the change in fair value of the derivative instruments is recorded in the same line item in the consolidated statement of income as the underlying exposure being hedged.
Use of Estimates
The preparation of the companys financial statements requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from these estimates.
New Accounting Pronouncements
In January 2003, the Financial Accounting Standards Board (FASB) issued FASB Interpretation No. 46, Consolidation of Variable Interest Entities (FIN 46). FIN 46 was subsequently revised in December 2003 by the issuance of FIN 46R to provide additional guidance on the application and scope of FIN 46. FIN 46 and FIN 46R provide accounting requirements for a business enterprise to consolidate related entities in which it is determined to be the primary beneficiary as a result of its variable economic interests. The interpretation provides guidance in judging multiple economic interests in an entity and in determining the primary beneficiary.
The interpretations outline consolidation and disclosure requirements for variable interest entities (VIEs). The company has reviewed the consolidation and disclosure requirements of FIN 46 and FIN 46R and determined that they have no current impact on the company.
In April 2003, the FASB issued Statement of Financial Accounting Standards (SFAS) No. 149, Amendment of Statement 133 on Derivative Instruments and Hedging Activities . This statement amends and clarifies financial accounting and reporting for derivative instruments, including certain derivative instruments embedded in other contracts and for hedging activities under SFAS No. 133, Accounting for Derivative Instruments and Hedging Activities . The company has reviewed the requirements of this standard and it has no current impact on the company.
In May 2003, the FASB issued SFAS No. 150, Accounting for Certain Financial Instruments with Characteristics of Both Liabilities and Equity . This statement established standards for how an issuer classifies and measures certain financial instruments with characteristics of both liabilities and equity. The company does not have any financial instruments subject to SFAS No. 150 as of December 31, 2003.
In December 2003, the FASB issued a revision to SFAS 132, Employers Disclosures about Pensions and Other Postretirement Benefits , which requires additional disclosures about the assets, obligations, cash flows, and periodic benefit costs of defined benefit pension plans and other defined benefit postretirement plans. Note 15 presents the new disclosure requirements for the companys domestic plans. Disclosure of additional information about foreign plans is not required until the companys next fiscal year.
Reclassifications
The consolidated balance sheet as of December 31, 2002 includes a reclassification of $12,522,000 of accumulated amortization to a long-lived asset that was previously classified as an other current liability to be consistent with the current period presentation.
NOTE 3 SPECIAL CHARGES
In the first quarter of 2002, management approved plans to undertake restructuring and cost saving actions during 2002, including costs related to the integration of the companys European operations. These actions included global workforce reductions, facility closings and product line discontinuations. As a result, the company recorded restructuring expense of $47,767,000 ($29,867,000 after tax) for the year ended December 31, 2002. This includes $36,366,000 for employee termination benefits, $6,180,000 for asset disposals and $5,221,000 for other charges. The company also incurred merger integration costs of $4,032,000 ($2,521,000 after tax) related to European and other operations. Restructuring and merger integration costs have been included as special charges on the consolidated statement of income with a portion of restructuring expenses included as a component of cost of sales. Amounts included as a component of cost of sales include asset disposals of $6,180,000 and manufacturing related severance of $2,797,000 for the year ended December 31, 2002.
Also included in special charges on the consolidated statement of income for the year ended December 31, 2002 is a one-time curtailment gain of $5,791,000 ($3,501,000 after tax), related to changes to postretirement healthcare benefits made in the first quarter of 2002.
Restructuring liabilities are classified as a component of other current liabilities.
Employee termination benefit expenses in 2002 included 695 net personnel reductions through voluntary and involuntary terminations, with the possibility that some of these people may be replaced. Individuals were affected through facility closures and consolidation primarily within the corporate administrative, operations and research and development functions.
Asset disposals include inventory and property, plant, and equipment charges. Inventory charges for the year ended December 31, 2002 were $2,391,000 and reflect the discontinuance of product lines which are not consistent with the companys long-term strategies. Property, plant and equipment charges during the year ended December 31, 2002 were $3,789,000 and reflect the downsizing and closure of production facilities as well as global changes to manufacturing and distribution operations in connection with the integration of European operations.
Other charges of $5,221,000 for the year ended December 31, 2002, include lease termination costs and other miscellaneous exit costs.
The company recorded restructuring and merger integration charges throughout 2002 and completed these activities by December 31, 2002.
During 2003, restructuring activity includes the reversal of
37
$1,359,000 of previously accrued severance costs as project expenses were favorable to previous estimates. Of this amount, $76,000 is included as a component of cost of sales and $1,283,000 is included as a component of special charges.
Also included in special charges is a write-off of $1,691,000 of goodwill related to an International business which was sold in 2003.
During the fourth quarter of 2001, the company incurred $940,000 in special charges to facilitate the acquisition of Henkel-Ecolab and to begin the integration process following the acquisition.
Management also approved various actions during the fourth quarter of 2000 to improve the long-term efficiency and competitiveness of the company and to reduce costs. These actions, which were completed in 2001, included personnel reductions, discontinuance of certain product lines, changes to certain manufacturing and distribution operations and the closing of selected sales and administrative offices. During 2001, revisions of prior year estimates related to inventory write-downs and severance amounts reduced 2001 cost of sales by $566,000 and special charges by $116,000, respectively.
For segment reporting purposes, each of these items has been included in the companys corporate segment, which is consistent with the companys internal management reporting. Changes to the restructuring liability accounts included the following:
(thousands) |
|
Employee
|
|
Asset
|
|
Other |
|
Total |
|
||||
|
|
|
|
|
|
|
|
|
|
||||
Restructuring liability, December 31, 2000 |
|
$ |
2,763 |
|
$ |
0 |
|
$ |
1,290 |
|
$ |
4,053 |
|
Cash payments |
|
(2,594 |
) |
|
|
(1,343 |
) |
(3,937 |
) |
||||
Revisions to prior estimates |
|
(169 |
) |
(566 |
) |
53 |
|
(682 |
) |
||||
Non-cash credits |
|
|
|
566 |
|
|
|
566 |
|
||||
Restructuring liability, December 31, 2001 |
|
0 |
|
0 |
|
0 |
|
0 |
|
||||
Initial expense and accrual |
|
36,366 |
|
6,180 |
|
5,221 |
|
47,767 |
|
||||
Cash payments |
|
(16,033 |
) |
|
|
(1,711 |
) |
(17,744 |
) |
||||
Non-cash charges |
|
|
|
(6,180 |
) |
|
|
(6,180 |
) |
||||
Restructuring liability, December 31, 2002 |
|
20,333 |
|
0 |
|
3,510 |
|
23,843 |
|
||||
Cash payments |
|
(16,770 |
) |
|
|
(2,471 |
) |
(19,241 |
) |
||||
Non-cash credits |
|
|
|
7 |
|
|
|
7 |
|
||||
Revisions to prior estimates |
|
(1,352 |
) |
(7 |
) |
|
|
(1,359 |
) |
||||
Effect of foreign currency translation |
|
1,222 |
|
|
|
670 |
|
1,892 |
|
||||
Restructuring liability, December 31, 2003 |
|
$ |
3,433 |
|
$ |
0 |
|
$ |
1,709 |
|
$ |
5,142 |
|
Subject to further revisions to estimates, the remaining liability balance will be settled through periodic contractual payments.
NOTE 4 GAIN FROM DISCONTINUED OPERATIONS
During the first quarter of 2002, the company resolved a legal issue related to the disposal of its ChemLawn business in 1992. This resulted in the recognition of a gain from discontinued operations of $1,882,000 (net of income tax benefit of $1,079,000), or $0.01 per diluted share during the year ended December 31, 2002.
NOTE 5 HENKEL-ECOLAB
Prior to November 30, 2001, the company and Henkel KGaA, Düsseldorf, Germany (Henkel), each owned 50 percent of Henkel-Ecolab, a joint venture of their respective European institutional and industrial cleaning and sanitizing businesses. The company accounted for this investment in Henkel-Ecolab under the equity method of accounting. On November 30, 2001, Ecolab purchased the remaining 50 percent interest of this joint venture it did not already own from Henkel. Because the company consolidates its international operations on the basis of their November 30 fiscal year ends, the balance sheet of Henkel-Ecolab as of November 30, 2001 was consolidated with the companys balance sheet beginning with year-end 2001. The income statement for the European operations was consolidated with the companys operations beginning in 2002.
For 2001, Henkel-Ecolab results of operations and the companys equity in earnings of Henkel-Ecolab included:
(thousands) |
|
2001 |
|
|
|
|
|
|
|
Henkel-Ecolab |
|
|
|
|
Net sales |
|
$ |
869,487 |
|
Gross profit |
|
419,635 |
|
|
Income before income taxes |
|
67,286 |
|
|
Net income |
|
$ |
40,043 |
|
|
|
|
|
|
Ecolab equity in earnings |
|
|
|
|
Ecolab equity in net income |
|
$ |
20,022 |
|
Ecolab royalty income from Henkel-Ecolab, net of income taxes |
|
2,123 |
|
|
Amortization expense for the excess of cost over the underlying net assets of Henkel-Ecolab |
|
(6,312 |
) |
|
Equity in earnings of Henkel-Ecolab |
|
$ |
15,833 |
|
Prior to November 30, 2001, the companys investment in Henkel-Ecolab included the unamortized excess of the companys investment over its equity in Henkel-Ecolab net assets. This excess was $92 million at November 30, 2001 and was included in goodwill, net at year-end 2001. The excess was being amortized on a straight-line basis over estimated economic useful lives of up to 30 years.
The company acquired the remaining 50 percent of Henkel-Ecolab for approximately 483.5 million euros, equal to approximately $432.7 million at rates of exchange prevailing at November 30, 2001, plus approximately $6.5 million of direct transaction related expenses.
The acquisition of Henkel-Ecolab was accounted for under the purchase method of accounting as a step-acquisition. Accordingly, the purchase price was applied to the 50 percent interest of Henkel-Ecolab being acquired.
The following table summarizes the estimated fair value of assets acquired and liabilities initially assumed at the date of acquisition and the final allocation made during 2002.
38
November 30, 2001 (thousands) |
|
Initial
|
|
Final
|
|
||
|
|
|
|
|
|
||
Current assets |
|
$ |
178,705 |
|
$ |
178,201 |
|
Property, plant and equipment |
|
66,538 |
|
67,966 |
|
||
Identifiable intangible assets |
|
119,257 |
|
119,203 |
|
||
Goodwill |
|
239,737 |
|
252,017 |
|
||
Other assets |
|
9,185 |
|
29,678 |
|
||
Total assets acquired |
|
613,422 |
|
647,065 |
|
||
Current liabilities |
|
115,559 |
|
130,199 |
|
||
Postretirement health care and pension benefits |
|
38,614 |
|
38,219 |
|
||
Other liabilities |
|
19,860 |
|
39,423 |
|
||
Total liabilities assumed |
|
174,033 |
|
207,841 |
|
||
Purchase price |
|
$ |
439,389 |
|
$ |
439,224 |
|
Identifiable intangible assets have a weighted-average useful life of approximately 14 years. Identifiable intangible assets included customer relationships of $83 million and intellectual property of $31 million. Goodwill was assigned to the International Cleaning & Sanitizing reportable segment. Approximately 30 percent of the goodwill will be deductible for income tax purposes.
Subsequent to the initial allocation of the purchase price, approximately $28.0 million of restructuring charges were incurred in connection with the acquisition of Henkel-Ecolab. These costs consisted of $24.1 million for employee termination benefits, $0.4 million for asset disposals, including inventory and property, plant and equipment, and $3.5 million for lease termination and other costs. Because the company acquired only 50 percent of Henkel-Ecolab, $14.0 million of these costs were treated as a liability assumed at the date of acquisition and have been treated as additional goodwill in 2002. The remaining $14.0 million, along with $1.9 million of merger integration costs, were treated as operating expenses during 2002 and are included in the special charges discussed in Note 3 to the consolidated financial statements.
The following unaudited pro forma financial information reflects the consolidated results of the company and Henkel-Ecolab assuming the acquisition had occurred at the beginning of 2001.
(thousands, except per share) |
|
2001 |
|
|
|
|
(unaudited) |
|
|
Net sales |
|
$ |
3,182,271 |
|
Income from continuing operations before cumulative effect of change in accounting |
|
192,009 |
|
|
Diluted income from continuing operations before change in accounting per common share |
|
$ |
0.74 |
|
These unaudited pro forma results are presented for information purposes only. These unaudited pro forma results also do not include the benefits of improvements from synergies the company anticipates it will realize. The results are not necessarily indicative of results that would have occurred had the acquisition been completed at the beginning of 2001, nor are they necessarily indicative of future operating results.
As part of the transaction, the stockholders agreement between the company and Henkel was amended and extended. The amended stockholders agreement provides, among other things, that Henkel is permitted to increase its ownership in the company to 35 percent of the companys outstanding common stock. Henkel remains entitled to proportionate representation on the companys board of directors.
Henkel beneficially owned 72.7 million shares, or approximately 28.2 percent, of the companys outstanding common stock on December 31, 2003.
In 2003, 2002 and 2001, the company and its affiliates sold products and services in the amount of $3,426,000, $6,986,000 and $507,000 to Henkel or its affiliates, and purchased products and services in the amount of $71,265,000, $74,192,000 and $4,628,000 from Henkel or its affiliates. Prior to 2002, Henkel-Ecolab also acquired and sold products to Henkel. Transactions between Henkel and Ecolabs European operations acquired on November 30, 2001, are reflected in the consolidated financial statements beginning in 2002. The transactions were made at prices comparable to prices charged to unrelated third parties.
NOTE 6 BUSINESS ACQUISITIONS AND DISPOSITIONS
Business Acquisitions
Business acquisitions made by the company during 2003, 2002 and 2001, excluding the acquisition of Henkel-Ecolab, were as follows:
Business Acquired |
|
Date of
|
|
Ecolab
|
|
Estimated
|
|
|
|
|
|
|
|
|
(unaudited) |
|
|
|
|
|
|
|
|
|
|
|
2003 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adams Healthcare |
|
Dec. 2002 |
|
Europe |
|
$ |
19 |
|
|
|
|
|
|
|
|
|
|
2002 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Kleencare Hygiene |
|
Jan. 2002 |
|
Europe |
|
30 |
|
|
Audits International |
|
Jan. 2002 |
|
Pest
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Terminix Ltd. |
|
Sept. 2002 |
|
Europe |
|
65 |
|
|
|
|
|
|
|
|
|
|
|
2001 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ecolab S.A. 23.5% interest in addition to prior 51% interest |
|
Dec. 2000 |
|
Latin America |
|
8 |
|
|
|
|
|
|
|
|
|
|
|
Randall International LLC 25% interest |
|
Jan. 2001 |
|
Institutional |
|
8 |
|
|
|
|
|
|
|
|
|
|
|
Envirocare Service Pte. Ltd. |
|
March 2001 |
|
Asia Pacific |
|
1 |
|
|
|
|
|
|
|
|
|
|
|
Microbiotecnica |
|
July 2001 |
|
Latin America |
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Commercial Parts & Services, Inc. |
|
Oct. 2001 |
|
GCS |
|
28 |
|
The total cash consideration paid by the company for these acquisitions and cash adjustments to prior year acquisitions was approximately $32 million and $63 million for 2003 and 2002, respectively. The total cash consideration paid by the company for the 2001 acquisitions, excluding Henkel-Ecolab, was approximately $30 million, of which approximately $18 million was allocated to goodwill.
These acquisitions have been accounted for as purchases and, accordingly, the results of their operations have been included in the financial statements of the company from the dates of acquisition. Net sales and operating income of these businesses were not significant to the companys consolidated results of operations, financial position and cash flows.
In January 2004, the company acquired Nigiko, a Paris-based provider of commercial pest elimination services throughout France. Nigiko pest elimination has annual sales of approximately $55 million. These operations will become part of the companys International Cleaning & Sanitizing operations in 2004.
In February 2004, the company acquired Daydots International, a Texas-based provider of food safety products. Daydots has annual sales of approximately $22 million. These operations will become part of the companys U.S. Cleaning & Sanitizing operations in 2004.
39
The changes in the carrying amount of goodwill for each of the companys reportable segments for the years ended December 31, 2003 and 2002 are as follows:
|
|
United States |
|
|
|
|
|
|||||||||
(thousands) |
|
Cleaning
&
|
|
Other
|
|
Total
|
|
International
|
|
Consolidated |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Balance |
|
|
|
|
|
|
|
|
|
|
|
|||||
December 31, 2001 |
|
$ |
121,046 |
|
$ |
44,796 |
|
$ |
165,842 |
|
$ |
431,083 |
|
$ |
596,925 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Goodwill acquired during year* |
|
3,532 |
|
4,510 |
|
8,042 |
|
58,862 |
|
66,904 |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Foreign currency translation |
|
|
|
|
|
|
|
38,472 |
|
38,472 |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Impairment losses upon adoption of SFAS No. 142 on January 1, 2002 |
|
|
|
|
|
|
|
(4,002 |
) |
(4,002 |
) |
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Impairment losses during 2002 |
|
(2,599 |
) |
|
|
(2,599 |
) |
|
|
(2,599 |
) |
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Balance |
|
|
|
|
|
|
|
|
|
|
|
|||||
December 31, 2002 |
|
121,979 |
|
49,306 |
|
171,285 |
|
524,415 |
|
695,700 |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Goodwill acquired during year* |
|
367 |
|
(377 |
) |
(10 |
) |
825 |
|
815 |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Goodwill allocated to business dispositions |
|
|
|
|
|
|
|
(2,708 |
) |
(2,708 |
) |
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Foreign currency translation |
|
|
|
|
|
|
|
103,404 |
|
103,404 |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Balance |
|
|
|
|
|
|
|
|
|
|
|
|||||
December 31, 2003 |
|
$ |
122,346 |
|
$ |
48,929 |
|
$ |
171,275 |
|
$ |
625,936 |
|
$ |
797,211 |
|
* All of the goodwill related to businesses acquired in 2003 and 2002 is expected to be tax deductible. Goodwill acquired in 2003 and 2002 also includes adjustments to prior year acquisitions. United States Other Services goodwill acquired during 2003 includes a reduction of $0.4 million for an adjustment related to the Audits International acquisition. International Cleaning and Sanitizing goodwill acquired during 2003 includes a reduction of $4.7 million for the Terminix acquisition primarily related to a finalization of the pension valuation at the date of acquisition.
Business Dispositions
In December 2002, the company sold its Darenas janitorial products distribution business based in Birmingham, United Kingdom. This sale resulted in a loss of approximately $1.7 million principally due to the amount of goodwill allocated to the disposed business. The annualized sales of this entity were approximately $30 million. In June 2003, the company sold its minority interest investment in Comac S.p.A., a floor care machine manufacturing company based in Verona, Italy, for a gain of approximately $11.1 million ($6.7 million after tax).The company accounted for this investment under the equity method of accounting. In September 2003, the company sold the consumer dermatology business of its recently acquired Adams Healthcare business at a nominal gain. Goodwill allocated to the sale of the dermatology business was approximately $1.0 million. The annualized sales of the dermatology business that was sold were approximately $2.5 million. These operations and investment were a part of the companys International Cleaning & Sanitizing segment.
NOTE 7 BALANCE SHEET INFORMATION
December 31 (thousands) |
|
2003 |
|
2002 |
|
2001 |
|
|||
|
|
|
|
|
|
|
|
|||
ACCOUNTS RECEIVABLE, NET |
|
|
|
|
|
|
|
|||
Accounts receivable |
|
$ |
670,013 |
|
$ |
589,149 |
|
$ |
544,371 |
|
Allowance for doubtful accounts |
|
(44,011 |
) |
(35,995 |
) |
(30,297 |
) |
|||
Total |
|
$ |
626,002 |
|
$ |
553,154 |
|
$ |
514,074 |
|
|
|
|
|
|
|
|
|
|||
INVENTORIES |
|
|
|
|
|
|
|
|||
Finished goods |
|
$ |
159,633 |
|
$ |
136,721 |
|
$ |
124,657 |
|
Raw materials and parts |
|
152,127 |
|
156,628 |
|
156,754 |
|
|||
Excess of fifo cost over lifo cost |
|
(1,801 |
) |
(1,843 |
) |
(1,626 |
) |
|||
Total |
|
$ |
309,959 |
|
$ |
291,506 |
|
$ |
279,785 |
|
|
|
|
|
|
|
|
|
|||
PROPERTY, PLANT AND EQUIPMENT, NET |
|
|
|
|
|
|
|
|||
Land |
|
$ |
26,921 |
|
$ |
21,914 |
|
$ |
20,349 |
|
Buildings and leaseholds |
|
243,795 |
|
231,119 |
|
221,054 |
|
|||
Machinery and equipment |
|
589,620 |
|
525,359 |
|
452,611 |
|
|||
Merchandising equipment |
|
949,553 |
|
821,109 |
|
743,404 |
|
|||
Construction in progress |
|
21,488 |
|
18,830 |
|
22,217 |
|
|||
|
|
1,831,377 |
|
1,618,331 |
|
1,459,635 |
|
|||
Accumulated depreciation and amortization |
|
(1,094,580 |
) |
(938,066 |
) |
(815,312 |
) |
|||
Total |
|
$ |
736,797 |
|
$ |
680,265 |
|
$ |
644,323 |
|
|
|
|
|
|
|
|
|
|||
GOODWILL, NET |
|
|
|
|
|
|
|
|||
Goodwill |
|
$ |
992,622 |
|
$ |
871,208 |
|
$ |
763,211 |
|
Accumulated amortization |
|
(195,411 |
) |
(175,508 |
) |
(166,286 |
) |
|||
Total |
|
$ |
797,211 |
|
$ |
695,700 |
|
$ |
596,925 |
|
|
|
|
|
|
|
|
|
|||
OTHER INTANGIBLE ASSETS, NET |
|
|
|
|
|
|
|
|||
Cost |
|
|
|
|
|
|
|
|||
Customer relationships |
|
$ |
153,479 |
|
$ |
120,324 |
|
$ |
104,277 |
|
Intellectual property |
|
77,793 |
|
71,104 |
|
66,418 |
|
|||
Trademarks |
|
52,283 |
|
50,308 |
|
48,540 |
|
|||
Other intangibles |
|
16,012 |
|
13,502 |
|
16,292 |
|
|||
|
|
299,567 |
|
255,238 |
|
235,527 |
|
|||
Accumulated amortization |
|
|
|
|
|
|
|
|||
Customer relationships |
|
(27,565 |
) |
(9,238 |
) |
(2,758 |
) |
|||
Intellectual property |
|
(45,809 |
) |
(39,641 |
) |
(35,800 |
) |
|||
Trademarks |
|
(9,313 |
) |
(5,947 |
) |
(5,097 |
) |
|||
Other intangibles |
|
(13,021 |
) |
(11,742 |
) |
(12,921 |
) |
|||
Total |
|
$ |
203,859 |
|
$ |
188,670 |
|
$ |
178,951 |
|
|
|
|
|
|
|
|
|
|||
OTHER ASSETS, NET |
|
|
|
|
|
|
|
|||
Deferred income taxes |
|
$ |
43,168 |
|
$ |
36,797 |
|
$ |
56,952 |
|
Pension |
|
161,098 |
|
106,314 |
|
|
|
|||
Other |
|
136,445 |
|
142,224 |
|
118,266 |
|
|||
Total |
|
$ |
340,711 |
|
$ |
285,335 |
|
$ |
175,218 |
|
|
|
|
|
|
|
|
|
|||
SHORT-TERM DEBT |
|
|
|
|
|
|
|
|||
Notes payable |
|
$ |
66,250 |
|
$ |
146,947 |
|
$ |
230,306 |
|
Long-term debt, current maturities |
|
3,953 |
|
13,152 |
|
3,087 |
|
|||
Total |
|
$ |
70,203 |
|
$ |
160,099 |
|
$ |
233,393 |
|
|
|
|
|
|
|
|
|
|||
OTHER CURRENT LIABILITIES |
|
|
|
|
|
|
|
|||
Discounts and rebates |
|
$ |
145,508 |
|
$ |
127,418 |
|
$ |
125,123 |
|
Other |
|
173,729 |
|
163,775 |
|
118,057 |
|
|||
Total |
|
$ |
319,237 |
|
$ |
291,193 |
|
$ |
243,180 |
|
|
|
|
|
|
|
|
|
|||
LONG-TERM DEBT |
|
|
|
|
|
|
|
|||
6.875% notes, due 2011 |
|
$ |
149,101 |
|
$ |
148,974 |
|
$ |
148,847 |
|
5.375% Euronotes, due 2007 |
|
364,399 |
|
299,777 |
|
|
|
|||
Commercial paper |
|
|
|
|
|
265,860 |
|
|||
7.19% senior notes, due 2006 |
|
75,017 |
|
75,000 |
|
75,000 |
|
|||
Other |
|
19,877 |
|
29,144 |
|
25,660 |
|
|||
|
|
608,394 |
|
552,895 |
|
515,367 |
|
|||
Long-term debt, current maturities |
|
(3,953 |
) |
(13,152 |
) |
(3,087 |
) |
|||
Total |
|
$ |
604,441 |
|
$ |
539,743 |
|
$ |
512,280 |
|
40
The company has a $275 million Multicurrency Credit Agreement with a consortium of banks that has a term through 2005 and a $175 million 364-day Credit Agreement with a consortium of banks that has a term through October 2004. The company may borrow varying amounts in different currencies from time to time on a revolving credit basis. The company has the option of borrowing based on various short-term interest rates. Each agreement includes a covenant regarding the ratio of total debt to capitalization. No amounts were outstanding under these agreements at year-end 2003, 2002 and 2001.
These credit agreements support the companys $450 million U.S. commercial paper program and its 200 million Australian dollar commercial paper program. The company had $64.1 million and $355.7 million in outstanding U.S. commercial paper at December 31, 2002 and 2001, respectively, with average annual interest rates of 1.4 percent and 2.0 percent, respectively. There was no U.S. commercial paper outstanding at December 31, 2003. The company also had 50.0 million, 50.0 million and 132.5 million of Australian dollar denominated commercial paper (in U.S. dollars, approximately $36 million, $28 million and $69 million, respectively) outstanding at December 31, 2003, 2002 and 2001, respectively, with average annual interest rates of 5.1 percent, 4.8 percent and 4.5 percent, respectively.
In June 2003, the company established a $200 million European commercial paper program to provide a source of funding for European and other international acquisitions and working capital requirements. The program is in addition to the companys $450 million U.S. and 200 million Australian dollar programs. As of December 31, 2003, the company had not issued any European commercial paper. All three programs were rated A-1 by Standard & Poors and P-1 by Moodys as of December 31,2003 and were supported by the companys $275 million and $175 million committed credit facilities.
In February 2002, the company issued euro 300 million ($265.9 million at rates prevailing at that time) of 5.375 percent Euronotes, due February 2007. The proceeds from this debt issuance were used to repay a portion of the U.S. commercial paper outstanding as of December 31, 2001. Therefore, $265.9 million of commercial paper outstanding at December 31, 2001 was classified as long-term debt. As described further in Note 8, the company accounts for a majority of the transaction gains and losses related to the Euronotes as a component of the cumulative translation account within accumulated other comprehensive income (loss).
As of December 31, the weighted-average interest rate on notes payable was 6.3 percent in 2003, 4.6 percent in 2002 and 4.4 percent in 2001.
As of December 31, 2003, the aggregate annual maturities of long-term debt for the next five years were: 2004 - $3,953,000; 2005 -$4,136,000; 2006 - $77,999,000; 2007 - $366,267,000 and 2008 -$754,000.
Interest expense was $49,342,000 in 2003, $47,210,000 in 2002 and $31,477,000 in 2001. Interest income was $3,997,000 in 2003, $3,315,000 in 2002 and $3,043,000 in 2001. Total interest paid was $47,428,000 in 2003, $45,056,000 in 2002 and $26,402,000 in 2001.
NOTE 8 FINANCIAL INSTRUMENTS
Foreign Currency Forward Contracts
The company has entered into foreign currency forward contracts to hedge transactions related to intercompany debt, subsidiary royalties, product purchases, firm commitments and other intercompany transactions. The company uses these contracts to hedge against the effect of foreign currency exchange rate fluctuations on forecasted cash flows. These contracts generally relate to the companys European operations and are denominated in euros. The company had foreign currency forward exchange contracts that totaled approximately $239 million at December 31, 2003, $199 million at December 31, 2002 and $130 million at December 31, 2001. These contracts generally expire within one year. In addition, at December 31, 2001 the company had approximately $190 million of foreign currency forward exchange contracts outstanding related to short-term financing of the Henkel-Ecolab acquisition. These contracts matured in February 2002. The gains and losses related to these contracts were included as a component of other comprehensive income until the hedged item is reflected in earnings.
Interest Rate Swap Agreements
The company enters into interest rate swap agreements to manage interest rate exposures and to achieve a desired proportion of variable and fixed rate debt.
In 2003, the company entered into an interest rate swap agreement that converts $30 million of the 7.19% senior notes from a fixed interest rate to a floating or variable interest rate. This agreement is effective until January 2006. The interest rate swap was designated as a fair value hedge and had an insignificant value as of December 31, 2003. The mark to market gain on this agreement has been recorded as part of interest expense and has been offset by the market to market on this portion of the 7.19% senior notes.
During 2002, the company entered into an interest rate swap agreement in connection with the issuance of its Euronotes. This agreement converts approximately euro 78 million (approximately $94 million at year-end 2003) of the Euronote debt from a fixed interest rate to a floating or variable interest rate and is effective until February 2007. This interest rate swap was designated as a fair value hedge and had a value of $6.4 million and $3.5 million as of December 31, 2003 and 2002, respectively. The mark to market gain on this agreement has been recorded as part of interest expense and has been offset by the loss recorded in interest expense on the mark to market on this portion of the Euronotes. There is no hedge ineffectiveness on this interest rate swap.
The company has also entered into an interest rate swap agreement to provide for a fixed rate of interest on the first 50 million Australian dollars (approximately $36 million at year-end 2003) of Australian floating-rate debt. This agreement is effective through November 2004 and has a fixed annual pay rate of approximately 6 percent. This interest rate swap agreement was designated as, and effective as, a cash flow hedge of the outstanding debt. The change in fair value of the interest rate swap is recorded in other comprehensive income and recognized as earnings to offset the forecasted hedged transactions as they occur.
Net Investment Hedges
In February 2002, the company issued euro 300 million of 5.375 percent Euronotes, due 2007. The company designated a portion (approximately euro 200 million at year-end 2002 and euro 290 million at year-end 2003) of this Euronote debt as a hedge of existing foreign currency exposures related to net investments the company has in certain European subsidiaries. Accordingly, the transaction gains and losses on this portion of the Euronotes that are designated and effective as hedges of the companys net investments have been included as a component of the cumulative translation account within accumulated other comprehensive income (loss).Total transaction losses related to the Euronotes and charged to this shareholders equity account were $52.5 million and $26.0 million for the years ended December 31, 2003 and 2002,
41
respectively. Transaction gains and losses on the remaining portion of the Euronotes have been included in earnings and were offset by transaction gains and losses related to other euro denominated assets held by the companys U.S. operations.
Credit Risk
The company is exposed to credit loss in the event of nonperformance of counterparties for foreign currency forward exchange contracts and interest rate swap agreements. The companys risk is limited to the fair value of these contracts. The company monitors its exposure to credit risk by using credit approvals and credit limits and selecting major international banks and financial institutions as counterparties. The company does not anticipate nonperformance by any of these counter-parties.
Fair Value of Other Financial Instruments
The carrying amount and the estimated fair value of other financial instruments held by the company were:
December 31 (thousands) |
|
2003 |
|
2002 |
|
2001 |
|
|||
|
|
|
|
|
|
|
|
|||
Carrying amount |
|
|
|
|
|
|
|
|||
Cash and cash equivalents |
|
$ |
85,626 |
|
$ |
49,205 |
|
$ |
41,793 |
|
Notes payable |
|
30,050 |
|
54,847 |
|
71,466 |
|
|||
Commercial paper |
|
36,200 |
|
92,100 |
|
424,700 |
|
|||
Long-term debt (including current maturities) |
|
608,394 |
|
552,895 |
|
249,507 |
|
|||
Fair value |
|
|
|
|
|
|
|
|||
Long-term debt (including current maturities) |
|
$ |
656,576 |
|
$ |
588,003 |
|
$ |
260,518 |
|
The carrying amounts of cash equivalents, notes payable and commercial paper approximate fair value because of their short maturities.
The fair value of long-term debt is based on quoted market prices for the same or similar debt instruments.
NOTE 9 SHAREHOLDERS EQUITY
The companys common stock was split two-for-one in the form of a 100 percent stock dividend paid June 6, 2003 to shareholders of record on May 23, 2003. All per share data have been adjusted to reflect the stock split, except for prior year data in the Consolidated Balance Sheet and the Consolidated Statement of Comprehensive Income and Shareholders Equity.
Authorized common stock, par value $1.00 per share, was 400 million shares in 2003, and 200 million shares in 2002 and 2001. Treasury stock is stated at cost. Dividends declared per share of common stock were $0.2975 for 2003, $0.275 for 2002 and $0.2625 for 2001.
The company has 15 million shares, without par value, of authorized but unissued preferred stock.
Each share of outstanding common stock entitles the holder to one-fourth of a preferred stock purchase right. A right entitles the holder, upon occurrence of certain events, to buy one one-hundredth of a share of Series A Junior Participating Preferred Stock at a purchase price of $115, subject to adjustment. The rights, however, will not become exercisable unless and until, among other things, any person or group acquires 15 percent or more of the outstanding common stock of the company, or the companys board of directors declares a holder of 10 percent or more of the outstanding common stock to be an adverse person as defined in the rights plan. Upon the occurrence of either of these events, the rights will become exercisable for common stock of the company (or in certain cases common stock of an acquiring company) having a market value of twice the exercise price of a right. The rights provide that the holdings by Henkel or its affiliates, subject to compliance by Henkel with certain conditions, will not cause the rights to become exercisable nor cause Henkel to be an adverse person. The rights are redeemable under certain circumstances at one cent per right and, unless redeemed earlier, will expire on March 11, 2006.
The company reacquired 6,218,000 shares of its common stock in 2003,165,000 shares in 2002 and 621,700 shares in 2001 through open and private market purchases under prior board authorizations. The equivalent number of shares reacquired on a post stock-split basis were 8,014,500 in 2003, 330,000 in 2002 and 1,243,000 shares in 2001. In October 2003, the company approved a new authorization to repurchase up to 10 million additional shares of Ecolab common stock for the purpose of offsetting the dilutive effect of shares issued for stock incentive plans and for general corporate purposes. As of December 31, 2003, 10.4 million shares remained to be purchased under all of the companys repurchase programs. On a pre-split basis, the company also reacquired 448,861 shares of its common stock in 2003, 33,778 shares in 2002 and 209,419 shares in 2001 related to the exercise of stock options and the vesting of stock awards.
NOTE 10 STOCK INCENTIVE AND OPTION PLANS
The companys stock incentive and option plans provide for grants of stock options and stock awards. Common shares available for grant as of December 31 were 8,674,459 for 2003, 12,305,052 for 2002 and 3,799,142 for 2001. Common shares available for grant reflect 12 million shares approved by shareholders during 2002 for issuance under the plans.
Options may be granted to purchase shares of the companys stock at not less than fair market value at the date of grant. Options granted in 2003, 2002 and 2001 generally become exercisable over three years from date of grant and expire within ten years from date of grant. A summary of stock option activity and average exercise prices is as follows:
Shares |
|
2003 |
|
2002 |
|
2001 |
|
|
|
|
|
|
|
|
|
Granted |
|
4,765,823 |
|
4,912,674 |
|
5,334,052 |
|
Exercised |
|
(6,383,227 |
) |
(4,432,722 |
) |
(3,128,274 |
) |
Canceled |
|
(379,634 |
) |
(1,473,670 |
) |
(1,112,668 |
) |
December 31: |
|
|
|
|
|
|
|
Outstanding |
|
21,867,726 |
|
23,864,764 |
|
24,858,482 |
|
Exercisable |
|
12,823,743 |
|
14,444,562 |
|
15,393,806 |
|
Average exercise price per share |
|
2003 |
|
2002 |
|
2001 |
|
|||
|
|
|
|
|
|
|
|
|||
Granted |
|
$ |
27.18 |
|
$ |
24.24 |
|
$ |
19.32 |
|
Exercised |
|
19.84 |
|
10.27 |
|
6.19 |
|
|||
Canceled |
|
21.87 |
|
21.08 |
|
22.34 |
|
|||
December 31: |
|
|
|
|
|
|
|
|||
Outstanding |
|
20.87 |
|
19.35 |
|
16.87 |
|
|||
Exercisable |
|
$ |
17.96 |
|
$ |
17.77 |
|
$ |
15.46 |
|
42
Information related to stock options outstanding and stock options exercisable as of December 31, 2003, is as follows:
Options Outstanding |
|
|||||||||||||
Range of
|
|
Options
|
|
Weighted-Average
|
|
Weighted-Average
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|||||
$ |
5.38- |
$ |
10.31 |
|
|
1,418,002 |
|
1.9 years |
|
$ |
7.07 |
|
||
$ |
10.95- |
$ |
18.96 |
|
|
5,370,187 |
|
6.9 years |
|
17.81 |
|
|||
$ |
19.27- |
$ |
20.06 |
|
|
5,176,870 |
|
6.4 years |
|
19.49 |
|
|||
$ |
20.23- |
$ |
24.34 |
|
|
5,206,844 |
|
8.7 years |
|
23.98 |
|
|||
$ |
24.55- |
$ |
27.39 |
|
|
4,695,823 |
|
10.0 years |
|
$ |
27.23 |
|
||
The weighted-average grant-date fair value of options granted in 2003, 2002 and 2001, and the significant assumptions used in determining the underlying fair value of each option grant, on the date of grant, utilizing the Black-Scholes option-pricing model, were as follows:
|
|
2003 |
|
2002 |
|
2001 |
|
|||
|
|
|
|
|
|
|
|
|||
Weighted-average grant date fair value of options granted |
|
|
|
|
|
|
|
|||
Granted at market prices |
|
$ |
7.85 |
|
$ |
7.10 |
|
$ |
5.63 |
|
Granted at prices exceeding market |
|
|
|
|
|
$ |
2.37 |
|
||
|
|
|
|
|
|
|
|
|||
Assumptions |
|
|
|
|
|
|
|
|||
Risk-free interest rate |
|
3.5 |
% |
3.6 |
% |
4.7 |
% |
|||
Expected life |
|
6 years |
|
6 years |
|
6 years |
|
|||
Expected volatility |
|
26.8 |
% |
26.5 |
% |
24.8 |
% |
|||
Expected dividend yield |
|
1.2 |
% |
1.1 |
% |
1.3 |
% |
|||
The expense associated with shares of restricted stock issued under the companys stock incentive plan is based on the market price of the companys stock at the date of grant and is amortized on a straight-line basis over the periods during which the restrictions lapse. Restricted stock awards generally vest over a 4-year period with 50 percent vesting 2 years after grant and the remaining 50 percent vesting 4 years after grant. Stock awards are not performance based and vest with continued employment. Stock awards are subject to forfeiture in the event of termination of employment. The company granted 10,500 shares in 2003, 67,200 shares in 2002 and 11,600 shares in 2001 under its restricted stock award program.
The company uses the intrinsic value-based method of accounting to measure compensation expense for its stock incentive and option plans. See Note 2 to the consolidated financial statements for the pro forma net income and related basic and diluted per common share amounts had the company used the fair value-based method of accounting to measure compensation expense.
NOTE 11 INCOME TAXES
Income from continuing operations before income taxes and equity in earnings of Henkel-Ecolab consisted of:
(thousands) |
|
2003 |
|
2002 |
|
2001 |
|
|||
|
|
|
|
|
|
|
|
|||
Domestic |
|
$ |
286,003 |
|
$ |
258,779 |
|
$ |
249,026 |
|
Foreign |
|
162,415 |
|
93,192 |
|
40,719 |
|
|||
Total |
|
$ |
448,418 |
|
$ |
351,971 |
|
$ |
289,745 |
|
The provision for income taxes consisted of:
(thousands) |
|
2003 |
|
2002 |
|
2001 |
|
|||
|
|
|
|
|
|
|
|
|||
Federal and state |
|
$ |
78,928 |
|
$ |
59,601 |
|
$ |
107,055 |
|
Foreign |
|
49,687 |
|
30,557 |
|
13,303 |
|
|||
Currently payable |
|
128,615 |
|
90,158 |
|
120,358 |
|
|||
|
|
|
|
|
|
|
|
|||
Federal and state |
|
33,178 |
|
43,974 |
|
(1,940 |
) |
|||
Foreign |
|
9,277 |
|
5,949 |
|
(1,010 |
) |
|||
Deferred |
|
42,455 |
|
49,923 |
|
(2,950 |
) |
|||
|
|
|
|
|
|
|
|
|||
Provision for income taxes |
|
$ |
171,070 |
|
$ |
140,081 |
|
$ |
117,408 |
|
The companys overall net deferred tax assets and deferred tax liabilities were comprised of the following:
December 31 (thousands) |
|
2003 |
|
2002 |
|
2001 |
|
|||
|
|
|
|
|
|
|
|
|||
Deferred tax assets |
|
|
|
|
|
|
|
|||
Postretirement health care and pension benefits |
|
$ |
1,008 |
|
$ |
19,249 |
|
$ |
47,792 |
|
Other accrued liabilities |
|
53,924 |
|
52,399 |
|
55,758 |
|
|||
Loss carryforwards |
|
11,756 |
|
13,932 |
|
18,679 |
|
|||
Other, net |
|
27,856 |
|
28,090 |
|
17,552 |
|
|||
Valuation allowance |
|
(2,719 |
) |
(1,462 |
) |
(1,462 |
) |
|||
Total |
|
91,825 |
|
112,208 |
|
138,319 |
|
|||
|
|
|
|
|
|
|
|
|||
Deferred tax liabilities |
|
|
|
|
|
|
|
|||
Property, plant and equipment basis differences |
|
61,062 |
|
53,320 |
|
40,956 |
|
|||
Intangible assets |
|
49,465 |
|
38,696 |
|
26,381 |
|
|||
Other, net |
|
4,714 |
|
3,273 |
|
5,403 |
|
|||
Total |
|
115,241 |
|
95,289 |
|
72,740 |
|
|||
|
|
|
|
|
|
|
|
|||
Net deferred tax assets (liabilities) |
|
$ |
(23,416 |
) |
$ |
16,919 |
|
$ |
65,579 |
|
A reconciliation of the statutory U.S. federal income tax rate to the companys effective income tax rate was:
|
|
2003 |
|
2002 |
|
2001 |
|
|
|
|
|
|
|
|
|
Statutory U.S. rate |
|
35.0 |
% |
35.0 |
% |
35.0 |
% |
State income taxes, net of federal benefit |
|
2.7 |
|
3.2 |
|
4.2 |
|
Foreign operations |
|
0.5 |
|
1.0 |
|
|
|
Other, net |
|
(0.1 |
) |
0.6 |
|
1.3 |
|
Effective income tax rate |
|
38.1 |
% |
39.8 |
% |
40.5 |
% |
Cash paid for income taxes was approximately $90 million in 2003, $95 million in 2002 and $99 million in 2001.
43
No provision has been made for income taxes on the undistributed earnings of foreign subsidiaries. In the event of a distribution of these earnings, foreign tax credits would be available to substantially offset any amount of applicable income tax and foreign withholding taxes that might be payable on these earnings.
NOTE 12 RENTALS AND LEASES
The company leases sales and administrative office facilities, distribution center facilities, automobiles, computers and other equipment under operating leases. Rental expense under all operating leases was $81,781,000 in 2003, $77,593,000 in 2002 and $60,365,000 in 2001. As of December 31, 2003, future minimum payments under operating leases with noncancelable terms in excess of one year were:
(thousands) |
|
|
|
|
2004 |
|
$ |
35,726 |
|
2005 |
|
29,470 |
|
|
2006 |
|
21,666 |
|
|
2007 |
|
15,805 |
|
|
2008 |
|
13,587 |
|
|
Thereafter |
|
22,271 |
|
|
Total |
|
$ |
138,525 |
|
The company enters into operating leases in the U.S. for vehicles whose noncancellable terms are one year or less in duration with month-to-month renewal options. These leases have been excluded from the table above. The automobile leases have guaranteed residual values that have historically been satisfied primarily by the proceeds on the sale of the vehicles. No estimated losses have been recorded for these guarantees as the company believes, based upon the results of previous leasing arrangements, that the potential recovery of value from the vehicles when sold will be greater than the residual value guarantee.
NOTE 13 RESEARCH EXPENDITURES
Research expenditures that related to the development of new products and processes, including significant improvements and refinements to existing products, were $53,171,000 in 2003, $49,860,000 in 2002 and $33,103,000 in 2001.
NOTE 14 COMMITMENTS AND CONTINGENCIES
The company and certain subsidiaries are party to various environmental actions that have arisen in the ordinary course of business. These include possible obligations to investigate and mitigate the effects on the environment of the disposal or release of certain chemical substances at various sites, such as Superfund sites and other operating or closed facilities. The effect of these actions on the companys financial position, results of operations and cash flows to date has not been significant. The company is currently participating in environmental assessments and remediation at a number of locations and environmental liabilities have been accrued reflecting managements best estimate of future costs. At December 31, 2003, the accrual for environmental remediation costs was approximately $3.9 million. Potential insurance reimbursements are not anticipated in the companys accruals for environmental liabilities.
The company is self-insured in North America for most workers compensation, general liability and automotive liability losses subject to per occurrence and aggregate annual liability limitations. The company is insured for losses in excess of these limitations. The company is also self-insured for health care claims for eligible participating employees subject to certain deductibles and limitations. The company determines its liability for claims incurred but not reported on an actuarial basis.
While the final resolution of these contingencies could result in expenses different than current accruals, and therefore have an impact on the companys consolidated financial results in a future reporting period, management believes the ultimate outcome will not have a significant effect on the companys consolidated results of operations, financial position or cash flows.
NOTE 15 RETIREMENT PLANS
Pension and Postretirement Health Care Benefits Plans
The company has a noncontributory defined benefit pension plan covering most of its U.S. employees. Effective January 1, 2003, the U.S. Pension Plan was amended to provide a cash balance type pension benefit to employees hired on or after the effective date. For participants enrolled prior to January 1, 2003, plan benefits are based on years of service and highest average compensation for five consecutive years of employment. For participants enrolled after December 31, 2002, plan benefits are based on contribution credits equal to a fixed percentage of their current salary and interest credits. The measurement date used for determining the U.S. Pension Plan assets and obligations was December 31. Various international subsidiaries also have defined benefit pension plans. Prior to the acquisition of Henkel-Ecolab at the end of fiscal 2001, the international plans were not significant. Beginning in 2002, the information below includes all of the companys significant international defined benefit pension plans.
The company provides postretirement health care benefits to certain U.S. employees. The plan is contributory based on years of service and family status, with retiree contributions adjusted annually. The measurement date used to determine the U.S. postretirement healthcare plan assets and obligations was December 31. Certain employees outside the U.S. were covered under government-sponsored programs, which are not required to be fully funded. The expense and obligation for providing International postretirement healthcare benefits was not significant.
44
A reconciliation of changes in the benefit obligations and fair value of assets of the companys plans is as follows:
|
|
U.S. Pension Benefits |
|
International
|
|
U.S. Postretirement Health Care
|
|
||||||||||||||||||
(thousands) |
|
2003 |
|
2002 |
|
2001 |
|
2003 |
|
2002 |
|
2003 |
|
2002 |
|
2001 |
|
||||||||
Benefit obligation, beginning of year |
|
$ |
485,155 |
|
$ |
396,827 |
|
$ |
347,430 |
|
$ |
245,876 |
|
$ |
172,328 |
|
$ |
131,206 |
|
$ |
134,116 |
|
$ |
110,002 |
|
Service cost |
|
26,442 |
|
21,635 |
|
18,925 |
|
11,997 |
|
9,412 |
|
7,447 |
|
2,814 |
|
7,342 |
|
||||||||
Interest cost |
|
32,208 |
|
29,237 |
|
26,461 |
|
14,633 |
|
10,973 |
|
8,597 |
|
7,651 |
|
8,826 |
|
||||||||
Company contributions |
|
|
|
|
|
|
|
|
|
137 |
|
|
|
|
|
|
|
||||||||
Participant contributions |
|
|
|
|
|
|
|
1,515 |
|
68 |
|
1,856 |
|
1,214 |
|
1,045 |
|
||||||||
Acquisitions |
|
|
|
|
|
|
|
1,086 |
|
43,135 |
|
|
|
|
|
|
|
||||||||
Plan amendments, settlements and curtailments |
|
|
|
|
|
726 |
|
(948 |
) |
1,522 |
|
(1,930 |
) |
(40,760 |
) |
|
|
||||||||
Changes in assumptions |
|
33,397 |
|
53,467 |
|
14,723 |
|
|
|
|
|
8,675 |
|
24,588 |
|
5,001 |
|
||||||||
Actuarial loss (gain) |
|
(5,232 |
) |
(1,889 |
) |
1,064 |
|
13,007 |
|
(2,554 |
) |
7,828 |
|
8,659 |
|
7,531 |
|
||||||||
Benefits paid |
|
(15,894 |
) |
(14,122 |
) |
(12,502 |
) |
(11,892 |
) |
(8,913 |
) |
(8,649 |
) |
(7,076 |
) |
(5,631 |
) |
||||||||
Foreign currency translation |
|
|
|
|
|
|
|
46,632 |
|
19,768 |
|
|
|
|
|
|
|
||||||||
Benefit obligation, end of year |
|
$ |
556,076 |
|
$ |
485,155 |
|
$ |
396,827 |
|
$ |
321,906 |
|
$ |
245,876 |
|
$ |
155,030 |
|
$ |
131,206 |
|
$ |
134,116 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Fair value of plan assets, beginning of year |
|
$ |
378,504 |
|
$ |
311,164 |
|
$ |
317,027 |
|
$ |
134,089 |
|
$ |
108,485 |
|
$ |
18,911 |
|
$ |
23,811 |
|
$ |
27,128 |
|
Actual gains (losses) on plan assets |
|
107,192 |
|
(43,112 |
) |
(19,244 |
) |
9,400 |
|
(9,438 |
) |
5,054 |
|
(2,866 |
) |
(1,627 |
) |
||||||||
Acquisitions |
|
|
|
|
|
|
|
263 |
|
23,331 |
|
|
|
|
|
|
|
||||||||
Company contributions |
|
75,000 |
|
124,574 |
|
25,883 |
|
12,743 |
|
7,794 |
|
4,807 |
|
3,828 |
|
2,896 |
|
||||||||
Participant contributions |
|
|
|
|
|
|
|
1,407 |
|
1,052 |
|
1,856 |
|
1,214 |
|
1,045 |
|
||||||||
Settlements |
|
|
|
|
|
|
|
(547 |
) |
|
|
|
|
|
|
|
|
||||||||
Benefits paid |
|
(15,894 |
) |
(14,122 |
) |
(12,502 |
) |
(11,892 |
) |
(7,800 |
) |
(8,649 |
) |
(7,076 |
) |
(5,631 |
) |
||||||||
Foreign currency translation |
|
|
|
|
|
|
|
25,512 |
|
10,665 |
|
|
|
|
|
|
|
||||||||
Fair value of plan assets, end of year |
|
$ |
544,802 |
|
$ |
378,504 |
|
$ |
311,164 |
|
$ |
170,975 |
|
$ |
134,089 |
|
$ |
21,979 |
|
$ |
18,911 |
|
$ |
23,811 |
|
A reconciliation of the funded status for the pension and postretirement plans is as follows:
|
|
U.S. Pension Benefits |
|
International
|
|
U.S. Postretirement Health Care
|
|
||||||||||||||||||||||||||
(thousands) |
|
2003 |
|
2002 |
|
2001 |
|
2003 |
|
2002 |
|
2003 |
|
2002 |
|
2001 |
|
||||||||||||||||
Funded status |
|
$ |
(11,274 |
) |
$ |
(106,651 |
) |
$ |
(85,663 |
) |
$ |
(150,931 |
) |
$ |
(111,787 |
) |
$ |
(133,051 |
) |
$ |
(112,295 |
) |
$ |
(110,305 |
) |
||||||||
Unrecognized actuarial loss |
|
160,939 |
|
201,006 |
|
73,641 |
|
44,123 |
|
25,881 |
|
63,559 |
|
56,823 |
|
20,644 |
|
||||||||||||||||
Unrecognized prior service cost (benefit) |
|
7,400 |
|
9,329 |
|
11,258 |
|
2,265 |
|
(55 |
) |
(34,059 |
) |
(37,431 |
) |
(6,893 |
) |
||||||||||||||||
Unrecognized net transition (asset) obligation |
|
(2,105 |
) |
(3,508 |
) |
(4,911 |
) |
627 |
|
833 |
|
|
|
|
|
|
|
||||||||||||||||
Net amount recognized |
|
$ |
154,960 |
|
$ |
100,176 |
|
$ |
(5,675 |
) |
$ |
(103,916 |
) |
$ |
(85,128 |
) |
$ |
(103,551 |
) |
$ |
(92,903 |
) |
$ |
(96,554 |
) |
||||||||
The net amount recognized in the balance sheet and the accumulated benefit obligation is as follows:
|
|
U.S. Pension Benefits |
|
International
|
|
U.S. Postretirement Health Care
|
|
||||||||||||||||||
(thousands) |
|
2003 |
|
2002 |
|
2001 |
|
2003 |
|
2002 |
|
2003 |
|
2002 |
|
2001 |
|
||||||||
Prepaid benefit cost |
|
$ |
154,960 |
|
$ |
100,176 |
|
$ |
|
|
$ |
26,533 |
|
$ |
13,175 |
|
$ |
|
|
$ |
|
|
$ |
|
|
Accrued benefit cost |
|
|
|
|
|
(5,675 |
) |
(146,180 |
) |
(99,355 |
) |
(103,551 |
) |
(92,903 |
) |
(96,554 |
) |
||||||||
Accumulated other comprehensive loss |
|
|
|
|
|
|
|
15,731 |
|
1,052 |
|
|
|
|
|
|
|
||||||||
Net amount recognized |
|
$ |
154,960 |
|
$ |
100,176 |
|
$ |
(5,675 |
) |
$ |
(103,916 |
) |
$ |
(85,128 |
) |
$ |
(103,551 |
) |
$ |
(92,903 |
) |
$ |
(96,554 |
) |
Accumulated benefit obligation |
|
$ |
441,488 |
|
$ |
375,406 |
|
$ |
305,780 |
|
|
|
|
|
$ |
155,030 |
|
$ |
131,206 |
|
$ |
134,116 |
|
45
For certain international pension plans, the accumulated benefit obligation exceeded the fair value of plan assets. Therefore, the company recognized a minimum pension liability in other comprehensive income of $14.5 million pre-tax ($9.5 million net of deferred tax asset) during 2003 and $1.1 million during 2002.
The aggregate projected benefit obligation, accumulated benefit obligation and fair value of plan assets for those plans with accumulated benefit obligations in excess of plan assets were $261,138,000, $238,819,000 and $95,655,000, respectively, at December 31, 2003, and $103,063,000, $90,428,000 and $14,163,000, respectively, at December 31, 2002. These plans relate to various international subsidiaries and are funded consistent with local practices and requirements. As of December 31, 2003 there were approximately $4.5 million of future post retirement benefits covered by insurance contracts.
Plan Assets
The companys plan asset allocations for its U.S. defined benefit pension and postretirement health care benefits plans at December 31, 2003, 2002 and 2001, and target allocation for 2004 are as follows:
Asset |
|
2004
|
|
Percentage of Plan Assets |
|
||||
Category |
|
Percentage |
|
2003 |
|
2002 |
|
2001 |
|
|
|
|
|
|
|
|
|
|
|
Large Cap Equity |
|
43 |
% |
46 |
% |
43 |
% |
39 |
% |
Small Cap Equity |
|
12 |
|
13 |
|
12 |
|
10 |
|
International Equity |
|
15 |
|
15 |
|
15 |
|
20 |
|
Fixed Income |
|
25 |
|
22 |
|
25 |
|
24 |
|
Real Estate |
|
5 |
|
4 |
|
5 |
|
7 |
|
Total |
|
100 |
% |
100 |
% |
100 |
% |
100 |
% |
As of year-end 2003, the fixed income securities mature in periods up to 30 years, with a weighted average maturity of 5.6 years. The companys U.S. investment strategy and policies are designed to maximize the possibility of having sufficient funds to meet the long-term liabilities of the pension fund, while achieving a balance between the goals of growing the assets of the plan and keeping risk at a reasonable level. Current income is not a key goal of the plan. The pension and health care plans demographic characteristics generally reflect a younger workforce relative to an average pension plan. Therefore, the asset allocation position reflects the ability and willingness to accept relatively more short-term variability in the performance of the pension plan portfolio in exchange for the expectation of a better funded status, better long-term returns and lower pension costs in the long run.
Since diversification is widely recognized as necessary to reduce risk, the pension fund is diversified across several asset classes and securities. Selected individual portfolios may be undiversified while maintaining the diversified nature of total plan assets.
The plan prohibits investing in letter stock, warrants and options, and engaging in short sales, margin transactions, or other specialized investment activities. The use of derivatives is also prohibited for the purpose of speculation or introducing leverage in the portfolio, circumventing the investment guidelines or taking risks that are inconsistent with the funds guidelines. Selected derivatives may only be used for hedging and transactional efficiency.
Cash Flows
The companys funding policy for the U.S. pension plan is to achieve a return on assets that meets the long-term funding requirements identified by the projections of the pension plans actuaries while simultaneously satisfying the fiduciary responsibilities prescribed by ERISA. The company is not required to make any contributions to the U.S. pension plan and postretirement health care benefit plans in 2004.
Net Periodic Benefit Costs
Pension and postretirement health care benefits expense for the companys operations was:
|
|
U.S. Pension Benefits |
|
International
|
|
U.S.
Postretirement Health Care
|
|
|||||||||||||||||||
(thousands) |
|
2003 |
|
2002 |
|
2001 |
|
2003 |
|
2002 |
|
2003 |
|
2002 |
|
2001 |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Service cost - employee benefits earned during the year |
|
$ |
26,442 |
|
$ |
21,635 |
|
$ |
18,925 |
|
$ |
11,997 |
|
$ |
9,412 |
|
$ |
2,945 |
|
$ |
2,814 |
|
$ |
7,342 |
|
|
Interest cost on benefit obligation |
|
32,208 |
|
29,237 |
|
26,461 |
|
14,633 |
|
10,973 |
|
8,597 |
|
7,651 |
|
8,826 |
|
|||||||||
Adjustments for death benefits for retired executives |
|
|
|
|
|
|
|
|
|
|
|
4,502 |
|
|
|
|
|
|||||||||
Expected return on plan assets |
|
(42,411 |
) |
(32,675 |
) |
(28,862 |
) |
(9,908 |
) |
(8,556 |
) |
(1,580 |
) |
(2,071 |
) |
(2,363 |
) |
|||||||||
Recognition of net actuarial loss (gain) |
|
3,451 |
|
|
|
|
|
932 |
|
394 |
|
6,293 |
|
2,005 |
|
|
|
|||||||||
Amortization of prior service cost (benefit) |
|
1,929 |
|
1,929 |
|
1,881 |
|
41 |
|
204 |
|
(5,302 |
) |
(4,431 |
) |
(551 |
) |
|||||||||
Amortization of net transition (asset) obligation |
|
(1,403 |
) |
(1,403 |
) |
(1,403 |
) |
493 |
|
272 |
|
|
|
|
|
|
|
|||||||||
Curtailment (gain) loss |
|
|
|
|
|
|
|
|
|
1,522 |
|
|
|
(5,791 |
) |
|
|
|||||||||
Total expense |
|
$ |
20,216 |
|
$ |
18,723 |
|
$ |
17,002 |
|
$ |
18,188 |
|
$ |
14,221 |
|
$ |
15,455 |
|
$ |
177 |
|
$ |
13,254 |
|
|
46
Total international pension expense, excluding the 50 percent owned Henkel-Ecolab operations, was $1,641,000 in 2001.
The company also has U.S. noncontributory non-qualified defined benefit plans, which provide for benefits to employees in excess of limits permitted under its U.S. pension plan. The recorded obligation for these plans was approximately $19 million at December 31, 2003. The annual expense for these plans was approximately $4 million in 2003, $3 million in 2002 and $3 million in 2001.
Plan Assumptions
|
|
U.S. Pension Benefits |
|
International
|
|
U.S. Postretirement
Health Care
|
|
||||||||||
|
|
2003 |
|
2002 |
|
2001 |
|
2003 |
|
2002 |
|
2003 |
|
2002 |
|
2001 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average actuarial assumptions used to determine benefit obligations as of December 31: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discount rate |
|
6.25 |
% |
6.75 |
% |
7.50 |
% |
5.39 |
% |
5.42 |
% |
6.25 |
% |
6.75 |
% |
7.50 |
% |
Projected salary increase |
|
4.30 |
|
4.80 |
|
4.80 |
|
3.31 |
|
3.40 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average actuarial assumptions used to determine net cost: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discount rate |
|
6.75 |
|
7.50 |
|
7.75 |
|
5.11 |
|
5.37 |
|
6.75 |
|
7.50 |
|
7.75 |
|
Expected return on plan assets |
|
9.00 |
|
9.00 |
|
9.00 |
|
5.97 |
|
5.26 |
|
9.00 |
% |
9.00 |
% |
9.00 |
% |
Projected salary increase |
|
4.80 |
% |
4.80 |
% |
4.80 |
% |
3.25 |
% |
3.36 |
% |
|
|
|
|
|
|
The expected long-term rate of return is generally based on the pension plans asset mix, assumptions of equity returns based on historical long-term returns on asset categories, expectations for inflation, and estimates of the impact of active management of the assets.
For postretirement benefit measurement purposes, 9.0 percent (for pre-age 65 retirees) and 11.0 percent (for post-age 65 retirees) annual rates of increase in the per capita cost of covered health care were assumed for 2003. The rates were assumed to decrease by 1 percent each year until they reach 5 percent in 2008 for pre-age 65 retirees and 5 percent in 2010 for post-age 65 retirees and remain at those levels thereafter. Health care costs which are eligible for subsidy by the company are limited to a 4 percent annual increase beginning in 1996 for certain employees.
Assumed health care cost trend rates have a significant effect on the amounts reported for the companys U.S. postretirement health care benefits plan. A one-percentage point change in the assumed health care cost trend rates would have the following effects:
|
|
1-Percentage Point |
|
||||
(thousands) |
|
Increase |
|
Decrease |
|
||
Effect on total of service and interest cost components |
|
$ |
593 |
|
$ |
(575 |
) |
|
|
|
|
|
|
||
Effect on postretirement benefit obligation |
|
10,115 |
|
(9,834 |
) |
||
Effective March 2002, the company changed its postretirement health care benefits plan to discontinue the employer subsidy for postretirement health care benefits for most active employees. These subsidized benefits will continue to be provided to certain defined active employees and all existing retirees. As a result of these actions, the company recorded a curtailment gain of approximately $6 million in the first quarter of 2002.
The Medicare Prescription Drug, Improvement and Modernization Act of 2003 (the Act) introduces a prescription drug benefit under Medicare as well as a federal subsidy to sponsors of retiree health care benefit plans. The companys U.S. Postretirement Health Care Benefits plan offers prescription drug benefits. In accordance with FASB Staff Position No. FAS 106-1 Accounting and Disclosure Requirements Related to the Medicare Prescription Drug Benefits, Improvement and Modernization Act of 2003 , the company has elected to defer recognition of the effects of the Act and any measures of benefit cost or benefit obligation in the financial statements or accompanying notes. Specific authoritative guidance on the accounting for the federal subsidy is pending and that guidance, when issued, could require the company to change previously reported information. The company does not anticipate that its plan will need to be amended in order to benefit from the new legislation and expects a favorable impact on future benefit expenses and the future financial status of the plan.
Savings Plan and ESOP
The company provides a 401(k) savings plan for substantially all U.S. employees. Prior to March 2002, employee contributions of up to 6 percent of eligible compensation were matched 50 percent by the company. In March 2002, the company changed its 401(k) savings plan and added an employee stock ownership plan (ESOP) feature to the existing plan. Employee before-tax contributions of up to 3 percent of eligible compensation are matched 100 percent by the company and employee before-tax contributions between 3 percent and 5 percent of eligible compensation are matched 50 percent by the company. The match is 100 percent vested immediately. Effective January 2003, the plan was amended to provide that all employee contributions which are invested in Ecolab stock will be part of the employees ESOP account while so invested. The companys contributions are invested in Ecolab common stock and amounted to $14,854,000 in 2003, $12,905,000 in 2002 and $9,491,000 in 2001.
47
NOTE 16 OPERATING SEGMENTS
The companys operating segments have generally similar products and services and the company is organized to manage its operations geographically. The companys operating segments have been aggregated into three reportable segments.
The United States Cleaning & Sanitizing segment provides cleaning and sanitizing products and services to United States markets through its Institutional, Kay, Textile Care, Professional Products, Vehicle Care, Water Care Services and Food & Beverage operations.
The United States Other Services segment includes all other U.S. operations of the company. This segment provides pest elimination and kitchen equipment repair and maintenance through its Pest Elimination and GCS Service operations.
The companys International Cleaning & Sanitizing segment provides cleaning and sanitizing product and service offerings to international markets in Europe, Asia Pacific, Latin America and Canada. Effective November 30, 2001, Henkel-Ecolabs total assets were included in the companys International Cleaning & Sanitizing operations. European operating data has been included beginning in 2002.
Information on the types of products and services of each of the companys operating segments is included on the inside front cover under Services/Products Provided of the Ecolab Overview section of this Annual Report.
The company evaluates the performance of its international operations based on fixed management currency exchange rates. All other accounting policies of the reportable segments are consistent with accounting principles generally accepted in the United States of America and the accounting policies of the company described in Note 2 of these notes to consolidated financial statements. The profitability of the companys operating segments is evaluated by management based on operating income. Intersegment sales and transfers were not significant.
Financial information for each of the companys reportable segments is as follows:
|
|
United States |
|
|
|
Other |
|
|||||||||||||||
(thousands) |
|
Cleaning
&
|
|
Other
|
|
Total
|
|
International
|
|
Foreign
|
|
Corporate Consolidated |
|
|||||||||
Net sales |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
2003 |
|
$ |
1,694,323 |
|
$ |
320,444 |
|
$ |
2,014,767 |
|
$ |
1,560,557 |
|
$ |
186,495 |
|
|
|
$ |
3,761,819 |
|
|
2002 |
|
1,615,171 |
|
308,329 |
|
1,923,500 |
|
1,497,935 |
|
(17,850 |
) |
|
|
3,403,585 |
|
|||||||
2001 |
|
1,548,882 |
|
273,020 |
|
1,821,902 |
|
474,089 |
|
24,719 |
|
|
|
2,320,710 |
|
|||||||
Operating income (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
2003 |
|
285,212 |
|
21,031 |
|
306,243 |
|
159,866 |
|
21,383 |
|
$ |
(4,834 |
) |
482,658 |
|
||||||
2002 |
|
271,838 |
|
33,051 |
|
304,889 |
|
138,373 |
|
(1,388 |
) |
(46,008 |
) |
395,866 |
|
|||||||
2001 |
|
246,936 |
|
29,338 |
|
276,274 |
|
44,575 |
|
2,268 |
|
(4,938 |
) |
318,179 |
|
|||||||
Depreciation & amortization |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
2003 |
|
114,516 |
|
4,903 |
|
119,419 |
|
85,521 |
|
17,766 |
|
6,950 |
|
229,656 |
|
|||||||
2002 |
|
112,303 |
|
4,615 |
|
116,918 |
|
105,765 |
|
(6,703 |
) |
7,448 |
|
223,428 |
|
|||||||
2001 |
|
118,298 |
|
5,384 |
|
123,682 |
|
28,587 |
|
4,782 |
|
5,939 |
|
162,990 |
|
|||||||
Total assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
2003 |
|
1,112,994 |
|
143,552 |
|
1,256,546 |
|
1,560,978 |
|
302,756 |
|
108,638 |
|
3,228,918 |
|
|||||||
2002 |
|
1,067,226 |
|
129,498 |
|
1,196,724 |
|
1,423,309 |
|
173,497 |
|
72,377 |
|
2,865,907 |
|
|||||||
2001 |
|
983,109 |
|
128,338 |
|
1,111,447 |
|
1,378,574 |
|
(39,377 |
) |
74,356 |
|
2,525,000 |
|
|||||||
Capital expenditures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
2003 |
|
117,361 |
|
3,726 |
|
121,087 |
|
80,271 |
|
10,536 |
|
141 |
|
212,035 |
|
|||||||
2002 |
|
111,349 |
|
3,105 |
|
114,454 |
|
134,591 |
|
(36,777 |
) |
489 |
|
212,757 |
|
|||||||
2001 |
|
$ |
114,427 |
|
$ |
6,911 |
|
$ |
121,338 |
|
$ |
33,628 |
|
$ |
2,271 |
|
$ |
700 |
|
$ |
157,937 |
|
Consistent with the companys internal management reporting, corporate operating income includes special charges recorded for 2003, 2002 and 2001. In addition, corporate expense includes an adjustment made for death benefits for retired executives in 2003 and corporate overhead costs directly related to the Henkel-Ecolab joint venture in 2001. Corporate assets are principally cash and cash equivalents.
The company has two classes of products and services within its United States and International Cleaning & Sanitizing operations which comprise 10 percent or more of consolidated net sales. Sales of ware-washing products were approximately 23 percent, 23 percent and 26 percent of consolidated net sales in 2003, 2002 and 2001, respectively. Sales of laundry products and services were approximately 10 percent, 11 percent and 10 percent of consolidated net sales in 2003, 2002 and 2001, respectively. Sales of the Henkel-Ecolab operations acquired on November 30, 2001 are reflected in these percentages beginning in 2002.
Property, plant and equipment of the companys United States and International operations were as follows:
December 31 (thousands) |
|
2003 |
|
2002 |
|
2001 |
|
|||
United States |
|
$ |
404,209 |
|
$ |
418,973 |
|
$ |
424,478 |
|
International |
|
288,951 |
|
230,196 |
|
219,807 |
|
|||
Corporate |
|
0 |
|
4,653 |
|
4,429 |
|
|||
Effect of foreign currency translation |
|
43,637 |
|
26,443 |
|
(4,391 |
) |
|||
Consolidated |
|
$ |
736,797 |
|
$ |
680,265 |
|
$ |
644,323 |
|
48
NOTE 17 CHANGE IN ACCOUNTING
Effective January 1, 2002, the company adopted the provisions of SFAS No. 142, Goodwill and Other Intangible Assets . This statement discontinued the amortization of goodwill, subject to periodic impairment testing. The adjusted amounts shown below reflect the effect of retroactive application of the discontinuance of the amortization of goodwill as if the new method of accounting had been in effect during 2001. The adjusted information for 2001 presents the historical information prior to the acquisition of the former European joint venture.
|
|
As Reported |
|
Adjusted |
|
|||||
(thousands, except per share) |
|
2003 |
|
2002 |
|
2001 |
|
|||
|
|
|
|
|
|
|
|
|||
Reported net income |
|
$ |
277,348 |
|
$ |
209,770 |
|
$ |
188,170 |
|
Goodwill amortization (net of tax) |
|
|
|
|
|
18,471 |
|
|||
Adjusted net income |
|
$ |
277,348 |
|
$ |
209,770 |
|
$ |
206,641 |
|
|
|
|
|
|
|
|
|
|||
Basic earnings per share Net income, as reported |
|
$ |
1.07 |
|
$ |
0.81 |
|
$ |
0.74 |
|
Goodwill amortization (net of tax) |
|
|
|
|
|
0.07 |
|
|||
Adjusted basic earnings per share |
|
$ |
1.07 |
|
$ |
0.81 |
|
$ |
0.81 |
|
|
|
|
|
|
|
|
|
|||
Diluted earnings per share Net income, as reported |
|
$ |
1.06 |
|
$ |
0.80 |
|
$ |
0.72 |
|
Goodwill amortization (net of tax) |
|
|
|
|
|
0.07 |
|
|||
Adjusted diluted earnings per share |
|
$ |
1.06 |
|
$ |
0.80 |
|
$ |
0.80 |
|
Per share amounts do not necessarily sum due to rounding.
The company was required to test all existing goodwill for impairment as of January 1,2002 on a reporting unit basis. Generally, the companys reporting units are its operating segments. Under SFAS No. 142, the fair value approach is used to test goodwill for impairment. This method differed from the companys prior policy of using an undiscounted cash flows method for testing goodwill impairment. An impairment charge is recognized for the amount, if any, by which the carrying amount of goodwill exceeds its implied fair value. Fair values of reporting units were established using a discounted cash flow method. Where available and as appropriate, comparative market multiples were used to corroborate the results of the discounted cash flow method.
The result of testing goodwill for impairment in accordance with the adoption of SFAS No. 142, was a non-cash charge of $4.0 million after tax, or $0.02 per share, which is reported on the accompanying consolidated statement of income as a cumulative effect of a change in accounting in 2002. The impairment charge relates to the Africa/Export operations, which is part of the International Cleaning & Sanitizing reportable segment. The primary factor resulting in the impairment charge was the difficult economic environment in the region.
Under SFAS No. 142, goodwill must be tested annually for impairment. Based on the companys testing in 2003 and 2002, there has been no additional impairment of goodwill. The company performs its annual goodwill impairment test during the second quarter. If circumstances change significantly within a reporting unit, the company would test it for impairment prior to the annual test for impairment.
49
NOTE 18 QUARTERLY FINANCIAL DATA (UNAUDITED)
(thousands, except per share) |
|
First
|
|
Second
|
|
Third
|
|
Fourth
|
|
Year |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||
2003 |
|
|
|
|
|
|
|
|
|
|
|
|||||
Net sales |
|
|
|
|
|
|
|
|
|
|
|
|||||
United States Cleaning & Sanitizing |
|
$ |
417,299 |
|
$ |
430,901 |
|
$ |
444,791 |
|
$ |
401,332 |
|
$ |
1,694,323 |
|
United States Other Services |
|
73,329 |
|
82,963 |
|
83,497 |
|
80,655 |
|
320,444 |
|
|||||
International Cleaning & Sanitizing |
|
360,558 |
|
389,596 |
|
399,967 |
|
410,436 |
|
1,560,557 |
|
|||||
Effect of foreign currency translation |
|
24,666 |
|
43,275 |
|
54,511 |
|
64,043 |
|
186,495 |
|
|||||
Total |
|
875,852 |
|
946,735 |
|
982,766 |
|
956,466 |
|
3,761,819 |
|
|||||
Cost of sales (including special charges (income) of $(45) and $(31) in first and fourth quarters) |
|
430,482 |
|
466,734 |
|
478,163 |
|
469,823 |
|
1,845,202 |
|
|||||
Selling, general and administrative expenses |
|
344,033 |
|
358,783 |
|
357,923 |
|
372,812 |
|
1,433,551 |
|
|||||
Special charges (income) |
|
(197 |
) |
(147 |
) |
1,224 |
|
(472 |
) |
408 |
|
|||||
Operating income |
|
|
|
|
|
|
|
|
|
|
|
|||||
United States Cleaning & Sanitizing |
|
69,906 |
|
71,943 |
|
82,472 |
|
60,891 |
|
285,212 |
|
|||||
United States Other Services |
|
3,647 |
|
6,785 |
|
8,755 |
|
1,844 |
|
21,031 |
|
|||||
International Cleaning & Sanitizing |
|
25,717 |
|
38,147 |
|
48,694 |
|
47,308 |
|
159,866 |
|
|||||
Corporate |
|
242 |
|
106 |
|
(1,184 |
) |
(3,998 |
) |
(4,834 |
) |
|||||
Effect of foreign currency translation |
|
2,022 |
|
4,384 |
|
6,719 |
|
8,258 |
|
21,383 |
|
|||||
Total |
|
101,534 |
|
121,365 |
|
145,456 |
|
114,303 |
|
482,658 |
|
|||||
Gain on sale of equity investment |
|
|
|
|
|
10,877 |
|
228 |
|
11,105 |
|
|||||
Interest expense, net |
|
10,703 |
|
11,752 |
|
12,051 |
|
10,839 |
|
45,345 |
|
|||||
Income before income taxes |
|
90,831 |
|
109,613 |
|
144,282 |
|
103,692 |
|
448,418 |
|
|||||
Provision for income taxes |
|
35,513 |
|
42,458 |
|
56,843 |
|
36,256 |
|
171,070 |
|
|||||
Net income |
|
$ |
55,318 |
|
$ |
67,155 |
|
$ |
87,439 |
|
$ |
67,436 |
|
$ |
277,348 |
|
Basic net income per common share |
|
$ |
0.21 |
|
$ |
0.26 |
|
$ |
0.34 |
|
$ |
0.26 |
|
$ |
1.07 |
|
Diluted net income per common share |
|
$ |
0.21 |
|
$ |
0.25 |
|
$ |
0.33 |
|
$ |
0.26 |
|
$ |
1.06 |
|
Weighted-average common shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|||||
Basic |
|
260,448 |
|
261,246 |
|
258,694 |
|
257,428 |
|
259,454 |
|
|||||
Diluted |
|
263,637 |
|
264,553 |
|
261,609 |
|
260,628 |
|
262,737 |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||
2002 |
|
|
|
|
|
|
|
|
|
|
|
|||||
Net sales |
|
|
|
|
|
|
|
|
|
|
|
|||||
United States Cleaning & Sanitizing |
|
$ |
392,349 |
|
$ |
402,113 |
|
$ |
426,339 |
|
$ |
394,370 |
|
$ |
1,615,171 |
|
United States Other Services |
|
70,490 |
|
78,824 |
|
81,629 |
|
77,386 |
|
308,329 |
|
|||||
International Cleaning & Sanitizing |
|
340,933 |
|
373,151 |
|
380,328 |
|
403,523 |
|
1,497,935 |
|
|||||
Effect of foreign currency translation |
|
(17,663 |
) |
(14,858 |
) |
6,570 |
|
8,101 |
|
(17,850 |
) |
|||||
Total |
|
786,109 |
|
839,230 |
|
894,866 |
|
883,380 |
|
3,403,585 |
|
|||||
Cost of sales (including special charges of $5,184, $1,908, $301 and $1,584 in first, second, third and fourth quarters) |
|
395,945 |
|
413,425 |
|
434,195 |
|
444,032 |
|
1,687,597 |
|
|||||
Selling, general and administrative expenses |
|
304,945 |
|
315,363 |
|
327,666 |
|
335,117 |
|
1,283,091 |
|
|||||
Special charges |
|
12,296 |
|
11,818 |
|
2,109 |
|
10,808 |
|
37,031 |
|
|||||
Operating income |
|
|
|
|
|
|
|
|
|
|
|
|||||
United States Cleaning & Sanitizing |
|
64,940 |
|
68,979 |
|
80,361 |
|
57,558 |
|
271,838 |
|
|||||
United States Other Services |
|
5,262 |
|
9,224 |
|
10,761 |
|
7,804 |
|
33,051 |
|
|||||
International Cleaning & Sanitizing |
|
21,402 |
|
35,360 |
|
41,711 |
|
39,900 |
|
138,373 |
|
|||||
Corporate |
|
(17,480 |
) |
(13,726 |
) |
(2,411 |
) |
(12,391 |
) |
(46,008 |
) |
|||||
Effect of foreign currency translation |
|
(1,201 |
) |
(1,213 |
) |
474 |
|
552 |
|
(1,388 |
) |
|||||
Total |
|
72,923 |
|
98,624 |
|
130,896 |
|
93,423 |
|
395,866 |
|
|||||
Interest expense, net |
|
10,512 |
|
11,955 |
|
10,988 |
|
10,440 |
|
43,895 |
|
|||||
Income from continuing operations before income taxes |
|
62,411 |
|
86,669 |
|
119,908 |
|
82,983 |
|
351,971 |
|
|||||
Provision for income taxes |
|
25,370 |
|
35,008 |
|
47,826 |
|
31,877 |
|
140,081 |
|
|||||
Income from continuing operations before change in accounting |
|
37,041 |
|
51,661 |
|
72,082 |
|
51,106 |
|
211,890 |
|
|||||
Change in accounting for goodwill |
|
(4,002 |
) |
|
|
|
|
|
|
(4,002 |
) |
|||||
Gain from discontinued operations |
|
1,882 |
|
|
|
|
|
|
|
1,882 |
|
|||||
Net income |
|
$ |
34,921 |
|
$ |
51,661 |
|
$ |
72,082 |
|
$ |
51,106 |
|
$ |
209,770 |
|
Basic income per common share |
|
|
|
|
|
|
|
|
|
|
|
|||||
Income from continuing operations |
|
$ |
0.14 |
|
$ |
0.20 |
|
$ |
0.28 |
|
$ |
0.20 |
|
$ |
0.82 |
|
Change in accounting for goodwill |
|
(0.02 |
) |
|
|
|
|
|
|
(0.02 |
) |
|||||
Gain from discontinued operations |
|
0.01 |
|
|
|
|
|
|
|
0.01 |
|
|||||
Net income |
|
0.14 |
|
0.20 |
|
0.28 |
|
0.20 |
|
0.81 |
|
|||||
Diluted income per common share |
|
|
|
|
|
|
|
|
|
|
|
|||||
Income from continuing operations |
|
0.14 |
|
0.20 |
|
0.28 |
|
0.19 |
|
0.81 |
|
|||||
Change in accounting for goodwill |
|
(0.02 |
) |
|
|
|
|
|
|
(0.02 |
) |
|||||
Gain from discontinued operations |
|
0.01 |
|
|
|
|
|
|
|
0.01 |
|
|||||
Net income |
|
$ |
0.13 |
|
$ |
0.20 |
|
$ |
0.28 |
|
$ |
0.19 |
|
$ |
0.80 |
|
Weighted-average common shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|||||
Basic |
|
256,812 |
|
257,810 |
|
258,575 |
|
259,391 |
|
258,147 |
|
|||||
Diluted |
|
260,361 |
|
261,225 |
|
261,223 |
|
262,416 |
|
261,574 |
|
Special charges are included in corporate operating income. Per share amounts do not necessarily sum due to changes in share outstanding and rounding.
50
management and auditors reports
REPORT OF MANAGEMENT
Management is responsible for the integrity and objectivity of the consolidated financial statements. The statements have been prepared in accordance with accounting principles generally accepted in the United States of America and, accordingly, include certain amounts based on managements best estimates and judgments.
To meet its responsibility, management has established and maintains a system of internal controls that provides reasonable assurance regarding the integrity and reliability of the financial statements and the protection of assets from unauthorized use or disposition. These systems are supported by qualified personnel, by an appropriate division of responsibilities and by an internal audit function. There are limits inherent in any system of internal controls since the cost of monitoring such systems should not exceed the desired benefit. Management believes that the companys system of internal controls is effective and provides an appropriate cost/benefit balance.
The Board of Directors, acting through its Audit Committee composed solely of independent directors, is responsible for determining that management fulfills its responsibilities in the preparation of financial statements and maintains financial control of operations. The Audit Committee recommends to the Board of Directors the appointment of the companys independent accountants, subject to ratification by the shareholders. It meets regularly with management, the internal auditors and the independent auditors.
The independent auditors provide an objective, independent review as to managements discharge of its responsibilities insofar as they relate to the fair presentation of the consolidated financial statements. Their report is presented separately.
Allan L. Schuman
Chairman of the Board and
Chief Executive Officer
Steven L. Fritze
Executive Vice President and
Chief Financial Officer
REPORT OF INDEPENDENT AUDITORS
To the Shareholders and Directors Ecolab Inc.
In our opinion, the accompanying consolidated balance sheet and the related consolidated statements of income, of comprehensive income and shareholders equity and of cash flows present fairly, in all material respects, the consolidated financial position of Ecolab Inc. as of December 31, 2003, 2002 and 2001, and the consolidated results of its operations and its cash flows for each of the three years in the period ended December 31, 2003, in conformity with accounting principles generally accepted in the United States of America. These financial statements are the responsibility of Ecolab Inc.s management; our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits of these statements in accordance with auditing standards generally accepted in the United States of America which require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
As discussed in Note 17 to the consolidated financial statements, Ecolab Inc. changed the manner in which it accounts for goodwill and other intangible assets as of January 1, 2002.
PricewaterhouseCoopers LLP
Minneapolis, Minnesota
February 26, 2004
51
summary operating and financial data
The former Henkel-Ecolab is included as a consolidated subsidiary effective November 30, 2001. Adjusted results for 1993 through 2001 reflect the effect of retroactive application of the discontinuance of the amortization of goodwill as if SFAS No. 142 had been in effect since January 1, 1993. For 1993 through 1994 the adjustments also reflect adjustments to eliminate unusual items associated with Ecolabs acquisition of Kay Chemical Company in December 1994. All per share, shares outstanding and market price data reflect the two-for-one stock splits declared in 2003,1997 and 1993. Return on beginning equity is net income divided by beginning shareholders equity.
52 - 53
EXHIBIT (21)
Registrant
ECOLAB INC.
Name of Affiliate |
|
State or
Other
|
|
Percentage
|
|
Ecolab (Antigua) Ltd. |
|
Antigua |
|
100 |
|
|
|
|
|
|
|
Ecolab S.A. |
|
Argentina |
|
100 |
|
|
|
|
|
|
|
Ecolab Australia Pty Ltd. |
|
Australia |
|
100 |
|
|
|
|
|
|
|
Ecolab Finance Pty Ltd. |
|
Australia |
|
100 |
|
|
|
|
|
|
|
Ecolab Pty Ltd. |
|
Australia |
|
100 |
|
|
|
|
|
|
|
Ecolab Water Care Services Pty Limited |
|
Australia |
|
100 |
|
|
|
|
|
|
|
Gibson Chemical Industries Pty Ltd. |
|
Australia |
|
100 |
|
|
|
|
|
|
|
Gibson Chemicals (NSW) Pty Limited |
|
Australia |
|
100 |
|
|
|
|
|
|
|
Gibson Chemicals Fiji Pty Limited |
|
Australia |
|
100 |
|
|
|
|
|
|
|
Gibson Chemicals Great Britain Pty Limited |
|
Australia |
|
100 |
|
|
|
|
|
|
|
Gibson Chemicals Pty Limited |
|
Australia |
|
100 |
|
|
|
|
|
|
|
Vessey Chemicals (Holdings) Pty Limited |
|
Australia |
|
95 |
|
|
|
|
|
|
|
Vessey Chemicals Pty Limited |
|
Australia |
|
100 |
|
|
|
|
|
|
|
Vessey Chemicals (Vic.) Pty Limited |
|
Australia |
|
100 |
|
|
|
|
|
|
|
Ecolab Ges.m.b.H |
|
Austria |
|
100 |
|
|
|
|
|
|
|
Ecolab Holding Europe GmbH |
|
Austria |
|
100 |
|
|
|
|
|
|
|
Ecolab Limited |
|
Bahamas |
|
100 |
|
|
|
|
|
|
|
Ecolab (Barbados) Limited |
|
Barbados |
|
100 |
|
|
|
|
|
|
|
Ecolab B.V.B.A./S.P.R.L. |
|
Belgium |
|
100 |
|
|
|
|
|
|
|
Kay N.V. |
|
Belgium |
|
100 |
|
|
|
|
|
|
|
Ecolab Emprecendimentos E Participacoes Ltda. |
|
Brazil |
|
100 |
|
|
|
|
|
|
|
Ecolab Quimica Ltda. |
|
Brazil |
|
100 |
|
Name of Affiliate |
|
State or
Other
|
|
Percentage
|
|
Ecolab EOOD |
|
Bulgaria |
|
100 |
|
|
|
|
|
|
|
Ecolab Co. |
|
Canada |
|
100 |
|
|
|
|
|
|
|
Ecolabone ULC |
|
Canada |
|
100 |
|
|
|
|
|
|
|
Ecolab Canada L.P. |
|
Canada |
|
100 |
|
|
|
|
|
|
|
Ecolab (Ontario) Holdings Ltd. |
|
Canada |
|
100 |
|
|
|
|
|
|
|
Ecolab S.A. |
|
Chile |
|
100 |
|
|
|
|
|
|
|
Ecolab Colombia S.A. |
|
Colombia |
|
100 |
|
|
|
|
|
|
|
Ecolab, Sociedad Anonima |
|
Costa Rica |
|
100 |
|
|
|
|
|
|
|
Ecolab d.o.o. |
|
Croatia |
|
100 |
|
|
|
|
|
|
|
Ecolab Holding (Cyprus) Limited |
|
Cyprus |
|
100 |
|
|
|
|
|
|
|
Ecolab Hygiene s.r.o. |
|
Czech Republic |
|
100 |
|
|
|
|
|
|
|
Ecolab ApS |
|
Denmark |
|
100 |
|
|
|
|
|
|
|
Ecolab Holding Denmark ApS |
|
Denmark |
|
100 |
|
|
|
|
|
|
|
Ecolab, S.A. de C.V. |
|
El Salvador |
|
100 |
|
|
|
|
|
|
|
Oy Ecolab AB |
|
Finland |
|
100 |
|
|
|
|
|
|
|
ABP SA |
|
France |
|
100 |
|
|
|
|
|
|
|
Aedes SA |
|
France |
|
100 |
|
|
|
|
|
|
|
Aidamort SA |
|
France |
|
100 |
|
|
|
|
|
|
|
Artois Chimie SA |
|
France |
|
100 |
|
|
|
|
|
|
|
Alpha Holding S.A.S. |
|
France |
|
100 |
|
|
|
|
|
|
|
Amboile Services SA |
|
France |
|
100 |
|
|
|
|
|
|
|
Amperia SARL |
|
France |
|
100 |
|
|
|
|
|
|
|
Assainissement Charpentes Batiment SA |
|
France |
|
100 |
|
|
|
|
|
|
|
Biophyte SARL |
|
France |
|
100 |
|
Name of Affiliate |
|
State or
Other
|
|
Percentage
|
|
Blue River SA |
|
France |
|
100 |
|
|
|
|
|
|
|
Centre de Dératisation et de Désinsectisation SARL |
|
France |
|
100 |
|
|
|
|
|
|
|
Centre Régional de Désinfectisation et de Dératisation SAS |
|
France |
|
100 |
|
|
|
|
|
|
|
Compagnie Française de Services SARL |
|
France |
|
100 |
|
|
|
|
|
|
|
Ecolab SAS |
|
France |
|
100 |
|
|
|
|
|
|
|
Ecolab SNC |
|
France |
|
100 |
|
|
|
|
|
|
|
Etablissements Enval et Cie SARL |
|
France |
|
100 |
|
|
|
|
|
|
|
Ets Lorillou SA |
|
France |
|
100 |
|
|
|
|
|
|
|
Figap SARL |
|
France |
|
100 |
|
|
|
|
|
|
|
France Nuisibles SARL |
|
France |
|
100 |
|
|
|
|
|
|
|
HIE Piguy SA |
|
France |
|
100 |
|
|
|
|
|
|
|
Hygiene Champenoise SA |
|
France |
|
100 |
|
|
|
|
|
|
|
Hygiène Service SAS |
|
France |
|
100 |
|
|
|
|
|
|
|
Lhygiene De lEst SA |
|
France |
|
100 |
|
|
|
|
|
|
|
Laboratoires Aufra SA |
|
France |
|
100 |
|
|
|
|
|
|
|
Lorillou Hygiene SA |
|
France |
|
100 |
|
|
|
|
|
|
|
Muliser SA |
|
France |
|
100 |
|
|
|
|
|
|
|
Nicol Hygiene SARL |
|
France |
|
100 |
|
|
|
|
|
|
|
Nigiko SA |
|
France |
|
100 |
|
|
|
|
|
|
|
Omniser SARL |
|
France |
|
100 |
|
|
|
|
|
|
|
Paragerm SNC |
|
France |
|
100 |
|
|
|
|
|
|
|
Sanigiène SARL |
|
France |
|
100 |
|
|
|
|
|
|
|
SCI Aphomia |
|
France |
|
100 |
|
|
|
|
|
|
|
SCI Dugard |
|
France |
|
100 |
|
Name of Affiliate |
|
State or
Other
|
|
Percentage
|
|
SCI Dumoulin |
|
France |
|
100 |
|
|
|
|
|
|
|
SCI Eliomys |
|
France |
|
100 |
|
|
|
|
|
|
|
SCI Erebia |
|
France |
|
100 |
|
|
|
|
|
|
|
SCI La Louvette |
|
France |
|
100 |
|
|
|
|
|
|
|
SCI Marco |
|
France |
|
100 |
|
|
|
|
|
|
|
SCI Orly |
|
France |
|
100 |
|
|
|
|
|
|
|
SCI Société Civile Immobilière de la Source Hodan |
|
France |
|
100 |
|
|
|
|
|
|
|
SNC Parly |
|
France |
|
100 |
|
|
|
|
|
|
|
Société des Eaux de Sources des Roches SA |
|
France |
|
100 |
|
|
|
|
|
|
|
Bionagro Natureprodukte GmbH |
|
Germany |
|
100 |
|
|
|
|
|
|
|
Ecolab Asset Administration GmbH & Co. KG |
|
Germany |
|
100 |
|
|
|
|
|
|
|
Ecolab Beteiligungs GmbH |
|
Germany |
|
100 |
|
|
|
|
|
|
|
Ecolab Deutschland Holding GmbH & Co. OHG |
|
Germany |
|
100 |
|
|
|
|
|
|
|
Ecolab Export GmbH |
|
Germany |
|
100 |
|
|
|
|
|
|
|
Ecolab GmbH |
|
Germany |
|
100 |
|
|
|
|
|
|
|
Ecolab GmbH & Co. OHG |
|
Germany |
|
100 |
|
|
|
|
|
|
|
Ecolab Management GmbH |
|
Germany |
|
100 |
|
|
|
|
|
|
|
Ecolab NFK Beteilgungen Management GmbH |
|
Germany |
|
100 |
|
|
|
|
|
|
|
Ecolab NFK R&D GmbH & Co. OHG |
|
Germany |
|
100 |
|
|
|
|
|
|
|
Ecolab NFK R&D Verwaltungs GmbH |
|
Germany |
|
100 |
|
|
|
|
|
|
|
Lang Apparatebau GmbH |
|
Germany |
|
100 |
|
|
|
|
|
|
|
Lang Engineering GmbH |
|
Germany |
|
100 |
|
|
|
|
|
|
|
Lang Hygiene Systeme GmbH |
|
Germany |
|
100 |
|
|
|
|
|
|
|
Ecolab A.E.B.E. |
|
Greece |
|
100 |
|
Name of Affiliate |
|
State or
Other
|
|
Percentage
|
|
Ecolab, Sociedad Anonima |
|
Guatemala |
|
100 |
|
|
|
|
|
|
|
Peter Cox Insurance Services Limited |
|
Guernsey |
|
100 |
|
|
|
|
|
|
|
Quimicas Ecolab, S.A. |
|
Honduras |
|
100 |
|
|
|
|
|
|
|
Ecolab Limited |
|
Hong Kong |
|
100 |
|
|
|
|
|
|
|
Ecolab Holding Hungary Ltd. |
|
Hungary |
|
100 |
|
|
|
|
|
|
|
Ecolab Hygiene Kft. |
|
Hungary |
|
100 |
|
|
|
|
|
|
|
P.T. Ecolab Indonesia |
|
Indonesia |
|
100 |
|
|
|
|
|
|
|
Eclab Export Limited |
|
Ireland |
|
100 |
|
|
|
|
|
|
|
Ecolab Co. |
|
Ireland |
|
100 |
|
|
|
|
|
|
|
Ecolab Finance Company Limited |
|
Ireland |
|
100 |
|
|
|
|
|
|
|
Ecolab (Holdings) Limited |
|
Ireland |
|
100 |
|
|
|
|
|
|
|
Ecolab Limited |
|
Ireland |
|
100 |
|
|
|
|
|
|
|
Ecolab JVZ Limited |
|
Israel |
|
100 |
|
|
|
|
|
|
|
Ecolab-Zohar Dalia L.P. |
|
Israel |
|
51 |
|
|
|
|
|
|
|
Ecolab-Zohar Dalia Management Company Ltd. |
|
Israel |
|
51 |
|
|
|
|
|
|
|
Elton Chemical Srl |
|
Italy |
|
100 |
|
|
|
|
|
|
|
Ecolab Holding Italy Srl |
|
Italy |
|
100 |
|
|
|
|
|
|
|
Ecolab Srl |
|
Italy |
|
100 |
|
|
|
|
|
|
|
Findesadue Srl |
|
Italy |
|
80 |
|
|
|
|
|
|
|
H. E. Distribution Srl |
|
Italy |
|
100 |
|
|
|
|
|
|
|
Ecolab Limited |
|
Jamaica |
|
100 |
|
|
|
|
|
|
|
Ecolab K.K. |
|
Japan |
|
100 |
|
|
|
|
|
|
|
Ecolab East Africa (Kenya) Limited |
|
Kenya |
|
100 |
|
|
|
|
|
|
|
Ecolab Korea Ltd. |
|
Korea |
|
100 |
|
|
|
|
|
|
|
Ecolab SIA |
|
Latvia |
|
100 |
|
Name of Affiliate |
|
State or
Other
|
|
Percentage
|
|
Ecolab Sdn Bhd |
|
Malaysia |
|
100 |
|
|
|
|
|
|
|
Ecolab, S. de R.L. de C.V. |
|
Mexico |
|
100 |
|
|
|
|
|
|
|
Ecolab Holdings Mexico, S.A. de C.V. |
|
Mexico |
|
100 |
|
|
|
|
|
|
|
Ecolab Maroc S. A. |
|
Morocco |
|
100 |
|
|
|
|
|
|
|
Ecolab (Proprietary) Limited |
|
Namibia |
|
100 |
|
|
|
|
|
|
|
Ecolab Finance N.V. |
|
Netherlands Antilles (Curacao) |
|
100 |
|
|
|
|
|
|
|
Ecolabtwo B.V. |
|
Netherlands |
|
100 |
|
|
|
|
|
|
|
Ecolab Holdings B.V. |
|
Netherlands |
|
100 |
|
|
|
|
|
|
|
Ecolab International B.V. |
|
Netherlands |
|
100 |
|
|
|
|
|
|
|
Ecolab B.V. |
|
Netherlands |
|
100 |
|
|
|
|
|
|
|
Ecolab Limited |
|
New Zealand |
|
100 |
|
|
|
|
|
|
|
Ecolab Nicaragua, S.A. |
|
Nicaragua |
|
100 |
|
|
|
|
|
|
|
Ecolab A/S |
|
Norway |
|
100 |
|
|
|
|
|
|
|
Ecolab S.A. |
|
Panama |
|
100 |
|
|
|
|
|
|
|
Ecolab Chemicals Ltd. |
|
Peoples Republic of China |
|
85 |
|
|
|
|
|
|
|
Ecolab Philippines Inc. |
|
Philippines |
|
100 |
|
|
|
|
|
|
|
Ecolab Sp.z o.o. |
|
Poland |
|
100 |
|
|
|
|
|
|
|
Ecolab S.R.L. |
|
Romania |
|
100 |
|
|
|
|
|
|
|
ZAO Ecolab |
|
Russia |
|
100 |
|
|
|
|
|
|
|
Ecolab Hygiene d.o.o. |
|
Serbia / Montenegro |
|
100 |
|
|
|
|
|
|
|
Ecolab Pte. Ltd. |
|
Singapore |
|
100 |
|
|
|
|
|
|
|
Ecolab s.r.o. |
|
Slovak Republic |
|
100 |
|
|
|
|
|
|
|
Ecolab d.o.o. |
|
Slovenia |
|
100 |
|
|
|
|
|
|
|
Ecolab (Proprietary) Ltd. |
|
South Africa |
|
100 |
|
Name of Affiliate |
|
State or
Other
|
|
Percentage
|
|
Ecolab Hispano-Portuguesa, S.A. |
|
Spain |
|
100 |
|
|
|
|
|
|
|
Ecolab (St. Lucia) Limited |
|
St. Lucia |
|
100 |
|
|
|
|
|
|
|
Ecolab AB |
|
Sweden |
|
100 |
|
|
|
|
|
|
|
Ecolab GmbH |
|
Switzerland |
|
100 |
|
|
|
|
|
|
|
Ecolab Ltd. |
|
Taiwan |
|
100 |
|
|
|
|
|
|
|
Ecolab East Africa (Tanzania) Limited |
|
Tanzania |
|
100 |
|
|
|
|
|
|
|
Ecolab Ltd. |
|
Thailand |
|
100 |
|
|
|
|
|
|
|
Ecolab Temizleme Sistemleri A.S. |
|
Turkey |
|
100 |
|
|
|
|
|
|
|
Ecolab East Africa (Uganda) Limited |
|
Uganda |
|
100 |
|
|
|
|
|
|
|
Ecolab LLC |
|
Ukraine |
|
100 |
|
|
|
|
|
|
|
Ecolab Limited |
|
United Kingdom |
|
100 |
|
|
|
|
|
|
|
Ecolab Services Limited |
|
United Kingdom |
|
100 |
|
|
|
|
|
|
|
Ecolab (U.K.) Holdings Limited |
|
United Kingdom |
|
100 |
|
|
|
|
|
|
|
LHS (UK) Limited |
|
United Kingdom |
|
100 |
|
|
|
|
|
|
|
Ecolab S. A. |
|
Uruguay |
|
100 |
|
|
|
|
|
|
|
Ecolab Foreign Sales Corp. |
|
U.S. Virgin Islands |
|
100 |
|
|
|
|
|
|
|
Ecolab S.A. |
|
Venezuela |
|
74 |
|
|
|
|
|
|
|
Ecolab Zimbabwe (Pvt) Ltd. |
|
Zimbabwe |
|
100 |
|
|
|
|
|
|
|
United States |
|
|
|
|
|
|
|
|
|
|
|
Daydots Inc. |
|
Delaware |
|
100 |
|
|
|
|
|
|
|
Ecolabone LLC |
|
Delaware |
|
100 |
|
|
|
|
|
|
|
Ecolabtwo LLC |
|
Delaware |
|
100 |
|
|
|
|
|
|
|
Ecolabthree LLC |
|
Delaware |
|
100 |
|
|
|
|
|
|
|
Ecolabfour LLC |
|
Delaware |
|
100 |
|
Name of Affiliate |
|
State or
Other
|
|
Percentage
|
|
Ecolabfive LLC |
|
Delaware |
|
100 |
|
|
|
|
|
|
|
Ecolabsix LLC |
|
Delaware |
|
100 |
|
|
|
|
|
|
|
Ecolabseven LLC |
|
Delaware |
|
100 |
|
|
|
|
|
|
|
Ecolab Finance Inc. |
|
Delaware |
|
100 |
|
|
|
|
|
|
|
Ecolab Finance (Australia) Inc. |
|
Delaware |
|
100 |
|
|
|
|
|
|
|
Ecolab Holdings Inc. |
|
Delaware |
|
100 |
|
|
|
|
|
|
|
Ecolab Holdings (Europe) Inc. |
|
Delaware |
|
100 |
|
|
|
|
|
|
|
Ecolab Investment Inc. |
|
Delaware |
|
100 |
|
|
|
|
|
|
|
Ecolab Israel Holdings LLC |
|
Delaware |
|
100 |
|
|
|
|
|
|
|
Ecolab Leasing Corporation |
|
Delaware |
|
100 |
|
|
|
|
|
|
|
Ecolab Manufacturing Inc. |
|
Delaware |
|
100 |
|
|
|
|
|
|
|
Ecolab Marketing LLC |
|
Delaware |
|
100 |
|
|
|
|
|
|
|
Facilitec Inc. |
|
Delaware |
|
100 |
|
|
|
|
|
|
|
GCS Service, Inc. |
|
Delaware |
|
100 |
|
|
|
|
|
|
|
Ecolab Foundation |
|
Minnesota |
|
100 |
|
|
|
|
|
|
|
Kay Chemical Company |
|
North Carolina |
|
100 |
|
|
|
|
|
|
|
Kay Chemical International, Inc. |
|
North Carolina |
|
100 |
|
|
|
|
|
|
|
ProForce Inc. |
|
North Carolina |
|
100 |
|
|
|
|
|
|
|
SSDC, Inc. |
|
Texas |
|
100 |
|
Certain additional subsidiaries, which are not significant in the aggregate, are not shown.
EXHIBIT (24)
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, That the undersigned, a director of Ecolab Inc., a Delaware corporation, does hereby make, nominate and appoint TIMOTHY P. DORDELL and LAWRENCE T. BELL, and each of them, to be my attorney-in-fact, with full power and authority to sign his name to the Annual Report on Form 10-K of Ecolab Inc. for the fiscal year ended December 31, 2002, and all amendments thereto, provided that the Annual Report and any amendments thereto, in final form, be approved by said attorney-in-fact; and his name, when thus signed, shall have the same force and effect as though I had manually signed said document.
IN WITNESS WHEREOF, I have hereunto affixed my signature this 28 th day of February, 2004.
|
/s/Les S. Biller |
|
|
Les S. Biller |
|
|
|
|
|
/s/Jerry A. Grundhofer |
|
|
Jerry A. Grundhofer |
|
|
|
|
|
/s/Stefan Hamelmann |
|
|
Stefan Hamelmann |
|
|
|
|
|
/s/James J. Howard |
|
|
James J. Howard |
|
|
|
|
|
/s/William L. Jews |
|
|
William L. Jews |
|
|
|
|
|
/s/Joel W. Johnson |
|
|
Joel W. Johnson |
|
|
|
|
|
/s/Jochen Krautter |
|
|
Jochen Krautter |
|
|
|
|
|
/s/Ulrich Lehner |
|
|
Ulrich Lehner |
|
|
|
|
|
/s/Jerry W. Levin |
|
|
Jerry W. Levin |
|
|
|
|
|
/s/Robert L. Lumpkins |
|
|
Robert L. Lumpkins |
|
|
|
|
IN WITNESS WHEREOF, I have hereunto affixed my signature this 29 th day of February, 2004.
|
|
|
|
/s/Douglas M. Baker, Jr. |
|
|
Douglas M. Baker, Jr. |
|
EXHIBIT (31)
CERTIFICATIONS
I, Allan L. Schuman, certify that:
1. I have reviewed this annual report on Form 10-K of Ecolab Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrants other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(c) Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and
5. The registrants other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.
Date: March 5, 2004
/s/Allan L. Schuman |
|
|
Allan L. Schuman |
|
|
Chairman of the Board and
|
|
I, Steven L. Fritze, certify that:
1. I have reviewed this annual report on Form 10-K of Ecolab Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrants other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(c) Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and
5. The registrants other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.
Date: March 5, 2004
/s/Steven L. Fritze |
|
|
Steven L. Fritze |
|
|
Executive Vice President
and
|
|
EXHIBIT (32)
SECTION 1350 CERTIFICATIONS
Pursuant to 18 U.S.C. Section 1350, each of the undersigned officers of Ecolab Inc. does hereby certify that:
(a) the Annual Report on Form 10-K of Ecolab Inc. for the year ended December 31, 2003 (the Report) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(b) information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Ecolab Inc.
Dated: March 5, 2004 |
/s/Allan L. Schuman |
|
|
Allan L. Schuman |
|
|
Chairman of the Board
and
|
|
|
|
|
|
|
|
Dated: March 5, 2004 |
/s/Steven L. Fritze |
|
|
Steven L. Fritze |
|
|
Executive Vice
President and
|
1
EXHIBIT (99)A
Code of
Conduct
The
Fabric
Of Our Company
i
Table of Contents
|
|||
|
|
||
|
|||
|
|
||
|
|||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
i
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|||
|
|
||
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ii
Our Quest for Excellence provides a clear, ethical standard of conduct: Our Companys business will be conducted in accordance with the law and stated corporate and societal standards of conduct . It follows that, as employees, we are held to the highest standard of integrity, and are expected to avoid situations which conflict with our Company responsibilities.
The Code of Conduct is a set of guidelines which are intended to assist in making decisions on behalf of Ecolab and in avoiding conflicts of interest. No guidelines can be all-inclusive. However, the guidelines which follow are particularly important.
Ultimately, the responsibility for proper conduct rests with each of us. There is no substitute for personal integrity and good judgment. When faced with a difficult situation, consider these questions:
Is my action or decision the right thing to do?
Could my action or decision withstand public review?
Will my action or decision protect Ecolabs reputation as an ethical company?
If the answer to each question is yes, the action or decision is probably the correct one.
Do not hesitate to ask your supervisor or a more senior manager if you have questions concerning our Code of Conduct . The Ecolab Law Department (651-293-2836) should also be asked to help interpret or apply the Code in general, or in a specific situation.
1
Reference to Ecolab or the Company in the Code of Conduct means Ecolab Inc. and all majority-owned United States and international subsidiaries and joint ventures, unless stated otherwise.
Failure to comply with the standards contained in the Code will result in appropriate discipline of the offending employee, up to and including termination, referral for criminal prosecution, and restitution for any losses or damages resulting from the violation.
Disciplinary action will be taken:
If you authorize or participate directly in actions which are a violation of the Code ;
If you deliberately fail to report a violation or deliberately withhold relevant and material information concerning a violation of the Code ;
Against a supervisor, to the extent that the circumstances of the violation reflect inadequate supervision or a lack of diligence;
Against any employee who retaliates, directly or indirectly, or encourages others to do so, against the person who reports a violation of the Code .
Nothing in the Code is intended to create enforceable employee contract rights
2
Conducting the business of Ecolab means that we deal with a variety of people and organizations including customers, suppliers, competitors, community and government representatives, and other employees. These relationships will be based on honesty and fairness. We will be truthful in representing Ecolab.
The company that fails its customers, fails! We will stay close to our customers, tell them the truth and earn their business every day. There will be no bribes, illegal payments or pricing practices. We will only promise what we can deliver. Our services, products and systems will be truthfully represented and ethically sold.
Working with Suppliers , Agents and Consultants
We will obtain materials, supplies, equipment, consulting and other services at the lowest total cost from suppliers who are able to meet Ecolab quality and service requirements. Source selection, negotiation, determination of contract awards and the administration of all purchasing activities will be ethically conducted. Mutually beneficial relationships with reliable suppliers and consultants will be sought.
Competition will be encouraged and maintained. Compliance with applicable government regulations and Company policies and procedures is required.
Payments to agents, consultants, brokers, professionals or other parties representing Ecolab must be limited to reasonable compensation for services rendered plus
3
reimbursement for legitimate expenses incurred. Contracts entered into with these parties will fully disclose the fees to be paid and the services to be rendered, and will require compliance with the Code of Conduct . No one may be hired by Ecolab to make payments or take any action which would be in conflict with any provisions of the Code .
The basic policy is for Ecolab employees to have no inappropriate contacts with our competitors. That way, we comply with the law and also maintain full independence and freedom to act. Any business activity which involves repeated or unusual contact with competitors - whether at meetings, in telephone calls or by correspondence - must be approved by your supervisor and the Law Department.
Also avoid unfair acts against competitors. Prohibited activities include:
Threats and harassment, physical abuse, and equipment tampering directed against a competitor;
Unlawfully interfering with an existing contractual relationship between a competitor and its customer; and
Raiding key employees with the intent to drive a competitor out of business.
4
Conducting Ecolab Business
Ecolab sells its services and systems on merit - not by making false or misleading comparisons with the competition. Specifically, in comparing Ecolab to the competition, we will not intentionally:
Misappropriate or misuse the trade names or trademarks of a competitor;
Make false or misleading statements about a competitor or its products, business practices, financial status or reliability; or
Engage in false or misleading advertising.
Gathering Competitor Information
Ecolab keeps up with competitive developments and reviews all pertinent public information concerning competitors. Information about competitors is collected from a variety of legitimate sources to help evaluate our products, services and marketing methods. Proper sources include information from customers or which is published or in the public domain, or information or product samples lawfully received from the owner or from an authorized third party.
Ecolab respects the trade secrets of others. There are limits to the ways that information can be ethically acquired and used. Espionage, burglary, wire tapping
5
and stealing are wrong. But so is hiring a competitors employees solely to get confidential information. So is gaining unauthorized access to electronic mail or other confidential competitor communications.
If possession is gained of competitor information that is marked confidential, or which is believed to be confidential, consult with the Law Department immediately.
A number of laws apply to dealings with competitors and the use of competitive information. Some impose harsh criminal penalties on employees and all impose substantial financial fines on both employees and their employers.
Whether specific conduct is lawful or violates the rights of a competitor or violates Ecolabs Code of Conduct , will depend upon an analysis of each situation. Before acting, especially before hiring former or current employees of Ecolab competitors, consult the Law Department. Also see Antitrust, page 18.
6
Working with Government Officials
Ecolab is prohibited by United States law from directly or indirectly offering, promising to pay or authorizing the payment of money or anything of value to a government official, employee or politician (official) outside the United States for the purpose of:
Influencing the acts or decisions of that official;
Inducing that official to act or fail to act in violation of his or her lawful duties; or
Inducing the official to use his or her influence to assist in obtaining or retaining business, or for directing business to any person.
Intermediaries, such as affiliates, agents, consultants or distributors, also may not be used to channel payments to officials outside the United States.
A payment of a nominal amount to a low-ranking government employee outside the United States, made to expedite or secure the performance of a routine government action, might not violate United States law if Ecolab can prove that such a payment is made for the purpose of expediting (rather than influencing) that particular decision. A routine government action is a non-discretionary function or service which the low- ranking government employee is obliged to perform as part of his or her responsibilities. Examples of such
7
services would be the issuing of visas or customs documents. However, such a facilitating payment could well violate other laws or damage Ecolabs reputation. Therefore, such a payment is discouraged.
If absolutely necessary, such payment should be made only after consultation with the senior corporate officer in charge of Ecolabs international operations and with the Law Department. Any such payment must be properly accounted for in the corporate books and records.
Doing Business with the United States Government
Special Nature of Government Business : To ensure receiving the best goods and services for the taxpayers money, the United States government has imposed stringent requirements on contractors with which it does business. We will maintain strict compliance in transacting business with the United States government. Once a contract is awarded, all contract terms will be met. No deviations or substitutions will be made without the appropriate notice to or approval of the authorized official.
Contract Negotiation and Pricing : Doing business with the United States government usually requires Ecolab to submit complete, current and accurate pricing and other factual information as part of contract negotiations. Discrepancies can lead to financial penalties and possible criminal charges against the Company and the individuals involved.
During the negotiation process, we will explain the significance of all important facts concerning a contract proposal and be prepared to certify the accuracy of the information provided. Extra care will be taken in preparing submissions to the government. Any changes affecting pricing data will be reported immediately to Contract Sales.
8
Product Specifications and Testing : All materials and processes will conform to the specifications called for in the contract. Any change from the contracts requirements must have the approval of an authorized government official.
Hiring of United States Officials : The government has enacted specific rules to eliminate even the appearance of a conflict of interest by officials who leave government employment and go to work for government contractors. Clearance from Human Resources is required prior to employing, or hiring as a consultant, any official currently or recently employed by the government, whether military or civilian.
No Gifts, Meals or Gratuities : Normal business courtesies in the commercial marketplace can be construed as an attempt to improperly influence someone in the government marketplace in the United States. Therefore, no Ecolab employee shall provide anything of value to a federal government customer, contractor or employee of such customer or contractor:
For the purpose of influencing the award, renewal or modification of a contract;
In exchange for some official act; or
To secure or reward favorable treatment in connection with procurement activities.
9
Any type of gratuity for employees of federal government customers, including but not limited to meals, refreshments, travel or lodging expenses, is prohibited. Whenever you and government personnel participate in a joint endeavor, government personnel must pay their fair share.
Rules may also be in effect by state, local and other national governments governing the acceptance of business courtesies such as meals and refreshments. These rules must be observed.
Employees involved with government contracts must be familiar with the Federal Government Contracts, Policies, and Procedures Manual.
All lobbying activities, offering testimony or making similar, major contacts with government personnel in the United States on behalf of Ecolab must be coordinated in advance by the corporate officer in charge of Public Affairs. Outside the United States, all activities that might constitute lobbying or attempts to influence government officials should first be reviewed with subsidiary management and legal counsel.
10
The intrinsic worth and dignity of each employee must be respected. Conduct which subtracts from that worth and dignity is contrary to Ecolabs culture.
Employees and applicants for employment will be evaluated on a non-discriminatory basis. Ecolab hires, compensates and promotes associates on the basis of their qualifications and performance. Only those criteria which are relevant to the job will be considered.
Ecolab has in place a proactive set of programs in order to ensure that we meet our objective to provide equal employment opportunity.
Respect for each other is basic to Ecolabs culture. Regardless of where it occurs, behavior that disrupts the productive work environment of our associates threatens the teamwork vital to Ecolabs success. Each of us must help ensure that our work environment is respectful and free from abusive behavior and harassment. Behavior that violates this policy must be reported and addressed.
As part of this policy, we will maintain a work environment free of sexual harassment. Generally, sexual harassment, regardless of intent, is direct or indirect, unwelcome, physical or verbal conduct of a sexual nature. Such harassment by any manager, employee, supervisor, customer or supplier of Ecolab will not be tolerated.
11
Entertainment/Gifts and Monetary Payments
Sales of Ecolab products and services, whether sold directly or through distributing customers, must always be free from inappropriately seeking, receiving, giving or furnishing gifts, favors or entertainment. Therefore, gifts, favors, entertainment or other forms of personal benefit may only be provided by, or on behalf of, Ecolab to a customer, or may only be accepted from a customer, if all of the following criteria are met:
The item is consistent with the normal and accepted business ethics of the country in which it is provided;
It does not violate the laws of the United States or the country in which it is provided, or Ecolab policy;
If a gift, it has only nominal value; and if a favor or entertainment, it is reasonable in cost, amount, quantity and frequency, and not excessive;
It cannot, under the surrounding circumstances, be reasonably construed as a bribe, payoff or kickback;
It involves no element of concealment;
Public disclosure of it would not embarrass Ecolab or damage Ecolabs reputation;
It does not violate standards of conduct of the recipients organization; and
The expense is documented and the business purpose is clearly stated.
12
Under no circumstances may a personal benefit take the form of cash or cash equivalents such as securities of Ecolab or any other corporation, nor may personal loans be advanced.
No employee may accept from a supplier, or from a business that wishes to become a supplier, any kind of business courtesy or gratuity such as meals, cocktails, discounts, hospitality, entertainment, recreation, transportation or other personal benefit unless all of the following criteria are met:
The item is consistent with the normal and accepted business ethics of the country in which it is provided;
It does not violate the laws of the United States or the country in which it is provided, or Ecolab policy;
If a gift, it has only nominal value; and if a favor or entertainment, it is reasonable in cost, amount, quantity and frequency, and not excessive;
It cannot, under the surrounding circumstances, be reasonably construed as a bribe, payoff or kickback;
It involves no element of concealment; and
Public disclosure of it would not embarrass Ecolab or damage Ecolabs reputation.
Solicitation of any favor or gratuity, regardless of value, or the suggestion that Ecolab will purchase from a supplier if the supplier purchases from Ecolab, is expressly prohibited.
13
Under no circumstances may a personal benefit take the form of cash or cash equivalents, nor may personal loans be accepted.
Payments for Goods or Services Outside the United States
Payments by Ecolab for goods and services provided to Ecolab outside the United States must be paid with an Ecolab check or other approved instrument payable to the person or company legally entitled to receive payment. Payments will only be made to a party in the country where the party resides, maintains a place of business, or has delivered the goods or provided the services. An exception may be made where it is clear that payment made in another country will not violate local laws, such as income tax or currency control laws, of all of the countries involved. Consult the Law Department for legal advice concerning these matters.
Payments to Employees Working Outside the United States
We will comply with all applicable tax and currency control laws of the countries where our employees have their principal employment. Any portion of the salary or benefits of an employee who resides outside the United States is to be paid in either the home country or in the country in which the employee is residing. (This includes United States employees who reside outside the United States.) Exceptions must be reviewed by the Human Resources, Tax and Law Departments.
14
Accounting/Financial and Corporate Information
Ecolabs accounting records are relied upon to produce reports to management, shareholders, investors, creditors, governmental entities, and others. All accounting records, and reports produced from these records, must be kept and presented in accordance with applicable laws. They must accurately and fairly reflect, in reasonable detail, Ecolabs income, cash flow, assets and liabilities and financial condition. Reasonable detail means the level of information and degree of assurance that would satisfy a prudent person in the conduct of his or her own affairs.
Accordingly:
No false or misleading entries will be made in the accounting records. Transactions will be properly classified as to account and accounting period and will be adequately documented;
Compliance with generally accepted accounting principles, Ecolab accounting policies and procedures is required;
Payments and other dispositions of assets will be described accurately, fairly, and in reasonable detail in Ecolabs accounting records, and will be made only for the purpose described in the relevant entries or documentation;
No undisclosed or unrecorded fund or asset will be established or maintained;
15
Sales will be properly recorded in the accounting records and in the appropriate accounting period, and only billed by written invoice. Exceptions must conform to Ecolabs asset disposition policy. Billing in excess of actual selling price is prohibited and rebates will be made only in accordance with approved Ecolab procedures;
Accounting estimates, including accruals, will be based on good faith judgment and on any applicable Ecolab policy; and
Complete and accurate information will be given to inquiries from Ecolabs internal and external auditors and Ecolabs legal counsel.
16
Ecolab is governed by United States Securities Law statutes administered by the Securities and Exchange Commission (SEC) and by the Rules of the New York Stock Exchange (NYSE). We will comply with these laws.
If statements made by Ecolab in public statements and communications or in filings with the SEC or NYSE are false or misleading as to a material matter, the responsible person and Ecolab can be exposed to civil and criminal penalties. A matter or information is material if it is important enough to influence an employee or others in the decision to purchase or sell the stock of Ecolab or any other company with whom Ecolab does business.
Accordingly, disclosures to the investing public, including periodic reports, press releases and analyst and stockholder communications will be accurate and timely. No willful or knowingly false or misleading statement or omission will be made in any disclosure, report or registration statement filed with the SEC or NYSE or any other stock exchange on which Ecolabs securities is listed. Also see Insider Trading, page 25 .
17
We will fully comply with the antitrust laws of the United States and all other applicable jurisdictions. These laws are intended to preserve our free enterprise system by ensuring that competition is the prime regulator of the economy.
The antitrust laws are complex, wide ranging and subject to changing interpretations. Advice of the Law Department should be obtained whenever a question arises over a contemplated course of action.
Antitrust law compliance is of critical importance. Employees must be familiar with Ecolabs Antitrust Policy and Guide to Compliance with the Antitrust Laws . Violation of these laws can subject Ecolab or individual employees to criminal sanctions, substantial fines and/or imprisonment.
Managers and supervisors are responsible for ensuring that employees under their supervision are aware of and comply with this policy. Knowing violation of, or authorizing or permitting a subordinate to violate, the antitrust will subject you to discipline, including termination, if appropriate.
18
Familiarity with the antitrust laws is not only important for Ecolab salespeople. Many other Ecolab associates are frequently in situations where antitrust considerations come into play. For example, some of us may have close friends who work for competitors, customers or suppliers. No one is asked to give up those relationships. However, a mutual understanding should be reached that there will never be any improper discussion of business matters. Finally, it is important to avoid conduct that could appear to constitute a violation of the law. No matter how innocent a particular act may be, legal difficulties can result if it leads others to believe that a violation has occurred.
United States antitrust laws and/or the laws of other jurisdictions may govern Ecolabs conduct or transactions outside the United States. Consult with the Law Department before engaging in any conduct or transaction outside the United States that is covered by this policy.
19
Each of us, as an employee anywhere in the global operations of Ecolab, will comply with:
Ecolab policies;
The ethical standards of each country in which business is conducted;
All legal requirements of each country in which business is conducted; and
United States laws that apply in other countries.
Compliance with United States Anti-boycott Laws
United States anti-boycott laws and regulations prohibit Ecolab and its subsidiaries and controlled affiliates from refusing to do business with a boycotted country or with any person who has dealt with a boycotted person or country, and require Ecolab to report to the United States government certain boycott requests.
Ecolab subsidiaries and controlled affiliates must comply with United States anti-boycott laws in the conduct of Ecolab business. Neither you nor any agent has the authority to act contrary to this policy or to authorize or condone violations of this policy. No one will provide information, statements, certificates or any other communication that violates United States anti-boycott laws and regulations. Because the boycott laws are very complex, all boycott requests are to be reported immediately to the Law Department.
20
Compliance with Export Control Laws
We will comply with all United States Export Control Laws. These laws restrict sales of many types of technologies, materials or products, originating in the United States, that could have significant military or police end uses. For example, these laws restrict sales to certain countries of technologies, materials and products that could be used in the design, development or production of chemical, biological or nuclear weapons or missile systems. Also, there are controls that impose trade sanctions and prohibit sales to certain named individuals and companies.
These control laws apply to indirect as well as direct export sales. Conversations of a technical nature with a citizen of another country may be considered an export, even when that citizen is in the United States. What international visitors see when they tour United States facilities can be considered an export. If there is any doubt about a pending situation, consult the Law Department.
In addition to complying with United States Export Control Laws, we will comply with applicable export control laws of all countries where business is conducted. For further information, consult the Law Department.
Compliance with Customs Laws and Regulations
We will comply with all customs laws and regulations in all Ecolab business operations. International movement of Ecolab products and materials requires appropriate
21
customs documentation, country-of-origin markings and proper valuation declarations.
No corporate funds or other assets will be paid or furnished, directly or indirectly, to a political party or political candidate or incumbent, unless legally permissible and if approved in writing in advance by the officer in charge of Public Affairs, the General Counsel, and the Controller of Ecolab. No political contribution may be made by you, individually, in the name of Ecolab or any affiliate. Also, you may not be directly or indirectly reimbursed by Ecolab or any affiliate for any political contribution.
We recognize that air, land and water are finite resources and must be used wisely in order to assure their suitability and supply for all users, both present and future. Accordingly, we will adhere to the Ecolab Environmental Principles.
22
We will be honest in performing our employment duties. Committing or contributing to acts of dishonesty against Ecolab, such as fraud, theft, embezzlement or misappropriation of corporate assets, will result in appropriate discipline. In addition, a criminal complaint will be filed against the offending employee when warranted by the evidence, circumstances and Ecolabs interests.
Each of us is responsible for protecting the assets of Ecolab. Assets include Ecolabs investment in trade secrets, technology and other proprietary information, as well as physical property. Managers are responsible for maintaining good controls to protect assets from loss or unauthorized use, or disposition not in accordance with Ecolabs asset disposition policy. Each of us is responsible for assisting in preventing waste and theft and assuring the integrity of the controls.
Protecting Proprietary Information
Confidentiality is required for corporate information regarding Ecolab, its subsidiaries and affiliates. Most of the information to which each of us has access or develops on the job is proprietary. It is Ecolab properly and a valuable business asset. Proprietary information of Ecolab may never be used for personal gain during or after employment with Ecolab.
23
Proper precautions must be taken to protect our proprietary information. Unauthorized disclosure could destroy its value to the Company and give unfair advantage to others. We are all responsible for protecting this information. Disclosure should be limited to those who have a need to know.
Responsibility to keep information confidential continues after separation from employment with Ecolab.
Proprietary information requiring protection includes, without limitation, any information not generally known about Ecolabs business, such as customer and supplier lists, financial data, sales reports, materials developed for in-house use, administrative and manufacturing processes, business plans, pricing strategies and lists, formulae, devices and compilations of information which give the Company a competitive advantage.
Any situation in which Ecolabs proprietary information has or may have been compromised must be reported immediately to the Law Department.
A conflict of interest exists where one or both parties in a relationship receive or give unfair advantage or preferential treatment because of the relationship. If not sure if your relationship with another organization or person conflicts with your job performance or Ecolabs interests, discuss the circumstances with your supervisor. Most potential conflict situations are readily resolved. It is always best to raise your concern.
24
In order to personally accept a gift, favor or entertainment from a customer, supplier, agent, consultant or other person or organization in connection with Ecolab business, a ll of the following criteria must first be met:
The item is consistent with the normal and accepted business ethics of the country in which it is provided;
It does not violate the laws of the United States or the country in which it is provided, or Ecolab policy;
If a gift, it has only nominal value; and if a favor or entertainment, it is reasonable in cost, amount, quantity and frequency, and not excessive;
It cannot, under the surrounding circumstances, be reasonably construed as a bribe, payoff or kickback;
It involves no element of concealment; and
Public disclosure of it would not embarrass Ecolab or damage Ecolabs reputation.
Under no circumstances may an employee accept cash or cash equivalents or personal loans. Also see Entertainment/Gifts and Monetary Payments, page 12.
You may not buy or sell Ecolab stock or other Ecolab securities for your own account or for members of your family while possessing material information about Ecolab
25
which has not been publicly released. You may not buy or sell securities of another company while possessing non- public, material information about that company which is related to an intended action by Ecolab of which you are aware. For example, you may not trade in the stock of a company based on the knowledge that Ecolab will shortly acquire the shares or assets of that company.
Furthermore, such non-public, material information must not be passed along to another person (including other employees, relatives or friends) who has no work- related need to know. A matter or information is material if it is important enough to influence an employee or others in the decision to purchase or sell the stock of Ecolab or any other company with whom Ecolab does business. Failure to observe this prohibition can expose you and Ecolab to civil and criminal penalties.
You may not engage in employment outside Ecolab if such employment competes with Ecolab, provides services or assistance to an Ecolab competitor, or interferes with your assigned duties at Ecolab. Examples of such interference would be the requiring of Ecolab time or facilities to perform the outside employment, or if the outside employment impairs the ability to give full attention to your position with Ecolab during normal working hours.
26
Your Responsibility to Ecolab
Outside Directorships and Investments
If you serve or seek to serve as a director of, or have a business or financial interest in, a firm having current or prospective dealings with Ecolab, you must disclose that fact to your supervisor so that it may be determined whether the situation presents a conflict of interest. This would include, without limitation, a supplier, customer, landlord, tenant or merger/acquisition candidate, or competitor of Ecolab. The business or financial interests of members of your immediate family living with you will also be considered to be your financial interests.
Any subsequent approval to continue or engage in such outside directorship or investment must be made in writing by your supervisor. The ownership of not more than one percent (1%) of a publicly-traded companys securities will be presumed not to be a conflict of interest and need not be disclosed.
Speculation or Competition with Ecolab
You may never take personal advantage of, or make available to others, any business opportunity in which it is known, or could reasonably be known, that Ecolab would be interested in, without advance written approval from your supervisor. The obvious examples are a purchase of real estate or other property, or any interest in a firm, in which Ecolab is known to have an interest in acquiring.
In no event may you deal for your own account in products sold or services performed by Ecolab.
27
Purchases from Employees or Family Members
Purchases by Ecolab from employees, family members, or others with close personal relationships can give rise to conflicts of interest. Except for individuals who will be paid through the Ecolab payroll system, Ecolab will not purchase any goods or services from any employee or close relative of an employee without the prior consent of your supervisor. While not intending to prohibit personal relationships, management is responsible for taking appropriate action, including disciplinary action, to protect the Company when a personal relationship is contrary to the Companys interest.
Your service in government positions is encouraged, but in some cases may present a conflict of interest. If election or appointment to such a position is anticipated, you must request the written approval of your supervisor. If you hold a government office, it is expected that you will abstain from any vote or decision which materially involves the interests of Ecolab.
28
You are responsible for understanding and complying with the Code of Conduct . It is the responsibility of your supervisor to assist you in applying the Code and to be aware of the ethical quality of your business behavior. Managers are also responsible for enforcing the Code within their areas of responsibility.
Written certification concerning Code of Conduct compliance will be periodically required from those employees designated by the Chairman of the Board or the Chief Executive Officer of Ecolab.
Any actual or contemplated conduct which you reasonably believe may constitute a violation of the Code of Conduct must be promptly reported to your supervisor or the General Counsel of Ecolab.
A VERBAL OR WRITTEN REPORT TO YOUR SUPERVISOR OR THE GENERAL COUNSEL IS THE PREFERRED METHOD OF REPORTING VIOLATIONS OR OBTAINING GUIDANCE IN COMPLYING WITH THE CODE OF CONDUCT . IF THIS IS NOT PRACTICAL, SUSPECTED VIOLATIONS CAN BE REPORTED, OR GUIDANCE CAN BE OBTAINED, BY CALLING THE HELPLINE TELEPHONE NUMBER ASSIGNED TO YOUR EMPLOYMENT LOCATION.
Ecolab will investigate possible violations. In doing so, it will respect the rights of all parties concerned. Employees will be expected to cooperate with any investigation. The identity of persons reporting possible violations will be kept confidential unless the Company is required to reveal it in order to enforce the Code , or by applicable law or judicial process.
29
EXHIBIT (99)B
In my role as a Senior Officer or Finance Associate at Ecolab, I have adhered to and advocated to the best of my knowledge and ability the following principles and responsibilities governing professional conduct and ethics:
1. Act with honesty and integrity, avoiding actual or apparent conflicts of interest in personal and professional relationships. A conflict of interest exists when an individuals private interests interfere or conflict in any way (or even appear to interfere or conflict) with the interests of the Company.
2. Provide information that is full, fair, accurate, complete, objective, relevant, timely and understandable, including in and for reports and documents that the Company files with, or submits to, the SEC and other public communications made by the Company.
3. Comply with all applicable laws, rules and regulations of federal, state and local governments, and other appropriate private and public regulatory agencies.
4. Act in good faith, responsibly, with due care, competence and diligence, without misrepresenting material facts or allowing my independent judgement to be subordinated.
5. Respect the confidentiality of information acquired in the course of business except when authorized or otherwise legally obligated to disclose the information. I acknowledge that confidential information acquired in the course of business in not to be used for personal advantage.
6. Proactively promote ethical behavior among my associates at the Company and as a responsible partner with industry peers and associates.
7. Maintain control over and responsibly manage all assets and resources employed or entrusted to me by Ecolab.
8. Adhere to and promote this Code of Ethics.
This Code of Ethics is intended to supplement the Ecolab Code of Conduct and company policies regarding ethical practices in the finance area. All procedures for upholding, enforcing, and complying with the Code of Conduct are also applicable to this Code of Ethics. The Ecolab Law Department should be asked to help interpret or apply this Code as required.